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Abstract
Metabolic engineering exploits microorganisms to build cell factories, allowing to produce
valuable compounds from their enzymatic machinery. It involves the selection of an or-
ganism, along with a set of genetic modifications to optimize the process. Information
regarding biological mechanisms are scattered among the literature. Metabolic databases
provide a centralized platform compiling existing biological data to build a catalog of all
known enzymatic transformations across all domains of life.
The development of genome-scale metabolic models allows to expose all possible bio-
chemical transformations that an organism can offer. Computer algorithms use these mod-
els to exploit the capabilities and limitations of the organisms. Constraint-based modeling
approaches allow to predict phenotype given modifications in the network. In recent years,
there has been a significant increase in the number of available models, and for certain
organisms several models were built. The accuracy of these methods is in many cases
dependent on the quality of these models, that is limited to the available information in
the literature (or databases).
This thesis improves the existing methods by developing better data management
strategies for the metabolic modeling community. Metabolic databases are usually the
input data for many modeling tools, and the quality of solutions depends on the quality
of the databases. Currently, several metabolic databases exist, most of them sharing a
common set of information, and there is a need for a centralized system to take the most
advantage of their content. However, each database adopts its own naming system to
catalog its instances, being in many cases, difficult to compare with others.
vii
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An integration pipeline is here designed to fuse metabolic databases into a common
namespace allowing better analysis of the entire metabolic catalog across several databases,
and exploring different methods to reconcile the metabolites and reactions included in these
databases.
In a second part of this work, the Systems Biology Markup Language which is the most
common medium to store and represent genome-scale metabolic models is analyzed. Like
databases, models also adopt unique nomenclatures for reactions and compounds. Here,
methods to annotate metabolites and reactions in models are developed allowing to connect
models with database instances, thus allowing to adopt a single naming system for their
entities. The purpose of the methods is to standardize the entire model, therefore, other
entities such as, genes, compartments, simulation media, are also considered to unify these
models. The standardization methods were implemented in the KBase platform, which
allows to improve the compatibility of this system with models built from external tools.
In the last part of this thesis, the pathway enumeration problem is revisited. Synthetic
biology explores cellular modifications to produce valuable products by inserting enzymatic
capabilities of other organisms. The selection of suitable set of genes is highly combina-
torial, since in many cases there are several alternatives to reach the target product. A
common limitation of most of the existing methods is the inability to fully explore this
combinatorial space. In this work, the (hyper)graph methods are analyzed and improved
to fully enumerate biological pathways. As result, two existing algorithms were improved
regarding to scalability, allowing to fully enumerate larger solution sets.
Resumo
Um dos objetivos da Engenharia Metabo´lica e´ a s´ıntese de compostos de valor acrescentado
atrave´s de microrganismos. Uma das etapas deste processo envolve a selec¸a˜o de organismos
em combinac¸a˜o com alterac¸o˜es gene´ticas que permitem otimizar este processo. As bases de
dados metabo´licas centralizam os dados biolo´gicos disponibilizando um cata´logo de todo o
conhecimento existente relacionado ao contexto enzima´tico.
A reconstruc¸a˜o de modelos metabo´licos a` escala geno´mica permite estudar os proces-
sos metabo´licos dos diversos organismos. Com o recurso a me´todos computacionais, estes
modelos permitem expor as capacidades e limitac¸o˜es dos diversos organismos. Abordagens
como a modelac¸a˜o baseada em restric¸o˜es permitem prever feno´tipos dadas alterac¸o˜es nas
vias metabo´licas. Nas u´ltimas de´cadas, houve um aumento significativo do nu´mero de
modelos publicados, e para alguns organismos existem va´rias verso˜es dispon´ıveis. A ca-
pacidade de previsa˜o destes modelos esta´ dependente da informac¸a˜o dispon´ıvel nas bases
de dados e na literatura.
Esta tese visa melhorar os me´todos anteriores abordando questo˜es relacionadas com a
integrac¸a˜o de dados. As bases de dados metabo´licas sa˜o geralmente a principal fonte de
informac¸a˜o para os me´todos existentes, implicando diretamente na capacidade de resoluc¸a˜o
destes problemas. Atualmente, existem va´rias bases de dados biolo´gicas, havendo uma
necessidade de desenvolver sistemas centralizados. No entanto, e´ comum estes adotaram
identificares pro´prios, na˜o sendo poss´ıvel executar uma comparac¸a˜o direta. Neste trabalho,
foram desenvolvidas estrate´gias para reconciliar bases de dados no contexto metabo´lico,
permitindo integrar compostos e reac¸o˜es.
ix
xNa segunda parte deste trabalho, este processo de integrac¸a˜o foi expandido para in-
cluir modelos metabo´licos a` escala geno´mica. De forma semelhante a`s bases de dados, os
modelos adotam tambe´m identificadores pro´prios para representar compostos e reac¸o˜es.
Para unificar modelos, foram desenvolvidos me´todos de anotac¸a˜o que permitem relacionar
as instaˆncias dos modelos com as bases de dados. Foram, tambe´m, implementadas es-
trate´gias para identificar genes, compartimentos e as restric¸o˜es da simulac¸a˜o. Neste tra-
balho, os me´todos forma implementados na plataforma KBase, permitindo melhorar a
compatibilidade do sistema com os modelos externos.
Por fim, va´rios me´todos de enumerac¸a˜o de vias metabo´licas foram abordados. A biologia
sinte´tica visa manipular o metabolismo celular para produc¸a˜o de compostos atrave´s da
inserc¸a˜o de genes. A selec¸a˜o destes genes e´ um problema combinato´rio, que, dado um
composto alvo, identifica va´rios conjuntos de genes capazes de concretizar a via sinte´tica.
Neste trabalho, pretende-se melhorar a capacidade de enumerar todas as vias poss´ıveis,
dado um conjunto limitado de reac¸o˜es e o tamanho das vias. Como resultado, foram
melhorados dois me´todos existentes baseados em hipergrafos, melhorando a escalabilidade
destes me´todos permitindo enumerar problemas ou vias de maior dimensa˜o.
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Chapter 1
Introduction
1.1 Context and Motivation
The re-engineering of cells for de novo synthesis of desirable metabolites involves several
steps, from data collection and curation, to optimal strain selection, pathway identification
and analysis of the best solutions.
Research in computational systems biology develops software tools to predict phenotype
responses given environmental and genetic modifications. In the past years, a vast catalog
of Bioinformatics software was developed to fit many topics in this field [21], ranging from
network reconstruction and representation problems to data visualization and metabolic
network analysis. Despite this effort, most topics still present a big challenge to software
development, since the reconstruction, analysis and optimization of large scale metabolic
networks still face many challenges.
Building computer models to predict cellular behavior is extremely data intensive. For
many organisms, the biological mechanisms are inferred from similar species to fill the
knowledge gaps. This makes data integration and analysis an important task to build
more accurate models.
Biological databases compile data from literature and biochemical knowledge, and they
are essential tools for many bioinformatics methods. Each database specializes into a
1
2 CHAPTER 1. INTRODUCTION
specific topic and there is an increasing need to implement methods that allow combining
and integrating distinct sources of data [44].
Because of the massive amount of information and expertise required to model biological
systems, several community collaborations emerged to curate the representation of many
levels of omics data [13]. As an example, the Gene Ontology (GO) was created to design a
standard method to represent cellular mechanisms and functions that in most cases were
defined as textual expressions.
In the software perspective, in the past years, many tools were developed to perform
important tasks related to this research topic. Metabolic Engineering is powered by in
silico analysis and, therefore, there is a demand for specialized integrated development
environments, that still offer a challenge for software engineers [57]. Libraries dedicated to
genome-scale modelling take advantage of the scripting environment of existing technolo-
gies to provide essential methods for analysis. The COnstraint-Based Reconstruction and
Analysis methods [111] COBRA and COBRApy [32] are libraries for MatLab and Python,
which provide many essential methods and tools to conduct constraint-based analysis stud-
ies. Standalone software programs such as OptFlux [107] integrate many techniques to
tackle problems in this field, reducing the learning curve to apply these methods for an
audience with less programming skills.
Advanced computational tools are currently able to identify optimal pathways through
stoichiometric network analysis by either computing algebraically steady states of the sto-
ichiometric network or from graph topological analysis. The computation of steady states
relies on the analysis of the feasible solutions which represent all possible steady state flux
distributions. Extreme Pathways (EP) [8] and Elementary Flux Modes (EFM) [114] both
compute flux vectors through convex analysis [33].
However, the interoperability of these platforms is essential since no platform is capa-
ble to implement all existing methods. The Systems Biology Markup Language [58] was
created to provide a common medium to share cellular models. Because of the flexibility of
the format to cover a variety of fields in systems biology, but also due to the limitations of
the earlier versions of the format, many tools implemented their own methods to represent
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several aspects regarding genome-scale modeling [31, 105].
Several tools were developed for model reconstruction, each adopting a variety of strate-
gies to assemble genome-scale models. Today there are several hundreds of curated models,
and if accounting for automated generated models these numbers go up to many thousands
[89, 84]. Because of compound and reaction aliasing, it is difficult to directly compare mod-
els generated from different tools. It is also difficult to correctly interpret the mathematical
components of the model because of the lack of proper standards [19, 31]. These problems
diminish the re-usability of existing models for future research.
1.2 Objectives
This thesis is dedicated to improve metabolic modeling and pathway optimization ap-
proaches by defining better strategies to manage and integrate their data context.
More specifically, the work will address the following scientific/ technological goals:
1. Integration of metabolic data sources:
Access existing biochemical databases;
Develop unification strategies to generate an unified database;
Implement a pipeline to integrate metabolites and reactions.
2. Standardization of genome-scale metabolic models:
Explore existing methods to represent GSM components in SBML;
Develop standardization strategies to conform genome-scale metabolic models.
Develop a Software tool that is capable to standardize SBML models.
Assess the proposed strategies with existing SBML models.
3. Enumeration synthetic pathways:
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Explore, validate and extend optimization algorithms that allow searching over
metabolic networks for the best routes from sets of source metabolites to target
metabolites.
Validate the solution with a case study.
1.3 Structure of the Thesis
This thesis is divided into five chapters, being their contents described bellow.
In this first chapter, Introduction, we provided a brief introduction of the motivation
and the main goals of this work.
The second chapter, Metabolic Database Integration, introduces several important as-
pects related to databases that are relevant to the metabolic modeling community. The
chapter is dedicated to improve existing methods to unify these databases, by exploring
better approaches and implement a standard pipeline to generate consensus databases.
The third chapter, Standardization of Genome-Scale Models, tackles the genome-scale
model representation by focusing the Systems Biology Markup Language modeling strate-
gies. This chapter explores existing variations to represent these models, and propose
standardization methods to reshape genome-scale metabolic models.
The fourth chapter, Pathway Optimization, explores synthetic pathway optimization
methods. This chapter is dedicated to explore existing alternatives of pathway enumera-
tion.
Lastly, the fifth chapter, Conclusions, presents the main conclusions of the work, also
proposing future research topics.
1.4 Scientific Output
Publications :
Liu, F., Vilac¸a, P., Rocha, I., Rocha, M. (2015). Development and application of effi-
cient pathway enumeration algorithms for metabolic engineering applications. Computer
1.4. SCIENTIFIC OUTPUT 5
Methods and Programs in Biomedicine, 118(2), 134–146.
Liu, F., Rocha, I., Rocha, M. (manuscript in preparation). Automated generation of
integrated metabolic databases.
Liu, F., Faria, J., Henry, C, Rocha, I., Rocha, M. (manuscript in preparation). SBML-
Tools: a KBase module to annotate and standardize SBML models.
(equal contribution) Santos, S., Liu, F., Costa, C., Vilac¸a, P., Rocha, M., Rocha, I.
(manuscript in preparation). MIYeasTK: The Metabolic Integrated Yeast Knowledgebase.
Poster Presentations :
Liu, F., Rocha, I., Rocha, M. (2017). Metabolic integration using graph databases.
Great Lakes Bioinformatics Conference 2017. Chicago, Illinois, USA, May 15-17
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tional Congress of Biochemistry. No. O5/03, Guimara˜es, Portugal, Dec 8-10, 37
(poster) Xavier, J., Liu, F., Ramalho, F., Rocha, I. (2017). Standardization, Com-
pletion and New Predictions of 121 Manually Curated Genome-Scale Prokaryotic Mod-
els. Copenhagen Biosciences Conferences - 11th Conference: Data-Driven Biotechnology,
Bench, Bioreactor and Bedside - Abstract Book. Copenhagen, Denmark, 7-11 May
(oral) Faria, J., Edirisinghe J., Liu, F., Henry C., (2017). Improving automated model
reconstruction. Metabolic Pathway Analysis 2017. Bozeman, Montana, USA, July 24-28,
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J., Gu, T., Zhang, Q., Rocha, I., Henry, C. (2017). Automated pathway curation and
6 CHAPTER 1. INTRODUCTION
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servation. ICSB 2017 - 18th International Conference on Systems Biology. Virginia, USA,
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mated Reconstruction and Comparison of Metabolic Models for Diverse Fungal Genomes.
Metabolic Engineering 12, Munich, Germany, June 24-28.
(submitted for conference) Faria, J., Edirisinghe J., Seaver, S., Liu, F., Weisenhorn,
P., Jeffryes, J., Gu, T., Zhang, Q., Henry, C., (2018). Improving Automated Model Re-
construction across Phylogenetically Diverse Genome-Scale Metabolic Models. Metabolic
Engineering 12, Munich, Germany, June 24-28.
(manuscript in preparation for journal article) Xavier, J., Liu, F., Ramalho, F., Rocha,
I. Standardization, Completion and New Predictions of 121 Manually Curated Genome-
Scale Prokaryotic Models.
Chapter 2
Metabolic Database Integration
Abstract
Metabolic (pathway) databases are catalogs of all known enzymatic biochemistry
found in the literature, describing enzymes in a functional approach rather than just
a descriptive annotation and being used as building blocks for genome-scale metabolic
reconstructions. Currently, there are several metabolic databases, along with many
dedicated to catalog small molecules. To capitalize on this ecosystem of databases,
it is desirable to have a unified catalog.
In this work, a comprehensive analysis of several of the most popular metabolic
databases is conducted, to study their degree of heterogeneity and propose approaches
to generate an unified catalog. An integration system is implemented that is capable
of generating on-demand, and in a fully automated way, an integrated database of
reactions and metabolites from several sources. A graph database is used to store
the raw entities, which proven to facilitate the analysis of the integration of the data
sources. The proposed methods for entity resolution allows users to configure the
certainty level of the automated merges of duplicates in the data sources.
The pipeline is tested to generate an integrated database, and it is compared against
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a manually curated set, but also with the integrated database MetaNetX to assess
its performance. The unified database created by this work can be explored with a
web application.
2.1 Introduction
Computer-aided design in the biological field is a highly data oriented exercise. Arguably,
this is one of the leading causes of the growth of bioinformatics data every year. The
increase of the computational power and the development of better omics methods and
technologies led to a significant increase of the number of databases, and their size each
year. The better support for crowd sourcing protocols also promoted the data boost in
biological repositories.
Metabolic databases are no exception, and currently there are hundreds of databases
for small molecules and biological pathways, increasing substantially in the last decades.
This phenomenon was already defined as a ”loose federation of bio-nations” [43]. One of
the reasons for the proliferation of biological resources is the inability for users to con-
tribute or reshape existing data repositories, which in several situations forced researchers
to develop their own alternative databases to fit their needs. A related reason is the need
for specialized repositories for specific topics [64, 118] (e.g., a disease, a organism, a class
of chemical compounds), where replicates of existing databases to reshape the logic for
a specific topic may allow a better understanding of the data. Lastly, the publication of
repositories is a method to gain reputation in a particular research field.
The increase of biological databases enriches the community, but may also pollute the
existing data ecosystem. Multiple chain references between databases may cause error
propagation, but also independent systems have different update cycles and maintenance
frequencies, which may cause inconsistencies (e.g., incoherent information, dead references,
etc). In general, this requires added human effort to keep all the databases updated and
clean. Indeed, information management became a relevant topic in science, engineering,
and biomedical fields [30].
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A common problem of biological databases is the high redundancy between data. Each
database adopts its own identifiers, making difficult to detect the unique instances, but also
to merge or translate duplicate information between databases. The advantage of having a
rich global data pool is diminished, because of the lack of interoperability between distinct
resources, making the effort to unify systems in many cases not affordable or justified.
Existing integrated solutions for metabolic databases address this problem by offering
access to a unified reference space of biochemical databases. Tools such as the Chemi-
cal Translation Service [125] or UniChem [17] offer a web service that allows to convert
among different database identifiers or from those into molecular properties (e.g., names,
structures, etc). The other approach is to materialize the unified space into a consen-
sus database [9, 74]. In this case, a new database is generated from existing metabolic
resources, providing an integrated repository.
The BKM-react [76] (now the BKMS-react) is a reconciliation that integrated the
BRENDA with KEGG and MetaCyc (later with the addition of SABIO-RK). The in-
tegration is limited to reactions only.
The MetRxn database [74] provides an integrated resource of KEGG, MetaCyc, BRE-
ANDA and Reactome plus several genome scale models into a unified dataset. The
database was built because of the need of an integrated biochemistry set for quality model
reconstruction. It includes 90 genome-scale models along with the metabolic databases.
With an identical purpose of the MetRxn, the ModelSEED [54] was created for the
purpose of genome-scale model reconstruction applications. It serves as a base biochemistry
set for automated scaffold of metabolic reconstructions. It initially was based on the KEGG
database merged with 13 published models, and later updated with the MetaCyc.
The MetaNetX/MNXRef [9, 90] is the largest integration currently available, integrat-
ing more than a hundred thousand compounds of a wide range of databases, including
all of the previously mentioned. The first version of the database unified 11 databases
(KEGG, MetaCyc, ChEBI, ModelSEED, etc), and several new resources were added since,
while also some of the old discontinued databases were discarded.
Automated integration is subject to errors, and in many cases this is inevitable since
10 CHAPTER 2. METABOLIC DATABASE INTEGRATION
these problems are caused by inconsistent information from the sources. No software tools
are provided to rebuild these databases, and the responsibility to update these integrations
is given to their owners.
This work explores metabolic database integration methods, being current implementa-
tions revised to understand the state of the art of data integration regarding the metabolic
universe.
A survey of several popular databases of small molecules and biological pathways is
conducted to assess their data content and their architecture for unification purposes.
Alternative methods are proposed to design an integration pipeline capable of generating
an integrated reference space of metabolic databases.
We propose several integration rules that include both positive and negative rules to
allow fine tunning the integration approaches. Each of these rules targets metabolites
that shares common properties (e.g., chemical formula, structure, name, etc) allowing to
match for both positive and negative similarity. All rules are weighted, allowing users to
customize their impact in the integration.
To assemble an integrated unified metabolic database, a framework is developed to
conduct all the necessary steps from data extraction up to entity resolution methods. The
framework is used to generate an integrated database of KEGG, MetaCyc and BiGG, and
it is compared against the latest reference space of the MetaNetX integrated database. To
benchmark the result an extensive manually curated dataset is used to compare with the
solution provided by this work and MetaNetX. The generated approach obtained a decrease
of 50% on false positives, with a cost of increasing 11% the number of false negatives.
The pipeline is distributed in a Docker container, with all required source code and
dependencies 1, allowing users to assemble integrated databases, but also programmatically
extensible to other data sources that were not included in this study.
A dedicated web application was created to explore the integrated solution, it provides
a standalone database (https://fxe.github.io/biodb/) for publishing and curation.
1GitHub repository: https://github.com/Fxe/biosynth-framework
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(a) D-Glucose (b) alpha-D-Glucose (c) beta-D-Glucose
Figure 2.1: Glucose structures. The connectivity layer includes atoms and bond valence,
the stereo layer adds additional spatial arrangement in a 3D space.
2.2 Molecules, Biochemistry and Databases
2.2.1 Representing Compounds
In a metabolic engineering perspective, in many publications, a compound, molecule or
metabolite have the same meaning, since they all refer to small molecules, most of them
organic since they are participants of cellular metabolism. Thus, they will be treated as a
single concept in the following text and in this work. A chemical molecule, as a computer
representation, is a simple undirected graph where vertices are atoms and edges are the
chemical bonds (Figure 2.1a). Although, for both vertices and edges they must be labeled
to define the atom type and the bond type.
However, not all molecules are flat (Figure 2.1), being the geometry of a compound
defined by its stereochemistry. In the figure, solid or dashed wedge are used to represent
atoms below or above the plane.
Also not all molecules are fully defined in computational representations. The R-groups
or ”Markush” structures (Figure 2.2a) are undefined groups to represent abstract struc-
tures. The use of R-groups to define incomplete molecules allows to create molecular hierar-
chies to group compounds into categories (Figure 2.2). As an example, the generic alcohol
(Figure 2.2a) is a substructure for alcohol molecules (i.e., ethanol, methanol, propanol,
butanol, etc), but also a substructure for many other structures where it fits.
In some cases, the R-group is a generic placeholder for a family of molecules. The DNA
12 CHAPTER 2. METABOLIC DATABASE INTEGRATION
(a) An Alcohol. (b) A short-chain primary al-
cohol.
(c) Butanol.
Figure 2.2: R-groups may define subclass of molecules. SMILES representation: a) - O[R],
b) - OC[R], c) - OCCCC. a), b), c) are sub instances with the following substitutions: a)
[R]→C[R]−−−−−→ b), b) [R]→CCC−−−−−−→ c)
is an example (Figure 2.3a) that contains placeholders for cytosine, thymine, adenine and
guanine molecules in its chains.
In general, the R-group allows to define a variable part of the structure. But not
all R-groups are used to define a small molecule. The acyl carrier protein is an important
component in the fatty acid biosynthesis, in its attached to a substrate form, the acyl carrier
protein is represented by the R-group (Figure 2.3b) since its structure is non definable, but
in this case the R-group is specific to the protein.
Polymers are represented by a repeating unit, that encloses a structure region marked
as variable, allowing to define a range of structures over the repeats. As an example, the
DNA molecule (Figure 2.3a) is also a polymer that repeats the center unit, each connecting
to an R-group to define variable nucleotide. The size of the polymer in some molecules
is also defined (Figure 2.4). This simplifies the visualization, as in certain scenarios these
could be very long molecules.
Given this diversity, there are several exchange formats for the representation of chem-
ical molecules. Some formats are capable to define most of the chemical properties, while
others are limited to some properties or can only represent sub-sets of defined molecules.
Since the basic structure of a molecule can be a single graph that connects atoms to each
other, connection tables are simple exchange formats that describe the molecule by listing
all connections between the atoms and their properties. The Mol file is a popular format
based on connection tables. It separates atoms and bonds in different blocks, each with
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(a) A single stranded DNA molecule. (b) Malonyl-ACP
Figure 2.3: a) A single stranded DNA molecule. Contains one repeating unit at the center,
with several R-groups (nucleotides). b) Malonic acid attached to acyl carrier protein.
(a) Defined polymer with 7 repeating units.
(b) The exact representation of the structure.
Figure 2.4: Defined polymer representation and its extended version.
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extra columns to define the atom and bond type, but also other chemical properties of the
atoms (e.g., charged atoms) and bonds (e.g., sterochemistry). The Mol tables also define
atom coordinates, allowing to store the relative position of the atoms for rendering tools
to draw molecules. The lack of coordinates would require the use of layout algorithms. For
complex molecules most of the layout algorithms fail to properly shape the spatial location
of the atoms.
The Chemical Markup Language (CML) is an XML based markup language to exchange
compounds. It is more human readable since all attributes are enclosed within tags and
it provides many options to store metadata (e.g., titles, comments, text formatting), but
also other relevant chemical properties such as spectral data.
A limitation of connection tables is the searching capability, since they are bulky, but
also not practical to share or for human interpretation.
The line notation formats are methods to represent compounds in a single string line.
This allows for an easier display, limited readability, and for searching purposes.
The InChI [53] string starts with the ”InChI=” prefix, followed by the version number.
Then it contains six layers separated by the symbol ”/” as separator (main / charge /
stereochemical / isotopic / fixed-h / reconnected layers).
Because of the detail of the InChI, the size of the string can go up to more than 500
characters, and the string uses a lot of numbers and symbols, in which are unfriendly to
search engines. To address this problem the InChIKey was created. The InChIKey is a
fixed 27 character string, that is generated from a InChI by using an hashing algorithm
function (the SHA-256) of the InChI string [122]. This string is just used for searching and
indexing purposes, since there is a collision probability, even though it is quite low.
The InChIKey also allows to rapidly compare two molecules in three distinct levels.
The string contains three blocks that are hashed from the connectivity, stereochemistry
and protonation layers. The first block is the connectivity layer, a mismatch implies that
two molecules have a different skeleton. The second block is the stereochemistry, two
InChIKey’s with identical first block, but with a distinct second block would imply different
stereochemistry. The last block is a single character that matches the protonation: the N
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character is used for the neutral state, then it moves backwards (M, L, K, etc) or forward
(O, P, Q, etc) up until twelve letters to define less or more protons. For a value higher or
lower than twelve protons the A character is used.
Since the InChIKey is an hash equality, it does not mean the original InChI is equal,
and neither can it be recovered from the InChIKey.
The Simplified Molecular Input Line Entry System (SMILES) [123] representation was
created in 1986 at the US Environmental Research Laboratory and later developed and
maintained by Daylight Chemical Information Systems, Inc 2. A community effort was
created to give an official definition of the SMILES known as OpenSMILES [94]. The
SMILES string allows simple definition of chemical structures by computing a spanning
tree over the structure graph, which only stores atoms and bond types. An advantage of
the SMILES format is human readability, while the major drawback is the non canonical
representation of molecules [92].
Both InChI and SMILES require auxiliary files or rendering algorithms to generate
atom coordinates to draw the molecules.
2.2.2 Representing Reactions
The representation of reactions is far more simple compared to the molecules. The common
method to define a reaction is just to describe its stoichiometry. While the molecular
structure describes the identity of a molecule, the identity of a reaction is defined by two
sets of compounds to describe the reactants and the products. The detailed reaction action
is described by the bond formation between the reactants and products.
The SMIRKS representation is an exchange format based on SMILES to describe re-
action transformations. It allows to encode the transformation between the reactants and
the products.
Some aspects may compromise the identity of a reaction. The protonation state of
the compounds, which may imply adding or removing proton molecules to balance the
2http://www.daylight.com/smiles/index.html
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KEGG Reaction: 2.7.1.40 (R00200)
ATP + Pyruvate←−→ ADP + Phosphoenolpyruvate
MetaCyc Reaction: 2.7.1.40 (PEPDEPHOS-RXN)
ATP + Pyruvate←−− ADP + Phosphoenolpyruvate + H+
MetaCyc Reaction: 1.10.3.14 (RXN0-5266)
O2 + 4 H
+ + 2 an ubiquinolmembrane −−→ 2 a ubiquinonemembrane + 2 H2O + 4 H+periplasm
KEGG Reaction: 2.7.7.7 (R00375)
dATP + DNA −−→ Diphosphate + DNA
Figure 2.5: The same reaction may have addition of protons due to the protonation state
of the participating compounds. Reactions may have the same compound in both sides of
the equation due to transport mechanisms. Polymerization reactions may have the same
compound in both sides, but representing different polymer units.
stoichiometry, makes the same reaction different in two different conditions.
Lumped reactions are used in some cases where the intermediates of a bioconversion are
not known (or not interesting for a given purpose). In these cases, a single reaction may be
used to summarize the entire set of conversions into a single reaction. Generic or abstract
compounds may describe abstract reactions, that represent combinations of biochemical
transformations between the family of the abstract compounds. Unlike metabolites, in a
biological perspective, the main interest to catalog reactions is also to associate them with
biological enzymes.
The reactions can be either metabolic or transporters (Figure 2.5). A transport reaction
moves a metabolite between cellular spaces (compartments) or onto the outside of the cell,
while metabolic reactions are other biochemical transformations. This characterization
is not that simple since some metabolic reactions may involve transferring a compound
between one cellular membrane to another or performing metabolism in two distinct cellular
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locations (i.e., mitochondria and cytoplasm).
In metabolic databases, most reactions are metabolic, since they represent the reaction
action of the enzymes not their actual activity within the cells since these can vary between
organisms. Therefore, in many cases the compartment of a transport reaction is an abstract
representation (such as inside/outside that can be either related to the cell it self or to an
organelle, e.g., mitochondria).
Another important aspect are the polymer compounds that were described earlier, since
a polymerization reaction may contain the same compound in both sides of the equation.
Here, we define basic reactions as those that have non repeated compounds in both sides
of the equation. These reactions represent most of the biochemistry in databases. For
modeling purposes, in the next chapter, additional reaction classifications are specified.
2.2.3 Biochemical Databases
Currently, the database list from the Nucleic Acid Research journal contains 36 active
databases for metabolic pathways, 21 of small molecules and 14 carbohydrates databases3,
while some of the databases share more than one category. These numbers are quite high.
For the purposes of metabolic engineering, the pathway and organisms databases are
the ones of higher interest since these organize information around biological entities, con-
necting biochemistry to organisms. Other databases specialized for certain metabolites are
relevant to provide finer detail about the chemical attributes of molecules.
The Kyoto Encyclopedia of Genes and Genomes [63] (KEGG) and MetaCyc are both
metabolic and genomic databases since they provide detailed information about metabolic
pathways of organisms.
KEGG is sub divided into several databases that are connected to each other, each
of these specialized into a specific topic. The KEGG LIGAND collection contains the
databases KEGG COMPOUND, GLYCAN, REACTION, RPAIR, RCLASS and ENZYME.
3Nucleic Acid Research journal database catalog: http://www.oxfordjournals.org/nar/database/
cap/
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These databases define the general biochemistry of metabolic enzymes. The KEGG COM-
POUND contains most of the small molecules that participate in the KEGG REACTION
database, a few specialized carbohydrate reactions use the KEGG GLYCAN molecules.
There is few redundancy between these databases.
The KEGG MEDICUS contains a set of databases oriented to health and pharma-
ceutical data. The KEGG DRUG database is a compound database specialized for drug
products in Japan, USA and Europe.
MetaCyc [16] is a database from the BioCyc consortium, where unlike KEGG, the
databases are specialized for a particular organisms (e.g., EcoCyc - Escherichia coli, Yeast-
Cyc - Saccharomyces cerevisiae, HumanCyc - Homo sapiens). MetaCyc is a generic
database that contains metabolic information adapted to all biological domains.
The Biochemical, Genetic and Genomic (BiGG) knowledge base provides pathway infor-
mation based on genome-scale metabolic models. The first version of BiGG (now referred
as BiGG1) was published in 2011.
The SEED platform [7] is a model reconstruction tool that allows to easily scaffold
genome-scale metabolic models from organisms complete genome, but it requires a library
of chemical reactions such as KEGG to assemble the network. This led the creation of
the ModelSEED database that is built based on a integration of KEGG, MetaCyc, BiGG
(version 1) additionally with a few genome scale models. The main purpose of the Mod-
elSEED database is to provide a dedicated resource for genome-scale metabolic model
reconstruction.
The BiGG and ModelSEED databases are both oriented for genome-scale metabolic
modeling, since both databases contain information for cellular compartments in the stoi-
chiometry of the reactions, transporter reactions and references to other models.
The Chemical Entities of Biological Interest [47] (ChEBI) contains many thousands
of detailed and curated chemical compounds with a chemical ontology, which later was
aligned with the Open Biomedical Ontologies (OBO) and Gene Ontology (GO) classifiers.
The purpose GO terms is to align gene function to a standard framework allowing cross
references between databases.
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The LIPID MAPS Structure Database [118] is a database dedicated to lipid structures.
Its motivation is to provide proper representation of lipids. Since lipids may have several
long carbon chains, it makes difficult for algorithms to draw a proper chemical represen-
tation. The database also implements a lipid classification system that splits the com-
pounds into eight groups (fatty acyls, glycerolipids, glycerophospholipids, sphingolipids,
sterol lipids, prenol lipids, saccha- rolipids and polyketides). The database contains over
10,000 lipids and with their complete chemical representation.
The Human Metabolome Database [124] (HMDB) and the Yeast Metabolome Database
[61] (YMDB) are dedicated databases to the metabolome of the human body and the
baker’s yeast (Saccharomyces cerevisiae), respectively. HMDB contains more than 40,000
metabolites since it catalogs every known compound that can be found in the human
body. The main purpose of the database is to provide spectroscopic information about
these metabolites for metabolomics studies.
The endless number of biochemical databases provides a rich pool of knowledge to study
biological pathways, however the information is scattered between databases and exploring
every source is unpractical and time consuming. In this study, the most relevant databases
regarding to metabolic modeling are taken into account (Table 2.1). The mechanisms of
data access are covered in the implementation section.
2.3 Integration System Design
2.3.1 Introduction
The integration of data has been motivated by the need to provide a centralized unified
access to view multiple data sources, such as enterprise information systems, that enables
the integration and analysis of business processes, usually with the purpose to support
business intelligence for decision making.
The data integration process can be defined by four tasks: data understanding, stan-
dardization, specification and execution [45]. To study the data sources is the first task
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Table 2.1: Summary of databases related to biological compounds and reactions. M -
Contains metabolites. R - Contains reactions. ? - included in this study.
Database URL Data Type
KEGG ? www.genome.jp/kegg All domains of life M, R
MetaCyc ? metacyc.org All domains of life M, R
ChEBI www.ebi.ac.uk/chebi Biological Compounds M
LipidMAPS ? www.lipidmaps.org Lipids M
HMDB ? www.hmdb.ca Human Metabolome M
YMDB www.ymdb.ca Yeast Metabolome M
BiGG1 ? bigg1.ucsd.edu Genome-Scale Models M, R
BiGG ? bigg.ucsd.edu Genome-Scale Models M, R
ModelSEED ? modelseed.org Integrated M, R
MetRxn metrxn.che.psu.edu Integrated M, R
MNXRef ? www.metanetx.org Integrated M, R
BKM-react bkm-react.tu-bs.de Integrated R
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for data integration. The data profiling exercise involves the discovery and extraction of
the shape and meaning of the data [91]. Heterogeneous data sources may share identical
attributes, but they may also have different meanings.
Also, it is necessary to capture the data types and missing values. The identification
of classes is an important step to understand the type of objects of each resource and
their hierarchy. Given the previously mentioned resources, some of their attributes may
be common to all.
The design of an integrated schema allows to decide how to represent the data sources
in an unified view. This requires the identification of the standard representation methods
and which attributes to include or transform for the standard representation format.
Data warehouses are databases that usually consolidate distinct heterogeneous data
sources into a single unified schema. These tasks are done with the aid of an Extract-
Transform-Load (ETL) tool to populate the system. ETL tools usually consist of a set
of program scripts that perform tasks to reshape information from several sources into
the data warehouse. These tools are not exclusive to tasks related to data cleansing and
conformity, but they also include other relevant mechanisms related to data maintenance,
such as reporting and scheduling for periodic refresh of the information.
An alternative to this approach is to create virtual data systems. Usually, this is done
by implementing a query mediator system, which translates user queries to source queries.
This allows to assemble an integrated view without the requirement to materialize data.
Other systems use a middleware to translate messages through the third party data
sources, or just to perform routing (if all systems use same protocol).
A common problem to all of the mentioned approaches is the schema and system
heterogeneity. These implementation approaches only solve technical and architectural
problems regarding performance, maintenance and flexibility of these systems, while data
conformity must be unavoidably dealt with domain specific human expertise. Thus, the
domain of the information system has a huge impact in the design of the integration
methods.
The proposed integration system follows the data warehousing approach, since the
22 CHAPTER 2. METABOLIC DATABASE INTEGRATION
Data Acquisition Subsystem
Knowledge Subsystem Integration Subsystem
Extract Transform LoadClean
Metabolite
Integration
Reaction
IntegrationCheminformatics Curation
Reporting Subsystem
API
Central Data
Storage
✓

Figure 2.6: Integration system overview. All modules operate with the central storage
unit.
purpose of the system is to be capable of generating an integrated catalog of biochemical
molecules and reactions. To build an integrated knowledge base of biochemical reactions,
an integration system is designed to be able to perform several necessary tasks.
The design of the system contains four subsystems: Data Acquisition, Knowledge,
Integration and Reporting (Figure 2.6). The core component is the central data storage
(CDS) module. The CDS stores all data collected from the source databases. Data in the
CDS are subject to cleansing and conforming processes, but no entity resolution is applied
since the main purpose of the CDS is to catalog all records of the source in a common data
space.
The data acquisition subsystem is a pipeline composed of several modules that execute
the extract, translate, load (ETL) tasks to shape data to the standards of the CDS. It is
the entry point of all data in the CDS.
The knowledge subsystem is responsible for the additional manipulation of existing
data in the CDS. As a general policy, information stored from the ETL process can not be
changed, but noisy or bad records can be flagged. This allows to track issues from source
databases, but also to execute cleaning and fixing tasks.
The reporting subsystem generates several types of reports, which allow to track the
content of the CDS. Finally, the integration subsystem provides the entity resolution meth-
ods to identify duplicates in the CDS. Their subsystems are covered in the following sec-
tions.
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2.3.2 A Generic Metabolic Repository
In this section several rules are defined to build the CDS module to be flexible but con-
sistent. The database should be able to accommodate new domains in the future, and be
able to host different shapes of instances, not limited to metabolites or reactions, but to
be expanded, for instance to genes, genomes and proteins.
Before describing the database rules, a general definition of the symbols that will be
used is provided:
Calligraphy typing M,R, E Special Sets
Capital letters M,R, S Sets
Lowercase letters m, r, e, o Variables or Objects
The square brackets 〈a, b, c, d〉 are used to define ordered tuples, while parenthesis
(a, b, c, d) represent the unordered tuples. The pin function returns the n-th element of
an ordered tuple. A dictionary (with function) is defined by {}. As an example, given a
dictionary dict = {attr : value}, then the key value pair is addressed as dict[attr] = value.
The {} is also used as the set builder notation (e.g., {x | x > 0}).
For simplification purposes the special sets are also used as functions, as an example
given a graph defined by G = 〈V , E〉, then V(G) is read as the V set of the G tuple (in this
case, V(G) = pi0(G)).
The top level of the database is defined by the set of namespaces. Every object in
the system must belong to a unique namespace, which is defined within the N domain
(Example 1), where N is the set of all namespaces.
Example 1. Namespaces
Consider a system that defines objects of two distinct databases (Database1, Database2)
having two types of properties (Formula, InChI). Then N = (Database1, Database2,
Formula, InChI) would be the namespace domain of the system. No other properties or
database namespaces may be present in this system.
The namespace is an abstract label that groups sets of objects in the database. An
object (Definition 1) in the database can represent any entity of interest. Each object must
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belong to a single namespace, although objects can be replicated into different namespaces,
for instance to spawn different versions of the same database.
Definition 1. Object
An object is an ordered tuple o = 〈id, n, a〉, such that n ∈ N , id is a string identifier, a
is a set of arbitrary attributes of o.
The object represents an entity, that can be either a metabolite or a reaction, but also
properties such as a formula or an InChI (Example 1). The meaning of the object is given
by the namespace that it belongs to. The set V is the set of all objects in the system.
A relationship (Definition 2) is an edge between two distinct objects.
Definition 2. Relationship
A relationship is a directed edge represented by an ordered tuple e = 〈o1, o2, t, a〉, such
that o1, o2 ∈ V × V , o1 6= o2, t is the type of the relationship, and a is a set of arbitrary
attributes of e.
The interaction e between two objects is defined by t(e) = pi3(e), where t is the type
of the interaction, such as an ownership (e.g, has formula, has inchi, etc), a relationship
(e.g, has crossreference to, instance of, etc), etc. As an example, the ownership of ob to oa
is defined as ea,b = 〈oa, ob, has an, {}〉. For simplification purposes, t and a are omitted
when not relevant (ea,b = 〈oa, ob〉).
Together, all objects and edges assemble an universal graph G (Definition 3), which is
the universal database for metabolites and reactions.
Definition 3. Universal Graph
Let V be the set of all objects, E the set of all edges, the universal graph G is defined as
G = 〈V , E〉
Duplicate identifiers can coexist in different namespaces (Definition 4), while objects
within the same namespace are not allowed to share the same identifier. Therefore, the
unique identifier is the pair 〈id, namespace〉 composed by an identifier and a namespace
(Example 2).
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Definition 4. Uniqueness
Let oa, ob ∈ V, such that, oa = 〈ida, na, attra〉 and ob = 〈idb, nb, attrb〉, then oa = ob if
and only if, ida = idb ∧ na = nb.
Example 2. Unique Objects
Given two objects o1 = 〈12345, PubChem, {}〉 and o2 = 〈12345, ChEBI, {}〉 although
they have the same identifier 12345, they are distinct objects since PubChem 6= ChEBI.
Instances in the database can be defined as a proxy. The function proxy : o→ Boolean
defines if an object is a proxy. Proxies are maybe objects that mark temporary placeholders
for future instances, since they may exist or not. They are essential to deal with database
referencing, since many databases reference others, but the actual information about the
references is only revealed if they are loaded afterwards from the original source. In some
cases, it is also possible that, for certain references, the referenced records may not exist
due to update cycles or referencing errors.
The universal graph G is actually a set of subgraphs, such that each defines a specific
domain of instances (i.e., metabolites, reactions). The metabolite graph Gm (Definition 5)
is the subgraph that defines the entire metabolite domain.
Definition 5. Metabolite Graph
LetM⊆ V ,Pm ⊆ V and Em ⊆ E, the metabolite graph is defined as Gm = 〈M∪Pm, Em〉.
The subgraph Gm defines all objects that represent metabolite instances M and their
property instances Pm together with their relationships Em.
The graph Gm is not bipartite since cross-referencing is represented by edges that con-
nect two metabolites. Properties p ∈ Pm also are allowed to be connected to each other
to define relevant relationships between biochemical properties (e.g, equivalent structure
formats).
A reaction entity works the same as the metabolite as they also must belong to a unique
namespace. The stoichiometry of the reaction is defined by having an edge between the
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reaction object and the metabolite object (Example 3) and the value is assigned in the
attributes of the edge.
Example 3. Stoichiometry
Let r be a reaction with the following stoichiometry a+ b −→ 2 c.
The stoichiometry would be defined with 3 edges ea = 〈r, a, left, {value : 1}〉, eb =
〈r, b, left, {value : 1}〉, ec = 〈r, c, right, {value : 2}〉
The reaction graph Gr (Definition 6) is the subgraph that defines the reaction’s domain.
Definition 6. Reaction Graph
Let M,R,Pr ⊆ V and Er ⊆ E, the reaction graph is defined as Gr = 〈M∪R∪Pr, Er〉.
Like in Gm, R is the set of all reaction objects and their properties Pr. The relationship
between M,R,Pr is defined in Er.
The subgraphs Gm and Gr together make the universal graph G, where V =M∪R ∪
Pm ∪ Pr and E = Em ∪ Er.
The universal graph G can be easily expanded to other domains of objects. In the
next chapter, the metabolic models will be introduced in the system, but also for future
reference, additional logical domains can be added such as genes and taxonomy.
2.3.3 Data Acquisition
The data acquisition subsystem is perhaps the bottleneck for expanding the integration
database, since each external resource requires dedicated methods to extract relevant in-
formation. The study and understanding of the domain logic of external databases is also
a manual and time consuming process because of schema heterogeneity.
In addition to these issues, another problem that integration systems have to tackle is
the syntactical heterogeneity of the third-party resources. Terms may have different names
in each of the external resource and it is important to capture which distinct terms are
synonyms and which equal terms are actually non-equal.
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The ETL pipeline requires three components, that two are specific for each individual
data source to be included in the CDS. The extract component is responsible to list and
pull instances from the data source. This depends on the physical location of the data, be
either local files or web API’s.
The transform component is responsible for transforming the extracted object into a
graph. At this stage, the object must conform to the standards of the CDS, which implies
the addition of the namespace tag and dissecting the properties into graph vertices.
Finally, the load component merges the extracted graph with the universal graph
database. This step is generic since all objects are already reshaped to fit the CDS rules.
Extract. Third-party data systems have their own specific methods and rules to access
the database information. The extraction phase is responsible for querying these systems.
External sources can be any stream of information, such as local files, web interfaces,
database systems, etc. For each external resource, it is necessary to develop or integrate
an extraction component.
The extraction component is responsible for two important functions: list and fetch the
records. The list function is responsible for returning a set of unique identifiers, which must
be valid for the fetch operation to pull from the database. The fetch operation produces
a raw entity e, that at this stage does not need to obey any rules of the integrated data
storage.
Transform. The transform function T : e → G ′ maps native e instances into graph
objects G ′ . Entities from the extract phase are transformed into a graph G ′ = 〈V ′, E ′〉.
The graph G ′ is usually star shaped, containing entities and properties objects with their
respective relationship edges.
Usually a single o ∈ V is non proxy (the entity itself) while the remaining are proxy
entities corresponding to the references of the extracted entity e.
The transform function is responsible for giving the namespace to each o ∈ V ′. This
would allow later to detect if these objects are already present in the CDS.
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Cleanse. Minor corrections are performed to conform a few of the properties. This
includes the translation of a few names, such as databases names (deduced from the initial
profiling step) into a controlled vocabulary that is in conformity with the global schema.
Chemical formulas are also corrected to a standard representation to avoid duplicates. It
is common that in a few cases the system is unable to translate or read properties because
of bad or invalid representation. In these scenarios, a warning is issued and logged, while
no correction is performed. Instances of each resource are reshaped to graph structures.
The properties of interest are translated into edge semantics.
However, the presence of resource specific attributes is also found in several of these
databases. The question is whether these attributes plays a significant role in the integra-
tion of the instances. As an example, the KEGG Ligand Compound database is referred
using distinct names in other resources, such as LIGAND-CPD or KEGG COMPOUND
accession in MetaCyc and ChEBI respectively. This problem also applies to attributes
and other properties. The understanding of third party domains is crucial to avoid future
problems that may compromise the integrity of the system, although later it is still possible
to fix and fuse the redundant classes. Another purpose of this task is to decide whether to
include the data source or to discard it in the system.
Load. Loading instances to the CDS is done by merging the G ′ = 〈V ′, E ′〉 from T with
the main graph G = 〈V , E〉. New objects are transfered to the graph, while for objects
present in both V ′ and V , the attributes of o ∈ V ′ are transferred to the previous instance
in V only if o is not a proxy. Then, the new edges in E ′ are all transferred to E .
2.3.4 Knowledge expansion
The cheminformatics module belongs to the knowledge subsystem, being an optional step
after the ETL pipeline and before the integration methods. The purpose of this module is
to apply computational methods to analyze and generate additional chemical data, such as
equivalent structures to exploit the interchangeability of chemical exchange formats [93].
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By generating alternative chemical representations from the existing metabolite prop-
erties, it allows to fill missing equivalent representations, but also to add relationships
between metabolite properties (e.g., a formula that is related to an InChI). It also allows
to perform structural validation between the structures annotated in the molecules, since
given a set of properties of a molecule, it is expected that they are related to each other.
The interchangeability of exchange formats is not always bidirectional. For instance,
an InChI is usually convertible to a SMILES representation, but not all SMILES may be
converted into an InChI. As an example, the generic R-groups are not supported by the
InChI representation, but are allowed in SMILES.
Due to the non canonical representation of the SMILES, an additional standardization
of SMILES structures is advised. The universal SMILES method [92] takes advantage of
the InChI canonization strategy to generate canonical SMILES. If a SMILES transforms
to itself, from the canonization method, it is considered universal.
The names of chemical compounds are usually referred in the literature as weak descrip-
tors to identify molecules, due to the ambiguity caused by the several synonyms. Structure
to name conversion is possible using the IUPAC naming system that allows to name or-
ganic molecules following the same philosophy of the InChI structure. The purpose of this
method is to implement a canonical name generating strategy, following the InChI princi-
ples. The name to structure methods allow to convert chemical names into structures by
using a controlled vocabulary, allowing to connect or generate their hypothetical structure.
Other properties, such as formula and InChIKey are also generated from the molecu-
lar structure. While they are unable to give the structural identity of a molecule, these
properties provide comparison methods to assess the similarity confidence.
The InChIKey hashes the InChI layers into three distinct blocks: the first includes
atomic content and the connectivity layer, while the second hash block is related to the
stereochemistry layer, and the last block is a single character, where N (neutral) stands for
the neutrally charged molecule and by increasing and decreasing the charge, the character
changes. Molecules with equal connectivity will share the first hash block, allowing for easy
comparison and grouping of compounds with similar connectivity or protonation states
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InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m1/s1
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Figure 2.7: Lactate stereoisomers chemical properties and their relationships. Properties
are connected to each other based on the output of the cheminformatics tools.
(Figure 2.7).
For integration purposes, the main properties are the universal SMILES, InChI for
identity purposes, while InChIKey and chemical formulas are valuable for match confidence.
The expanding process is iterated and stops when every possible property is generated
and connected to related properties. The terminal properties are all of the properties
(Table 2.2) that are only generated (i.e., chemical formula, InChIKey), being the order to
scaffold additional properties as follows: Mol Format; Name; SMILES; InChI.
From a structural point of view, the chemical structure dictates the identity of a
molecule. A clustering of the properties allows to detect inconsistencies in the database
instances. In general, a single cluster of properties should be related to each molecule.
However, multiple clusters are also allowed if they only differentiate in the protonation of
the structure.
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Table 2.2: Property conversion table. I - InChI, K - InChI Key, S - SMILES, U - Universal
SMILES, n - Name, N - IUPAC Name, F - Molecular Formula, M - Mol Format
From \ To I K S U n N F M
I X X X
K
S X X X
U X X
n X
N X X X
F
M X X X
2.4 Integration
2.4.1 Biochemistry Integration
The integration pipeline is a cyclic process that may take many iterations. Staring with
metabolite clustering, this first step of the pipeline merges equivalent metabolite instances
of the M domain.
The second step unifies reaction instances, where the reconciliation of reactions is solely
dependent on the metabolite integration since their identity is based on the stoichiometry.
The following steps extract useful knowledge from the reaction sets, a common practice
in other reconciliations is to extract metabolite similarity from the unpaired metabolites
of the partial matching formulations [74, 9].
Finally, before the next iteration user input and evaluation is used to refine the next
cycle, and declustering methods may also be applied for a more conservative integration.
The product of the integration pipeline are reference sets that merge database references
similar to the MetaNetX unified reference space [90]. The assembly method materializes
the references into a consensus record that unifies the properties and attributes of the
clusters.
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Figure 2.8: Integration pipeline. The ETL pipeline populates the CDS, followed by the
knowledge expansion module to analyze and extend the chemical properties. In integration
of metabolites and reactions takes place at the end as an iterative cycles between both.
2.4.2 Integration of Metabolites
Integration of metabolites takes place by clustering all metabolite instances of m ∈M into
sub-sets Mi ⊆ M, where each is an integrated metabolite set, i.e. represents information
on a simple metabolite, or ideally seeks to do so.
The clustering rules of the instances are defined by the purpose of the integration. In
the following methods, two given metabolites are considered duplicates if they represent
the same molecule. This implies that the different protonation states of compounds are
considered to be equal.
The integration is calculated by pairwise entity resolution, i.e. merging pairs of enti-
ties, between all possible metabolites and assigning those numerical values (weights). A
similarity function φ : (a, b) 7→ R is defined, where a, b ∈M, that computes the similarity
score between two metabolites.
Definition 7. Identity ≡
Let m1,m2 be two metabolites in M and ω ∈ R+ a constant value, if φ(m1,m2) > ω,
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Figure 2.9: Metabolite clustering by pairwise matching.
then it is said that m1 is identical to m2, such that m1 ≡ m2.
The ω is a defined threshold to be set by the integration engine, defining the mini-
mum similarity score to consider two metabolites as duplicates. According to identity rule
(Definition 7), the challenge is to define the true φ function and optimal value for ω.
The set Γ (Equation 2.1) defines the space of all pairs of metabolites in M. Γφ is a
subset of Γ, being the space of all pairs of metabolites that are duplicates filtered by φ and
ω.
Γ = {(a, b) ∈M×M, a 6= b} (2.1)
Γφ = {(a, b) ∈ Γ | φ(a, b) > ω} (2.2)
The Γ set is a complete graph (Figure 2.9a) with all metabolites inM. Independently
of how many data sources are in M, every instance is subject to deduplication.
Each metabolic database may catalog thousands of instances and, thus, in a complete
graph the number of edges increases exponentially
n(n− 1)
2
for n vertices. It is computa-
tionally infeasible to calculate the score for all pairs given the size of M.
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For most of the edges e in Γ, it is likely that φ(e) ≤ 0 since most metabolites are totally
unrelated to each other (Figure 2.9b).
The FilterGammaSubset algorithm (Algorithm 1) computes the subset Γ′ of Γ that
contains only pairs of metabolites that might have at least one relationship in common.
The formula property is an exception and it does not count as an interaction, since it
cannot by itself define ≡ between compounds. Later, the formula is used to amplify or
diminish the overall score of the ≡.
Algorithm 1 Compute Γ subset
1: procedure FilterGammaSubset(M,Pm, E)
Input: M, Pm, E (the domain of metabolites, metabolite properties and edges)
Output: 〈VΓ, EΓ〉 (A graph Γ′ ⊆ Γ )
2: VΓ ← ∅ . Initialize empty vertice set
3: EΓ ← ∅ . Initialize empty edge set
4: for e ∈ E such that pi2(e) ∈ Pm do
5: p← pi2(e)
6: M ← ∅ . Initialize empty metabolite set
7: for e ∈ E such that pi1(e) ∈M do
8: M ←M ∪ pi1(e)
9: E ← {〈a, b〉 | 〈a, b〉 ∈ ℘(M)} . All combinations of a, b in M
10: VΓ ← VΓ ∪M
11: EΓ ← EΓ ∪ E
12: return 〈VΓ, EΓ〉
To define the φ function, previous integration methods are reviewed to assess the ex-
isting strategies for metabolite integration.
Molecular structural analysis should be the most reliable property for duplication de-
tection, which is used by the previous reconciliations (BKM-react, MetRxn, MetaNetX).
However, due to the integration goals, molecules that are presented in distinct protonation
states should be considered identical, which implies manipulation of the structure format
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to detect such occurrences. The BKM-react drops the layers related to the ionization state,
while the other two databases attempt to transform the molecular structures at a certain
pH value, allowing to standardize the InChI’s and SMILES’s.
The metabolite nomenclatures also contribute to the integration. However, the exact
mechanism in most of the integrations is not clearly detailed. The BKM-react states that
names and synonyms were combined, while the MNXRef applies an automated reconcilia-
tion when matches are found between names and molecular formula. MetRxn uses names
for curation purposes, being the names tokenized by highlighting stereo information (e.g.,
L-/D-, cis/trans, etc), or equivalences (e.g., ”-ic acid” and ”-ate”).
The reaction context strategy allows to infer equivalent metabolites by matching the
stoichiometry of the reactions. Given two reactions r1 and r2, if there is only a single
metabolite in the stoichiometry that differs if may hint a potential duplicate. This method
was used by MNXRef and MetRxn.
According to Bernard et al.[9], none of the previous integrations reported the use of
cross-references to integrated the databases (with the exception of the cross-references
between reactions in MetaNetX).
The standard similarity function (Equation 2.3) is a definition of φ to mimic previous
integration methods. The function involves three components: names, structures and
reactions. Each of the components are contribution functions that add up to the similarity
score, representing different properties used to create and weight links between pairs of
metabolites.
φstd = Nstd + Sstd +Rstd (2.3)
To mimic the exact approach for each method would be impossible for several reasons:
• It is not known exactly how the names of the compounds contribute for the integration
in many of the previous methods.
• It is also not clear which were the exact methods used to compute the InChI sub
layers or how the comparison is made.
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• The method used to standardize the molecules to a certain pH may involve different
tools, such as the commercial software Marvin.
• Most of the original datasets of these integrations are outdated versions which are
inaccessible.
To compare to existing methods all of the subcomponents of φstd are defined as binary
functions (e.g., Sstd : M×M 7→ {0, 1}) and ω is set to be 1, such that ma and mb are
equal if one of the components is true.
The structure function Sstd is 1 for every two metabolites that share the same connec-
tivity and stereo structure.
The reaction function Rstd is the feedback from the reaction integration. The contribu-
tion of this function is possibly 1 in the second iteration (and following) of the integration.
The name function Nstd is set to be undefined, since it is not known how exactly they
are defined in the other databases.
The major drawback of the φstd is that it lacks the interaction between each component.
This implies that each of the contribution functions are independent of each other, and a
single function is enough to declare if ma ≡ mb.
To improve the scoring method, the interaction between the functions is extended to
capture negative rules. This allows the scoring function to reject incorrect properties based
on the overall contribution of all other properties in the metabolites.
The improved functions are defined as follows:
The function N : (a, b) 7→ R (Equation 2.4) defines a name scoring method. The
positive name rules count the occurrence of name matches between a and b split into three
categories: matches between IUPAC names niupac, matches between exact strings nexact
and matches between similar strings nmod, each with their own weight, αn, βn, γn ∈ R.
The IUPAC names should have a higher score of all of the three, while the other should
have smaller scores. The matches between modified names only occur because of the
transformation and/or cleansing performed in the previous ETL phase. In this work only
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case insensitive matches are considered. It is known that for certain names (e.g., molecular
formulas), the context may change if the string is treated
The negative rule Nneg (Equation 2.5) takes into account the number of unmatched
names, but only if the number of synonyms ncount surpasses a certain ρn ∈ Z limit. Com-
pounds with only a single name have low match probability, even if they are true equals
due to many synonyms. Still, if the maximum number of synonyms increases, the expected
odds to have a positive match should be much higher if two compounds are truly equal.
N = nexact.αn + nmod.βn + niupac.γn +Nneg (2.4)
Nneg =
−κn if ncount > ρn ∧ (nexact + nmod + niupac) < 10 otherwise (2.5)
To summarize, the N function take five parameters: αn, βn and γn are similarity
weights, the ρn defines the number of synonyms to utilize the negative rule, and the κn is
the penalty for failing the rule.
To evaluate structural similarity both InChI and SMILES are considered, each with a
positive (Equation 2.6) and a negative (Equation 2.7) component.
In fact, every molecular exchange format can be considered as a general structural data
comparison function
∑
stype S
+
stype +S
−
stype, but since only InChI and SMILES are regularly
used, the S functions were defined to cover only these two types (S±i for InChI and S
±
s for
SMILES).
S+i/s =

α+i/s if an exact match occurs
β+i/s if there is a protonation mismatch
0 otherwise
(2.6)
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S−i/s =

−α−i/s if there is connectivity mismatch
−β−i/s if stereo mismatch occurs
0 otherwise
(2.7)
The positive part scores exact matches and partial matches (distinct protonation lev-
els). The negative parts penalizes different connectivities or stereos mismatches each with
individual scores.
S = S+i + S
−
i + S
+
s + S
−
s (2.8)
The final function S (Equation 2.8) sums the contribution of the molecular exchange
formats, the α± and β± weights allow to tune the strength of chemical representation in
the similarity score.
Two scenarios are considered for cross referencing (Equation 2.9) between databases: if
the reference is unidirectional, such that either only Ma references Mb or vice versa, then
a lower score value maybe considered, while if both reference each other a higher score can
be given.
X =
αx if reference is bidirectionalβx if reference is unidirectional (2.9)
The molecular formula F : (a, b) 7→ R functions analyse the atomic composition of
the two compounds. Fully determined molecular formulas can match exactly (fexact) or
only mismatch hydrogen (fH). Molecular formulas matching with the R-group are given a
different weight (γf ) since it is not trivial to decide whether both R-groups have the same
meaning or not. As a special category, some formula strings may fail software parsing
(contain invalid atoms or have string descriptions in the middle), but in some cases they
are inherited from other databases (these formulas are represented as fbad and have a
separate score assigned).
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Overall, F is defined as:
F (a, b) = fexact.αf + fH .βf + fR.γf + fbad.ηf (2.10)
where fexact, fH , fR and fbad are the occurrences of exact matches, matches with exception
of hydrogen atoms, matches containing R-groups and matches between unparseable formula
strings, with their respective weights αf , βf , γf and ηf .
The reaction function takes into consideration the reactions where the two compounds
a, b participate. In this case, the negative feedback is given if two distinct compounds a
and b participate in the same reaction r.
Let r be any reaction in R, let e1, e2 be any edges in E , then if
∃r∈R∃e2,e2∈E [pi1(e1) = pi1(e2) = r ∧ pi2(e1) = a ∧ pi2(e2) = b ∧ e1 6= e2] (2.11)
This constraint implies that either the stoichiometry of r contains the metabolite twice
or simply a ≡ b is not true. The first is unlikely to happen, therefore this assertion is used
as negative feedback (Definition 2.12) scored by αr. In fact, this could also be considered a
strong negative feedback since merging elements within the stoichiometry of any reaction
may imply severe inconsistencies.
The reaction function also receives feedback from the integration of reactions. This is,
however, only possible after the first iteration of the integration process since an initial
integrated set of compounds is necessary to integrate the reactions. The R function is
revised in the next section to define the βr rule.
R(a, b) =

−αr ∃e1∃e2 [e1 6= e2 ∧ pi1(e1) = pi1(e2) = r ∧ pi2(e1) = a ∧ pi2(e1) = b]
βr if there is reaction integration feedback
0 otherwise
(2.12)
For curation purposes, users can manually group compounds into sets. This set of
compound sets is referred as a curated set. The function C (Equation 2.13) scores instances
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based on manually assigned groups in the curated set U . The positive feedback is given by
the score αc, when there is a set M ∈ U that contains both metabolites. A negative score
βc is given if the metabolites are found in two distinct sets in U .
C(a, b, U) =

αc if ∃M∈U [a ∈M ∧ b ∈M ]
−βc if ∃M1,M2∈U [a ∈M1 ∧ b ∈M2 ∧M1 6= M2]
0 otherwise
(2.13)
The last function Z(a, b) handles the exceptional attributes that may be relevant to
identify compound identity (e.g, database specific attributes). For instance, BiGG1 and
BiGG are related to each other, therefore they are merged by simple a identifier (i.e., BiGG
abbreviation) comparison. A few string transformations also take place since in the recent
BiGG database, where the dash character was replaced by double a underscore.
φ = (N + S +X +R + Z + C).(1 + F ) (2.14)
The integrated metabolite space is defined in the set I (Definition 8), the final product
of the integration method that contains sets of metabolites M that are the integrated
metabolite clusters.
Definition 8. Integrated Metabolites
I = {M ∈ ℘(M)\∅}
The integrated metabolite domain is actually given by the connected components (CC)
of Γφ. Therefore, the function CC(Γφ) = I performs the clustering of the metabolites.
2.4.3 Integration of Reactions
The reaction properties Pr are not suitable for integration. Indeed, unlike metabolites,
most of the reactions have little to zero attributes. The name and the Enzyme Commission
Number (EC number) are usually the only properties found for reactions.
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The EC number is a system to classify enzymes based on their biochemical activity.
It consists of four positive integers (i.k.j.l), displayed hierarchically. The first number
represents the major function of the enzyme, of a total of six classes (Oxidoreductases,
Transferases, Hydrolases, Lyases, Isomerases, Ligases). The second level indicates the
functional groups that the enzyme is acting upon (e.g, CH-OH groups), while the two
remaining numbers characterizes the cofactors (e.g., NAD/NADP) and substrates.
A problem of this classification method is the lack of specificity. As an example, the
EC 1.1.1.1 which represents the role of an alcohol dehydrogenase is assigned to more than
10 reactions.
Two reactions are said to be equal if they have equivalent reaction stoichiometry. This
implies that reactants and products are the same and the coefficients are also equivalent.
The reversibility of the reaction is defined by several factors. In most studies, the
Gibbs free energy of the reaction is used to decide if a reaction is reversible or irreversible.
However, enzyme kinetics and substrates concentration may also play a role to decide
whether a reaction is bidirectional or unidirectional [4].
Because of this, many databases do not have a defined reversibility for reactions. There-
fore, the distinction of product and reactant by assuming the original direction of the re-
action is many times ambiguous and pointless. Instead, the reactants and products are
defined as left (LHS) or right (RHS) components of the stoichiometry (Definition 9). The
assignment of the molecules to either left of right is purely based on the original position
of the compounds found in the stoichiometry of the external databases.
Definition 9. Reaction Stoichiometry
Let StoichEdges(r, E) = {e | (∃e∈Er)[pi1(e) = r ∧ ns(e) ∈ {left, right}]} be the set of
all stoichiometry edges of a reaction r.
The stoichiometry of a reaction r is an ordered tuple, where Stoich(r, E) = 〈LHS(r, E),
RHS(r, E)〉, such that:
LHS(r, E) = {〈pi2(e), value(e)〉 ∈ M× R | e ∈ StoichEdges(r, E) ∧ t(e) = left}
RHS(r, E) = {〈pi2(e), value(e)〉 ∈ M × R | e ∈ StoichEdges(r, E) ∧ t(e) = right}
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where, t(e) is the type of the edge. Both LHS and RHS are ordered tuples of a metabolite
and a positive real value.
The stoichiometry is defined by an ordered tuple containing two unordered sets. The
Stoich(r, E) function (Definition 9) assembles the tuple from the edges E . For simplifica-
tion, in the Stoich(r, E) function, the global parameter E is omitted, and the function call
is rewritten as Stoich(r).
The equality of two reactions if given by the equality function ('), which is true if
there is a match between both left and right sets of their stoichiometry.
Definition 10. Reaction Equality
Let s(ra) = 〈LHSa, RHSa〉 and s(rb) = 〈LHSb, RHSb〉, then:
s(ra) ' s(rb) if and only if
(LHSa = LHSb ∧RHSa = RHSb) ∨ (LHSa = RHSb ∧ LHSb = RHSa)
The stoichiometry definition Stoich(r) (Definition 9) is insufficient to integrate reactions
from distinct domains for two reasons:
• Metabolites in distinct domains have an unique identity (Definition 4), therefore the
stoichiometry of reactions with metabolites in different namespaces are never equal.
• In some cases, it is necessary to exclude irrelevant compounds; the proton (H+) is
a common example of exclusion since it is added to the stoichiometry based on the
protonation of the compounds to balance the reaction.
The integrated stoichiometry substitutes every single metabolite with the integrated
metabolite domain function I : M 7→ ℘(M). This expands single metabolites m into
metabolite sets M that map all metabolites of m that are identical (clusters).
Definition 11. Reaction Integrated Stoichiometry
IntegratedStoich(r, I,X ) = 〈LHSI(r, I,X ), RHSI(r, I,X )〉, where:
LHSI(r, I,X ) = {(I(pi1(p)), pi2(p)) ∈ ℘(M)× R | p ∈ LHS(r) ∧ pi1(p) /∈ X}
RHSI(r, I,X ) = {(I(pi1(p)), pi2(p)) ∈ ℘(M)× R | p ∈ RHS(r) ∧ pi1(p) /∈ X}
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The IntegratedStoich(s, I,X ) (Definition 11) expands the stoichiometry Stoich(r) by
replacing the metabolites in the tuples with metabolite sets. This allows to compare the
reactions if they share the same metabolite sets in the stoichiometry.
The exclusion set X defines the metabolites to be excluded from the stoichiometry. For
the integrated stoichiometry, X is replaced by X I = ⋃x∈X I(x) that expands the excluded
metabolites to their respective integrated sets.
The reaction sets are added to the integrated space I (Definition 8) expanding the
sets of integrated instances. The stoichiometry also gives additional information on the
compounds. Let m1, m2 be two distinct metabolites in M, if I(m1) = M1 and I(m2) =
M2. If there are two reactions that have partial stoichiometry match with the exception
of m1 and m2, this might imply that m1 ≡ m2.
Example 4. Partial Reaction Matching
Let m1,m2 ∈ M, such that m1 6= m2, and I(m1) = M1, I(m2) = M2. Let r1, r2 ∈ R,
such that r1 6= r2.
Let sI(r1) = 〈 (〈M1, v1〉, p1), (p2, p3)〉, and sI(r2) = 〈 (〈M2, v2〉, p1), (p2, p3)〉.
If v1 = v2, the s
I(r1) = sI(r2) if and only if M1 = M2.
The singleton sets of partial stoichiometry generate a complementary set of integrated
metabolites that are candidate merges. Sets that contain a single compound for each
namespace may give strong evidence of possible duplicates.
Still it is known that it is possible for two distinct reactions to differ only in the product.
As an example, KEGG reactions R10950 and R03427 differ only in one metabolite, and
thus this serves only as a possibility.
The SingletonMiss (Algorithm 2) detects all sets of integrated stoichiometry that
Stoich(ra) ' Stoich(rb) if one of the metabolites in either LHS or RHS is dropped from
the stoichiometry. The algorithm returns two maps: the reactions groups the reactions
such that Stoich(ra) ' Stoich(rb) is only true if one of the metabolites is dropped, the
metabolites groups the compounds that were dropped from the stoichiometry.
The Ic set is the integrated set that is assembled from the metabolite sets of the
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metabolites map from the SingletonMiss. These are all hypotheses of unintegrated
metabolites that were not merged in the previous methods with shared reaction stoichiom-
etry (with exception to themselves).
Ic extends the previous reaction contribution function R (Equation 2.15) with the βr
parameter given two metabolites found within the same complement set if theres is a unique
namespace for each.
R(a, b, Ic) =

−αr ∃e1∃e2 [e1 6= e2 ∧ pi1(e1) = pi1(e2) = r ∧ pi2(e1) = a ∧ pi2(e1) = b]
βr Ic(a) = Ic(b) ∧ size(Ic(a)) =
size({N (x) | x ∈ Ic(a)})
0 otherwise
(2.15)
The reaction integration is the last step of the integration cycle. Further iterations
should include curation feedback.
2.5 Implementation
The integration system is implemented through a JavaTM7 library that contains several
module (Figure 2.10). The core module consists on basic and generic components and
interfaces of the entire system (e.g., Metabolite, Reaction).
The biodb contains resource specific implementations of entities and data access meth-
ods (e.g., KeggCompound, BiGGMetabolite, etc).
The chemanalysis module implements all cheminformatics functions using several li-
braries. The commercial software Marvin allows to convert defined structures to names,
but the reverse is also possible. The OPSIN library [81] allows to parse molecule names to
generate InChI structures. The Chemistry Development Kit [117] (CDK) is a Java chem-
informatics library that provides several parsers to interpret chemical exchange formats,
but also includes the JNIInchi library to read and generate InChIKeys.
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Algorithm 2 Groups integrated stoichiometry having a single unintegrated metabolite.
1: procedure SingletonMiss(R, E , I,X )
Input: R reactions, E edges, I integrated sets, X metabolite exclusion
Output: A map reactions : S 7→ R that maps the partial stoichiometry to reaction
sets. A map metabolites : S 7→ M that maps the partial stoichiometry to metabolite
sets
2: for r ∈ R do
3: s← IntegratedStoich(r, I,X )
4: L← ∅ . L is the left side filtering all singleton M
5: R← ∅ . R is the right side filtering all singleton M
6: Z ← ∅ . Z is the set of singletons
7: for 〈M, v〉 ∈ pi1(s) do . Filter left pairs
8: if |M | 6= 1 then
9: L← 〈M, v〉
10: else
11: Z ← Z ∪M
12: for 〈M, v〉 ∈ pi2(s) do . Filter right pairs
13: if |M | 6= 1 then
14: R← 〈M, v〉
15: else
16: Z ← Z ∪M
17: s′ ← 〈L,R〉
18: if |Z| = 1 then
19: reactions[s′] = reactions[s′] ∪ r
20: metabolites[s′] = metabolites[s′] ∪ Z
21: return reactions,metabolites
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biosynth-framework
core chemanalysis
integrationbiodb
org.neo4j
org.springframework
loggers, commons, etc
org.openscience.cdk
org.jgrapht
uk.ac.cam.ch.opsin
Figure 2.10: The pipeline and methods are implemented as a Java library (biosynth-
framework) with several modules.
The integration module provides the interfaces and methods for the integration pipeline,
here the CDS access methods are also implemented while it is designed to be independent
of the biodb.
2.5.1 Graph Database Systems
The flexibility of the database is one of the most important requirements of the CDS system.
Biological entities and their functions are not trivially characterized. It is common that
databases have a set of records with lack of literature evidence or just to simply to support
an hypothesis, which in turn makes the data highly volatile and subject to future changes.
Recently, graph databases gained more attention in data integration approaches. Since
graphs are common strategies to define relationships, the graph storage model suits the
needs for the data complex heterogeneous models allowing for easy ad hoc addition of new
relations [119].
In recent years, there is a increasing popularity of using graph databases for bioinfor-
matics application, since they have proven to be easier to maintain, while having much
higher speed up gains for extensively relational queries [56, 70, 49].
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The neo4j graph database is used to build the CDS. Like most of the NoSQL databases,
neo4j offers a flexible schema. The addition of new entities and attributes can be easily
achieved with little impact in the database performance, allowing an incremental schema
design to adapt the needs of the data.
Each record in neo4j databases is either a node (vertex) or relationship (edge). Both
nodes and relationships are allowed to have a set of arbitrary properties, while nodes
are allowed to have several Labels and relationships may only be assigned to a single
RelationshipType. In order to organize the database information, a set of rules is applied
to define a simple generic data schema to fit all the data requirements.
Each neo4j Node and Relationship must have a unique numeric identifier, being the ids
of the objects stored in the properties of the node as a string attribute.
To define the namespace of the object, a Label is assigned to the Node, and in its
properties the namespace string attribute marks the Label that corresponds to the object
namespace (since Nodes are allowed to have several Labels).
The central data storage defines a relationship and class hierarchy for the domain
of metabolites and reactions (Figure 2.11). Since each node may have several labels,
the abstract labels are used to define the class of the objects. These are the supersets
of M, R, Pm, Pr that are labeled as Metabolite, Reaction, MetaboliteProperty and
ReactionProperty, respectively.
A vocabulary is defined to represent the interactions between the instances. These are
the meanings given by the e ∈ E . As an example, given e = (m, p), such that m ∈M and
N (p) = InChI, the relationship e is limited to has inchi.
The Cypher query language is a neo4j specific query language to manipulate the
database. For the uniqueness constraint, the following query allows to force the database
to refuse duplicate attributes within a Label (n):
∀n∈N CREATE CONSTRAINT ON (o:n) ASSERT o.id IS UNIQUE
Relational queries can be easily achieved using the following cypher expression:
MATCH (ϕ1)-[ψ1]->(ϕ2) RETURN (τ)
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ChEBI LigandComp
ound
LigandDrug LigandGlyca
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Reaction
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MetaCyc
BiGG
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MetabolicPathway
Name
MolecularFor
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InChI
SMILES
Charge
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MetaboliteProperty ReactionProperty EnzymeCommissio
Metabolite
Reaction
subclass_of
has
subclass_of
in_pathway
subclass_of subclass_of
subclass_of
has_formula
has_inchikey
has_formula
subclass_of
subclass_of
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has
subclass_of
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is_a
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subclass_of
subclass_of
subclass_of
subclass_of
has_reference
has_reference
Figure 2.11: Neo4j Labels defined for the CDS namespace domain. Metabolite, Reaction,
MetaboliteProperty, ReactionProperty represents the sets M,R,Pm and Pr, respectively.
Light Green - Property namespaces. Yellow - Database namespaces. Additional names-
paces can be added if needed (e.g., Metabolic Pathway).
2.5. IMPLEMENTATION 49
The ϕ1 and ϕ2 are nodes matching predicates with the following pattern:
ϕ = variable:Label1:. . . :Labelx {attribute1:value1, . . . ,attributey:valuey}
allowing to filter nodes by label and attributes. As an example, to select a particular set
of metabolites of a database, the following expression would be sufficient:
MATCH (m:LigandCompound) RETURN m
or to select a particular compound:
MATCH (m:LigandCompound {id:"C00022"}) RETURN m
The omitted arrow block is the traversal condition that matches if connected to the
node predicate ϕ2 and all the connections satisfy the predicate ψ1. As an example, the
following expression catches every compound in the system that have a particular chemical
formula:
MATCH (m:Metabolite)-[:has formula]->(m:MolecularFormula {id:"C3H4O3"})
RETURN (m)
In this case, this would allow matching graph paths of length 1 (although the result
could be a star-shaped subgraph the maximum diameter would be 1), the expression can
be extended with the addition of arrow blocks . . . -[ψ2]→(ϕ3)-. . . -[ψj]→(ϕj+1).
Alternatively, the reaction predicate accepts a multiplicity value:
MATCH (m:LigandCompound {id: "C00022"})-[:has reference*]-(n:Metabolite) RETURN (n)
MATCH (m:LigandCompound {id: "C00022"})-[:has reference*..3]-(n:Metabolite) RETURN (n)
The first expression catches the entire subgraph that connects the KEGG Compound
C00022 with other metabolites by cross-referencing, while the second limits the search up
to a diameter of 3.
The integration exploits the capability of the Cypher query language to perform all the
necessary queries, to implement the proposed integration methods.
50 CHAPTER 2. METABOLIC DATABASE INTEGRATION
2.5.2 Extract and Translation Methods
The implementation of extraction methods is considered the main bottleneck for the expan-
sion of the integrated metabolic database. Third-party resources provide their own data
access methods and protocols to expose their data, while most of the modern platforms
implement a REST API, but the output format and schema may be different for each of
the external resources.
The addition of a new database to the system implies the implementation of a specific
DataAccessObject (DAO) and a Transform function (Figure 2.12). These are the only
components that are required per data source.
The DAO is responsible for listing and extracting database specific objects e from
third-party resources. The entities extracted from the DAO do not need to conform the
standards of the CDS universe, while its main purpose is to interpret and extract correctly
the desired attributes.
The transform function T : e 7→ G conforms the raw entities into the respective graph
objects o and edges e. The transform function is responsible for giving the namespace of
each o. A dictionary to conform referenced databases is needed to unify the different names
given by the databases (e.g., KEGG-CPD, KEGG Compoumd, Ligand Compound).
The ETL pipeline is designed to only integrate the relationships of the loaded instances,
while integration of the metabolites and reactions is done afterwards.
The cleansing is only performed after the transformation (Figure 2.13) and it is respon-
sible to fix the properties of the transformed instances. The need to implement a cleansing
system is to perform minimal standardization for the properties to avoid proliferation of
equivalent attributes. As an example, the atom order of the chemical formulas can be
rearranged in several ways (e.g., H2O,OH2, H2O1, O1H2). In fact, all the properties could
be loaded as they are, then the cheminformatics subsystem could unify all the properties
in the system, but many of these occurrences would be trivial.
The formulas are rewritten to a standard atom order using the CDK library. The
MolecularFormulaManipulator is used to rewrite the formulas with the getMajorIsotope-
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,dao : DataAccessObject<E>
EtlExtract<M>
+get(id : string) : M
+list() : set<string>
<<Interface>>
DataAccessObject<E>
+transform(entity : E) : G
<<Interface>>
Transform<E, G>
+load(graph : G) : int
+exists(id : string, namespace : strin
<<Interface>>
Load<G>
+cleanse(graph : G) : G
<<Interface>>
Cleanse<G>
+etl() : set<int>
EtlPipeline<E,G>
KEGGCompoundDao
+list() : set<string>
+extract(id : string) : E
<<Interface>>
Extract<E>
KEGGCompoundTrasnform
-cheminformatics
DefaultGraphCleanse
,service : GraphDatabaseService
Neo4jEtlLoad
A data access object is needed for each
Figure 2.12: The ETL pipeline requires a DAO and Transform function for every data
source. Databases that contain both metabolites and reactions count as two distinct data
sources.
MolecularFormula function. The names are also modified to lower case to minimize the
noise in the central database, but for all modifications, the original value is stored in the
attributes of the e and flagged as corrected.
The current library implements DAO and Transform objects for several pathway and
metabolite databases. The details era given as follows:
KEGG: Kyoto Encyclopedia of Genes and Genomes The KEGG database has a
REST API to fetch its data. The only format given is a semi structured text file (Figure
2.14).
A parser was developed to split the content from the text file and to extract the at-
tributes of each record. Without a defined schema, it is not trivial to detect the existing
attributes of all the records and their possible data-types or missing values.
The API exposes a simple REST access:
http://rest.kegg.jp/<operation>/<argument>[/<argument2[/<argument3> ...]]
52 CHAPTER 2. METABOLIC DATABASE INTEGRATION
loop
[For each identifier 6idy]
Iftrue
ETL
Extract Transform Cleanse LoadAction
1: etl
1.13: loaded identifiers
1.4: boolean
1.12: internal id6Gy
1.10: G 6with cleasing annotationy
1.8: graph G
1.6: entity E
1.11: load6Gy
1.9: cleanse6Gy
1.7: transform6Ey
1.5: extract6idy
1.3: exists6idy
1.2: set of identifiers
1.1: list
Figure 2.13: The ETL pipeline. The extract component returns all identifiers of a third-
party database and loops for each the ETL process.
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For extraction, only the list and get operations are needed.
The KEGG database is split into three sets, corresponding to compounds, glycans and
drugs. Each of these records have a specific starting prefix capital letter, C, G, and D
respectively, and R for reactions. Each database is stored in a different namespace.
MetaCyc: Metabolic Pathway Database The BioCyc [65] collection covers several
databases known as pathway/genome databases (PGDBs). The MetaCyc [16] PGDB is
the reference database of Biocyc covering the metabolism of the other organism specific
PGDBs (e.g., EcoCyc, YeastCyc, HumanCyc).
The PGDBs are created and managed by the Pathway Tools [66] platform that provides
a query API to retrieve and search data in a XML format. The BioVelo [77] query processor
is a specific query language to allow complex queries over the Pathway Tools relationship
schema, available in:
https://websvc.biocyc.org/xmlquery?[x:x<-[PGDB]^^[CLASS]]
The individual objects are obtained from the xmlget function:
https://websvc.biocyc.org/getxml?[PGDB]:[OBJECT-ID]
For the MetaCyc database, the PGDB is assigned to META but the access to other
databases uses the same interface just by changing the PGDB (e.g., ECOLI - Escherichia
coli, YEAST - Saccharomyces cerevisiae, HUMAN - Homo sapiens),
BiGG: Biochemical Genetic and Genomic knowledgebase The BiGG database
is split into the old BiGG (BiGG1) [110] database4 and the latest BiGG [68] database5.
Unlike other genome pathway databases, the BiGG databases are built based on published
genome-scale metabolic models. The early BiGG1 database was built by merging 10 mod-
els, while the recent BiGG contains more than 80 models with standardized identifiers and
a public API.
4http://bigg1.ucsd.edu/
5http://bigg.ucsd.edu/
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ENTRY C06142 Compound
NAME 1−Butanol ;
n−Butanol ;
Butan−1−o l
FORMULA C4H10O
EXACT MASS 74.0732
MOL WEIGHT 74.1216
REMARK Same as : D03200
REACTION R03544 R03545 R11343 R11344 R11448
PATHWAY map00650 Butanoate metabolism
map01120 Microb ia l metabolism in d i v e r s e environments
map01220 Degradation o f aromatic compounds
ENZYME 1.1 .1 .− 1 . 1 . 2 . 9 1 . 1 . 5 . 1 1 1 . 1 4 . 1 3 . 2 3 0
BRITE Pharmaceutical a d d i t i v e s in Japan [BR: br08316 ]
S o l u b i l i z a t i o n agent
D03200 [ 101088 ] Butanol
So lvent
D03200 [ 101088 ] Butanol
DBLINKS PubChem: 8398
ChEBI : 28885
ChEMBL: CHEMBL14245
KNApSAcK: C00035814
PDB−CCD: 1BO
3DMET: B00907
NIKKAJI : J2 .374D
ATOM 5
1 C1b C 24.4358 −15.4702
2 C1b C 23.2158 −14.7756
3 C1b C 25.6384 −14.7639
4 C1a C 22.0074 −15.4761
5 O1a O 26.8526 −15.4702
BOND 4
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
///
Figure 2.14: KEGG Compound - C06142 (n-butanol), an example of the KEGG text
format. Attributes are separated by fixed space columns.
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abbrv name formula c cmp kegg id cas id bigg id found in
glu-D D-Glutamate C5H8NO4 -1 [c] C00217 6893-26-1 34285 1,10,3,4,5,7
pre6b Precorrin 6B C44H49N4O16 -7 [c] C06319 1800230 10,4
23dhb 2,3-Dihydroxybenzoate C7H5O4 -1 [c] C00196 303-38-8 34227 1,5
ru5p-L L-Ribulose 5-phosphate C5H9O8P -2 [c] C01101 36809 1,10,5,7
18harachd 18 hydroxy arachidonic acid C20H31O3 -1 [r] 2300206 2
ca2 Calcium Ca 2 [e], [c], [p] C00076 7440-70-2 33764 10,2,5,9
lpp lipoprotein XC16H30O1 0 [p] C01834 2707630 5
Figure 2.15: Example of BiGG1 CSV records. abbrv - abbreviation, c - charge, cmp -
compartment, found in - 1) E. coli iJR904; 2) H. sapiens Recon 1; 3) H. pylori iIT341; 4)
P. putida iJN746; 5) E. coli iAF1260; 6) S. cerevisiae iND750; 7) S. aureus iSB619; 8) E.
coli textbook; 9) M. barkeri iAF692; 10) M. tuberculosis iNJ661;
The BiGG1 database allows to download the entire database to a file with the CSV
format (Figure 2.15). However, a profiling step is still required to determine the data-type
of each column. Some columns may be defined as single values (strings, integers, decimals)
or lists of entities (e.g., compartment, found in).
The latest BiGG provides a documented REST API to browse and fetch data in the
JSON format. The list of all metabolites and reactions can be accessed through REST
web calls:
http://bigg.ucsd.edu/api/v2/universal/reactions
http://bigg.ucsd.edu/api/v2/universal/metabolites
HMDB: The Human Metabolome Database Some databases are oriented to a spe-
cific species. In the case of the HMDB [124], it is dedicated to metabolites found in the
human body. The HMDB is contains only metabolite information, but with an enriched
set of features such as, sprectroscopic, quantitative, analytic and physiological information
about the human metabolome.
HMDB allows to bulk download the entire dataset in XML format from their web page.
LIPID Metabolites and Pathways Strategy The LIPID MAPS database is dedi-
cated to a specific class of metabolites which are the lipids. The purpose of this database
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is to provide a better classification system for the lipids, while focusing also in the chemical
structure of these and the ability to draw such complex structures.
Lipids usually contain large chains that are troublesome to draw and display using
current methods to generate atom coordinates, such that for the same lipid it is common
to be displayed in many different conformations in distinct resources.
The LIPID MAPS database can be bulk downloaded in the SDF format.
Model SEED The ModelSEED [7] database was developed to connect biochemical reac-
tions to genome annotation for the purpose of model reconstruction. The reactions in the
ModelSEED database are assigned to particular gene roles, which are given by the RAST
annotation systems, allowing to directly link the metabolic function from the genome an-
notation.
The metabolic information of the ModelSEED database can be found in their github
repository6 in both TSV and JSON formats.
2.6 Results
2.6.1 Building an integrated metabolite database
Here, an integrated metabolic database is generated using the implemented pipeline de-
scribed in the previous sections. Each step of the pipeline is detailed with a discussion in
the following sections.
The implemented ETL modules are ran to load several external resources into the CDS
(Table 2.3). At the time of writing, most of the databases collected match the latest
versions available.
It is possible to observe that there is a significant number of proxy instances in the CDS
after the ETL step. This may imply that there is a certain lack of synchronization between
resources, since a proxy is usually caused by database referencing to a non existing entity
6https://github.com/ModelSEED/ModelSEEDDatabase
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Table 2.3: Biochemical resources in the final integrated database
Resource Version Type Format Instances Proxies
KEGG Compounds 84.0 (October 1, 2017) REST text 18.111 443
KEGG Glycans 84.0 (October 1, 2017) REST text 11.015 2
KEGG Drugs 84.0 (October 1, 2017) REST text 10.440 0
MetaCyc 21.1 (August 15, 2017) REST xml 18.242 1343
BiGG1 2010 (discontinued) dump CSV 2.835 255
BiGG 1.4 (October 14, 2017) REST json 6.215 34
ModelSEED 190fb3e (master) GitHub json 27.693 0
LIPID MAPS 6Dez16 dump SDF 40.772 10
HMDB 3.6 (2014) dump json 41.758 11
in another resource. In some cases, this could also be related to bad referencing (e.g.,
malformed identifiers in the source databases).
Most of the BiGG1 proxies have origin on the ModelSEED instances. A closer analysis
reveals that these are references to external metabolic models that were not included in
BiGG1. However, in the ModelSEED they were assigned as BiGG1 metabolites.
The majority of MetaCyc proxies came from ModelSeed (around 1000), but also both
HMDB and BiGG have referenced around 100-200 deleted records. Databases that have a
higher number of proxies are also more popular, since for both KEGG and MetaCyc they
are subject to regular updates, and other databases are unable to keep up with the regular
update cycles.
Regarding the integration logic, the proxy records do not take part in the integration
methods since they contain no information except the origin of the reference.
A summary of raw attributes (Table 2.4) allows the identification of type of attributes
found in the raw instances. Of all the attributes, the name and formula have regular
presence in most of the collected instances, with the exception for the KEGG Glycan
database, which does not provide any molecular formulas (instead it provides the sugar
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composition). Many other compound characteristics are not taken into account for the
integration methods. These attributes can be inherited in the final database since they are
domain specific.
To evaluate the designed integration methods an instantiation of the parameters is
defined ignoring manual curation (Table 2.5). The curated compound sets are used later
to compare against the predicted integration, the databases used for integration are the
KEGG (compounds only), MetaCyc, and both the BiGG and BiGG1 databases. These are
the main metabolic pathway databases and they contain both reactions and metabolites.
Since the BiGG database uses references from MetaNetX, these are removed from the
system. The BiGG1 references were kept.
The integrated reference space of MNX is used to compare against the results from the
implemented methods in this work.
As of today, there are three versions of the MNX (version 1.0, 2.0, 3.0), but only the
last version is used (Figure 2.16). The MNX integration suffered many modifications from
version to version, and it is possible to see a significant increase of the total of instances, but
also in the latest version many discontinued databases were discarded from the integration.
In fact, the MNX contains many databases not studied in this work. Only the compound
instances that were found within our metabolite domain (M) are considered. The instances
of other databases are removed from the MNX set.
The latest version of MNX discarded the first version of BiGG (BiGG1), for comparison
purposes the BiGG1 database is discarded from the predicted sets.
For integration evaluation purposes, a set of curated integrated metabolites was man-
ually annotated to compare against the automated integration. The set consists on the
integration of KEGG Compound, MetaCyc, BiGG1 and BiGG, covering a total of 782,
785, 761, 761 metabolites, for each of the databases respectively.
All the curated metabolites participate in at least one reaction, since these are the most
relevant compounds for the integration.
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Table 2.4: Frequency of the raw attributes collected from each of the resources. MS -
ModelSEED, MC - MetaCyc, LC - KEGG Compound, LG - KEGG Glycan, LD - KEGG
Drug, HM - HMDB, B - BiGG, B1 - BiGG1
Attribute MS MC LM LC LG LD HM B B1 Type Mapping
name 1.00 1.00 0.78 1.00 0.12 1.00 0.99 1.00 1.00 String Name
synonyms 0.22 String Name
systematicName 0.87 String Name
iupacName 0.99 String Name
abbreviation 1.00 String
formula 0.82 0.71 0.99 0.96 0.82 0.99 0.93 1.00 String Formula
composition 1.00 String
inchi 0.70 0.99 0.99 String InChI
inchiKey 0.99 String InChIKey
inchikey 0.99 String InChIKey
smiles 0.86 0.99 String SMILES
structure 0.78 String InChI
charge 0.86 1.00 Number
defaultCharge 1.00 Number
mass 0.88 0.94 Number
exactMass 0.99 Number
cmlMolWeight 0.72 Number
molWeight 0.72 Number
averageMolecularWeight 0.99 Number
monisotopicMoleculateWeight 0.99 Number
deltaG 0.97 Number
deltaGErr 0.97 Number
gibbs 0.70 Number
description 1.00 String
oldIdentifiers 1.00 String
internalId 1.00 Number
tissues 0.15 String
ontology origins 0.89 String
ontology status 0.99 String
ontology biofuncions 0.79 String
ontology applications 0.85 String
ontology cellular locations 0.94 String
biofluids 0.13 String
secondary accession 0.13 String
pubchemSubstanceUrl 0.92 String
lipidMapsCmpdUrl 1.00 String
category 1.00 String
mainClass 1.00 String
subSlass 0.92 String
classLevel4 0.26 String
core 1.00 Boolean
cofactor 1.00 Boolean
obsolete 1.00 Boolean
remark 0.19 0.18 0.68 String
comment 0.86 0.22 0.54 String
status 1.00 Boolean
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Table 2.5: Parameters values defined for the similarity function.
Function Parameter Type Value
N αn similarty 0.3
βn similarty 0.15
γn similarty 0.1
κn penalty 1
ρn names count 3
S α+i similarty 1
β+i similarty 0.8
α−i penalty 1
β−i penalty 1
α+s , β
+
s similarty 0
α−s , β−s penalty 0
X αx similarty 1
βx similarty 0.5
F αf similarty 1
βf similarty 1
γf similarty 0.8
ηf similarty 0.8
C αc similarty 0
βc penalty 0
R αr penalty 10
βr similarty 1
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Figure 2.16: Metabolite instances that are both present in the CDS and each of the MNX
versions.
2.6.2 Statistics for the knowledge expansion
To assess the impact of the cheminformatics module, the properties are split into two
categories (Figure 2.17): the source properties are all properties inherited from the data
sources, while the translated properties are the generated from other properties.
The MetaCyc and HMDB were the only databases that had high present of a both
translated and source structures for a single compound (Figure 2.17c and 2.17d). The
KEGG structures were all translated from the Mol files with the exception of glycans that
provided no structural information. All structures in the BiGG database were generated,
since it does not provide any original information regarding these.
Only the KEGG Glycan took additional benefit from formula translation (Figure 2.17b),
but it was generated from the KEGG glycan composition and it is KEGG specific. The
presence of both translated and source formulas are also low compared to the structures,
which may indicate low structural conflict but possible stereo or protanation conflicts.
Name to structure (Figure 2.17a) displays if the metabolites contain names that were
parseable by the OPSIN library. Only HMDB had a majority of the compounds with at
least one synonym that is compatible with the OPSIN library, the remaining databases all
scored around 20% and 30%. This is due the fact that HMDB had a specific field for a
IUPAC name that was generated from the ChemAxon tool (Table 2.4).
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(a) Percentage of instances with OPSIN
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Figure 2.17: Property coverage of the database instances. Translated (orange) properties
were generated by the cheminformatics module. IUPAC names are all compounds that
had at least one name that was converted to InChI by OPSIN.
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Figure 2.18: Classification of each name property in the databases. IUPAC and traditional
names that had a match with a name generated with the Marvin StructureToName plugin.
OPSIN are names that are parseable with the OPSIN library. Regular are all names that
fail all the previous tests.
To evaluate structure to name translation (Figure 2.18), the existing name properties
are flagged as IUPAC, Traditional, OPSIN or regular, receptively. The top priority are the
IUPAC names that were generated from all the structures in the CDS using the Marvin
StructureToName plugin, then matched with the existing names in the CDS. Only a few
names did match to the IUPAC names generated from the structures. However, if using
the traditional name given by the plugin, these numbers are much higher. The OPSIN
library is able to cover many more names compared with the ones generated from the
Marvin plugin. Perhaps the lack of adoption of IUPAC names is because of the non
human friendly nomenclature, which in many cases leads to very large names with many
repeating sequences.
In many cases, the translated properties may add an additional structure to molecules
because of inconsistencies in the existing ones. This, however, is only a problem if the
additional structure and the original are not equivalent molecules (i.e., same molecule
different protonation state).
To find structural conflicts, the properties are clustered together since the translation
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Figure 2.19: Classification of the property clusters (SMILES, InChI, Mol) for each
database. Single - all structures match. Protonation - multiple structure, but same
molecule. Stereo - multiple structure, but same connectivity, Multiple - multiple struc-
tures with different connectivity.
method connects properties to each other (Figure 2.7). For each metabolite, three types of
clusters are evaluated: single structure are all metabolites that connect to structures that
represent exactly one metabolite, protonation structures are metabolites that connect to
several structures but represent one molecule, while stereo clusters are those with several
structures differing in the stereo layer but with equal connectivity, and multiple are the
molecules that differ in both stereo and connectivity.
The clustering of structures without any translated properties (Figure 2.19a) shows
many cases of multiple stereo clusters in the MetaCyc compounds. The MetaCyc provides
SMILES without any stereo information, this explains the high amount of both translated
and source InChI and SMILES for each compound (Figure 2.17c and 2.17d). The clustering
of structures with the translated properties (Figure 2.19b) shows that for some compounds
there were conflicts between the generated structures and the original ones, but the numbers
are low with the exception of the HMDB that had more than 20% of increase in the number
of conflicts.
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The OPSIN library was able to distinguish protonation state from the compound
names. As an example, the KEGG pyruvate7 molecule has five names displayed: Pyru-
vate, Pyruvic acid, 2-Oxopropanoate, 2-Oxopropanoic acid, Pyroracemic acid ; only the last
name was unable to parse. This is an example that the expansion module would generate
a protonation conflict.
Another example is the KEGG Inosine 5’-monophosphate8 that has 9 names assigned,
unlike the previous example, 3 names were non OPSIN (IMP, 5’-Inosine monophosphate,
5’-IMP), while other 5 generated the correct InChI structure that matches with the Mol file
from KEGG. However, one of the synonyms (5’-Inosinate) generated a structure without
the phosphate group, since it did not make any reference to the phosphate.
To fix mismatching generated structures, every chemical structure that is generated
from the cheminformatics module is excluded if it does not match the original structures.
The owner of the mismatching structure is also flagged as ambiguous, this may help future
decisions since these properties may be problematic for the integration methods, and should
be subject to curation analysis.
2.6.3 Integration Results
2.6.3.1 Comparison with MNX
The integration cycle was ran automatically five times, each cycle feeding the next with
the reaction context. This generates five sets that are represented as i0, i1, . . . , i4.
The first analysis is to check the sizes of each integrated compound set. In the final
integration (iteration i4) the number of integrated sets of size 2 and 3 are of a similar
total amount compared to the sets provided from the MNX integration (Table 2.6). The
usage of negative rules allowed for a more conservative approach for merging since a single
matching property (e.g, a cross-reference) may not be sufficient.
The reactions have proven to be essential to catch up with the numbers of the MNX
7KEGG Compound: C00022 - http://identifiers.org/kegg.compound/C00022
8KEGG Compound: C00130 - http://identifiers.org/kegg.compound/C00130
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Table 2.6: Cluster sizes of MetaNetX and the integrated database of KEGG (Compound),
MetaCyc, BiGG.
I 2 3 4 5 6+
MNX
MNX 1.0 4984 1248 134 34 13
MNX 2.0 5284 1564 200 60 31
MNX 3.0 5832 1358 191 55 34
Integration Iterations
i0 4962 1253 84 23
34
i1 5472 1300 87
24
i2 5584
1309
89
i3 5624
90
i4 5637
integration. However, after three iterations the gains from reactions have dropped to
insignificant levels per iteration.
Since the methods applied are more conservative, the number of oversize clusters is
lower. The ideal scenario are clusters of size 3 and for both of the integrations they found
approximately the same amount of sets.
Perhaps the total number of 1000 integrated compounds is enough to describe most
of the metabolite products and intermediates for essential pathways in cell metabolism,
to cover DNA, RNA, protein, fatty acids and cofactors biosynthesis in prokaryotes (since
most of the BiGG content is about prokaryotic pathways).
2.6.3.2 Curated Set
The sets translation function (Algorithm 3) maps elements of an integrated set against
another set. To evaluate the integrations, each set is mapped to (Translate(Icura, I)) and
from (Translate(Icura, I)) the curated set.
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The assumption is that elements in the curated set that are merged together are con-
sidered as true positives, and elements that are in the curated set but not together are
considered true negatives, and for the remaining elements that are not present, then noth-
ing is known about these.
If the curated set is bidirectionally mapped against the integration, then:
• Match: occurrences of C mapping to a single M and vice versa.
• Mismatch: occurrences of M matching multiple C sets. These are examples of over-
integration (splitting is necessary).
• Miss: occurrences when C matches to empty set or with multiple M sets. These are
examples of under-integration (merging is necessary).
• No information: occurrences of M matching to empty set. These are examples when
no information is found in the curation sets regarding to M .
Algorithm 3 Translates integrated metabolite sets of two integrated domains
1: procedure Translate(Ia, Ib)
Input: Ia integration a, Ib integration b
Output: T mapping of sets of Ia to sets of Ib
2: T = {}
3: for M ∈ Ia do
4: for m ∈M do
5: T [M ]← T [M ] ∪ Ib(m)
6: return T
Example 5. Sets Translation
Let, A = {a1 = (1, 2), a2 = (3, 4), a3 = (5, 6), a4 = (7, 8)} and B = {b1 = (4, 9, 10), b2 =
(7, 11), b3 = (5, 6), b4 = (8, 12)}
T (a1) = (∅), T (a2) = (∅, b1), T (a3) = (b3), T (a4) = (b2, b4)
The sensitivity (true positives) and specificity (true negatives) of the integration would
be how many instances were correctly merged or split.
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Table 2.7: Translation cases between the curated sets and the integration. C is a set in
Icura. M is a set in I. a) - Match; b) - Mismatch; c) - Miss; d) No information.
Scenario Class 1.0 2.0 3.0 i0 i4
T = Translate(Icura, I)
T [C] = ∅ c) 29 26 36 40 19
T [C] = (∅,M) a), c) 144 81 102 120 124
T [C] = M a) 619 690 655 635 643
T [C] = (M0,M1, . . . ,Mi) c) 20 15 19 17 26
T = Translate(I, Icura)
T [M ] = ∅ d) 5616 6344 6682 5571 6293
T [M ] = (∅, C) d), a) 123 158 160 118 131
T [M ] = C a) 668 631 621 663 680
T [M ] = (C0, C1, . . . , Ci) b) 6 6 7 4 4
Table 2.8: Confusion matrices of the MNX and i4 integrations compared against the curated
sets.
MNX
Actual
≡ 6≡
P
re
d
ic
te
d
≡ 1915 57
6≡ 218 2579938
i4
Actual
≡ 6≡
P
re
d
ic
te
d
≡ 1889 28
6≡ 244 2579967
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The first test is to evaluate the MetaNetX integrated sets to test the performance of
the curated sets.
As an exception, the curated set splits the protonation set of a few compounds, namely
between H2O and OH, NH3 and NH4, H2CO3, HCO3 and CO3. All of these three sets
were found to be merged in all of the three version of MetaNetX references.
From the curated set it is possible to compute the amount of true positives and true
negatives edges such that φ(e) > ω. These are compared with the predicted clusters of
this study and with the MNX 3.0 integration. As expected the amount of true negatives
outnumbers the true positives (around 0.01% of the e ∈ Γ are true positives).
Given the selected configuration, our method resulted in less 50% of false positives (29
occurrences), while regarding false negatives there was an increase of 26 cases (Table 2.8).
In fact both numbers are similar, but it is hard to tell how exactly the MNX clusters
were integrated and if there was any post integration curation.
2.7 Conclusions
The bottleneck to cover more data sources is limited to how much effort is spent to de-
velop the ETL interface. The understanding of the data schema, but also the data access
mechanism of these databases is one of the most laborious tasks.
A quality integration is achievable, but errors are unavoidable. Having a more conser-
vative approach allows to generate more confidence in the clustering but in return more
instances are left unintegrated. Therefore, manual curation of data is necessary for a proper
consensus database, since it is unpractical to verify entire databases, this task demands
community curation efforts.
The integrated pipeline proven to be doable for on-demand integration of metabolites
and reactions fitting the needs for the user of how conservative should the final dataset
be, thus allowing to control the quality of the integration versus number of integrated
instances.
The curation function is a powerful method that allows to combine solutions of previous
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integrations but also external sets, allowing to include community curation efforts and other
sources of integrated databases.
The implemented data management system is designed to be flexible to the addition of
further domains of instances. By using the neo4j graph database it is possible to include
additional metabolic domains without having any negative impact with the previous en-
tities and methods, while taking immediate advantage of the entire system. This enables
incremental upgrade of the system, to include additional metabolic databases but also
other biological domains (e.g., genes and proteins databases).
Chapter 3
Standardization of Genome-Scale
Models
Abstract
Genome-scale metabolic models are a valuable instrument to study biological organ-
isms. They are capable of performing in silico prediction of phenotypes after genetic
or environmental changes. These models are built from the functional annotation of
the organism’s genes that assemble its biochemical network, allowing to expose the
enzymatic machinery of the organism.
The Systems Biology Markup Language (SBML) is the most common exchange for-
mat to describe these models, and it is widely adopted by many of the existing
software platforms within this field.
There are several limitations in the earlier versions of the SBML specification that
limits the annotation of many relevant attributes, such as: genes, constraints, reac-
tions and compounds references. Because of that, many tools implemented their own
methods to describe these attributes.
In this work, the SBML format is analyzed to create a framework that is capable of
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standardizing previous (or alternative) representation methods into the latest stan-
dards.
The implemented framework is used to address two case studies to conduct com-
parative analysis of genome-scale models. The first case study uses the pipeline to
standardize 108 models of prokaryotes providing a strong benchmark to test the suc-
cess rate of the integration methods. The second case study is the unification of
Saccharomyces cerevisiae models to generate a dedicated database that provides a
consensus view of yeast models.
The integration and standardization tools were implemented into a single module
in the KBase platform that improves the compatibility of the system with external
SBML models.
3.1 Introduction
In the last decades, sequencing technologies suffered many improvements, having the cost
of whole genome sequencing decreased significantly, and the availability of fully sequenced
genomes increased. This made genome-wide analysis projects more appealing and feasible.
From the genome, it was given the promise to decipher the machinery that keeps
cells functioning [95], allowing researchers to exploit the cellular capabilities, but also its
limitations, for a broad range of applications, such as, biotechnology, ecology, health, etc.
Functional annotation exploits this genetic blueprint to build computer models to ex-
pose these features. The first genome scale metabolic model (GSM) was developed in the
year 2000 for Haemophilus influenzae[113] allowing a genome wide pathway quantification.
Up to date, genome-scale modeling techniques and tools have been vastly improved.
Dedicated software tools provide better integration of many necessary tools to annotate
and assemble GSMs [29]. Automated pipelines were developed that are capable to scaffold
a GSM by only requiring its genome sequence [99, 6].
The Systems Biology Markup Language (SBML) was created to increase interoperabil-
ity between existing tools, allowing them to adopt a common exchange format for models.
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Although they share the same format, the earlier SBML versions had several limitations
regarding annotation options. Distinct research groups adopted their own methods to an-
notate important attributes in the SBML file, and in some cases in-house extensions were
developed.
In a recent work, Chindelevitch et al.[19] claimed that the current state for GSM pre-
dictions was inconsistent and an exact arithmetic solver is necessary for reproducibility
of the analysis. However, this was later counterclaimed[31], suggesting that most of the
problems found for miscalculation of the results was due to incorrectly parsing the models,
thus the main issue was the lack of standard representation. In fact, a major drawback of
the SBML is the lack of options to specify important attributes related to the annotation
of the model components[105], which led to an increasing number of different approaches
that were improvised by the modeling community.
For annotation (both metabolites and reactions), there are only a few tools. The
Metingear[85] is a Java application that allows automated annotation with support for
KEGG, MetaCyc, ChEBI, LipidMAPS and HMDB. The application requires users to setup
the databases which might not be practical. Metabolic databases are bulky and in many
cases the loaders gets deprecated with the update cycles.
Web applications (MetExplore[87], MEMOSys[100]) are more suited for this job since
they provide the data infrastructure to support the annotation, however these tools are
highly limited to the number of databases supported.
The purpose of this chapter is to explore the representation taxonomy of SBML GSMs
and develop strategies for unification and standardization of these models. In this chapter,
several interpretation methods were developed to extract relevant GSM attributes from a
variety of representation patterns that are found in published SBML models. A standard-
ization pipeline is implemented to unify SBML GSMs to the latest standards in a fully
automated approach.
The developed tool was applied to standardize 108 published GSMs of prokaryte mi-
croorganisms, providing a large sample of existing representation methods in SBML GSMs
and allowing to benchmark the developed tools. The pipeline was able to integrate in
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average 70% of the metabolites in these models with external database references.
In the second case study, several Saccharomyces cerevisiae GSMs were integrated for
comparative analysis. As a result, a standalone database was generated to catalog in-
tegrated models that represents the metabolism of yeast. The generated database was
enriched with additional information regarding yeast genomics.
Finally, an application was developed and made available for public usage in the DOE
Systems Biology Knowledgeable (KBase) platform, that allows to standardize SBML mod-
els. It includes automated standardization methods (e.g., medium identification, genome
strain detection, nomenclature translation), but also manual assignment of other compo-
nents such as: the biomass reaction, definition of compartments, user defined references of
metabolites, reactions and genes.
3.2 Constraint Based Genome-Scale Models
A genome-scale network reconstruction (GENRE) is a compilation of all possible biochem-
ical reactions that are available in an organism’s genome. With functional analysis tools,
it is possible to extract the metabolic functions of the respective genes to assemble a
metabolic network (MN). Therefore, each GENRE is actually a library that compiles all
the possible biochemistry of the organisms either inferred from the genome or extracted
from literature data.
The detail level of a GENRE is at the reaction level, metabolites are connected to each
other by a chain of biochemical transformations. Several efforts are made to increase the
detail of the models to add additional constraints, such as gene expression [80], protein
structure [12], or regulatory effects [34]. To date, most of the GSMs are solely composed
of metabolic constraints since they required less data.
Most of the reconstruction tools attempt to associate gene annotation with the bio-
chemistry of generic pathway databases (mentioned in the previous chapter). There are
several approaches to link genes with reactions, such as: extracting the EC number from
the genome annotation [28], standardizing the annotation with a controlled vocabulary[24],
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and protein orthology [1].
However, unlike the previous biochemistry databases, the reactions in genome-scale
models must be compartmentalized. The compartmentalization of a reaction defines in
which physical space of the cell it is occurring. When the reaction occurs in several com-
partments it is duplicated in the model, since the enzyme activity occurs in several places.
For bacterial models, this problem is simplified since most of these species have only 2-3
compartments (i.e., extracellular space, cytosol, periplasm), but for eukaryotes an addi-
tional effort is required to predict the subcellular localization of the enzymes. The transport
of molecules between compartments is possible by adding transporter reactions, which re-
quire the identification of membrane proteins that are capable to transfer compounds
between cellular spaces[27].
The completeness and the accuracy of a GENRE is coupled with the quality of gene
annotation in the organism genome. For species with less literature data, most the func-
tional annotation in the genome is most likely inferred by computational methods (e.g.,
protein similarity).
3.2.1 Constraint-Based Modelling
Constraint-Based Modeling (CBM) is a common alternative to kinetic modeling, which
requires mechanistic rates of the equations for each reaction. Kinetic models are hard
to simulate and to parameterize, requiring information difficult to acquire to accurately
simulate dynamic systems. For large-scale networks, this problem becomes intractable
[116]. In CBM approaches, the only critical parameters are the reaction stoichiometric
coefficients and reaction bounds, which are much more accessible. The basis of steady
state analysis is granted by the assumption that the system is at equilibrium, i.e. there is
no change in the concentration of the internal metabolites. This allows to define the feasible
space of the system by defining linear constraints, enabling to understand the capabilities
of the system under several conditions.
Flux Balance Analysis (FBA) [112, 98] (Definition 12) is one of the earliest CBM
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methods to explore cellular metabolism. Based on the assumption that the system is in a
pseudo steady state, it can be described, by a set of linear equations. In FBA, the organism
is assumed to pursue a certain metabolic goal in the form of a linear objective function
(3.1), which the FBA method uses to optimize the flux distribution that maximizes this
goal. The formulation of the linear program (LP) consists in the stoichiometric matrix
(S) of a MN with m metabolites and n reactions. The reaction boundaries are defined by
setting a lower and upper bound (3.3) coming from thermodynamics (reversibility), from
uptake rates or simply by setting large negative/ positive values (unbounded).
Definition 12. (Flux Balance Analysis) The FBA is defined by the following LP:
max Z =
n∑
j=i
cj.vj (3.1)
s.t.
n∑
j=1
Sij.vj = 0 , ∀i = 1, . . . ,m (3.2)
vLBj ≤ vj ≤ vUBj , ∀j = 1, . . . , n (3.3)
where Z is the objective function; Sij is the stoichiometric matrix with i metabolites and j
reactions; vj is the flux vector; v
LB
j , v
UB
j are reversibility constants (reaction lower/ upper
bounds).
The most common objective function is the biomass maximization, which represents a
proxy for cellular growth. Other functions may also be used, such as maximization of ATP
production or of the production of a certain metabolite.
The transformation of a GENRE to a GSM includes the addition of the mathematical
components that are necessary to formulate the LP to predict phenotype. Depending
on how complete and accurate is the genome annotation, the GENRE may have several
reactions missing that leave gaps in the biochemistry. Gap-filling algorithms[106, 55] add
missing reactions to connect the GENRE, which is necessary for a functional mathematical
model. These algorithms fill the missing reactions using heuristics to predict possible
reactions that are needed to fill the gaps (although they have no real evidence).
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Having a fully connected network still requires the addition of other components, that
are related to modeling purposes.
Biomass Reaction: The biomass reaction is the most common objective function (BOF)
in prokaryote GSMs. It is a pseudo-reaction that mimics cellular growth by assembling es-
sential macromolecules (e.g., DNA, RNA, protein, lipids, etc) and demanding their building
block compounds (e.g., nucleotides, amino acids, fatty acids, etc) as biomass components
[38]. This objective function is based on the assumption that cells evolved to optimize
the nutrient consumption towards growth potential. In a flux analysis perspective, the
biomass objective tests for the network capability to supply all the components, while still
maintaining the steady state constraint. Therefore, the participating components directly
influence the complexity of the GSM since a basic BOF demands fewer pathways.
Drain Reactions: The drain reactions allow to unbalance the network allowing model
consumption and accumulation of metabolites. These reactions are categorized into three
different types of drains: exchange, sink and demand reactions. The separation of the
drains is solely used for better manipulation of the model since not all drains have the
same meaning.
The exchange reactions are all drains that represent the change of concentration in the
media (or environment). These reactions are usually subject to software manipulation to
evaluate the model behavior in different media composition.
The demand and sink reactions are auxiliary drains that are necessary for the model to
carry a certain flux distribution (e.g., biomass production). As an example, a model may
require internal accumulation (in many cases only a residual value) of a certain compound
with unknown fate to synthesize a biomass component. It is also a common practice to
add sinks and demand reactions for debugging purposes.
Gene Protein Reaction Association: The connection between the genome and the
model is held by gene-protein-reaction (GPR) rules. The reactions in the GSM are assigned
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to genes in the genome that are responsible for the enzymatic activity. Because genes are
multi-functional and for certain reactions a multi-enzyme complex is required, a GPR is
described as a Boolean expression of the possible gene combinations that are necessary for
the reaction to take place.
3.3 Systems Biology Markup Language
The systems biology field is highly interdisciplinary since it bridges several omics technolo-
gies to study system wise interactions[59].
Many tools were developed to apply a variety of approaches to model these systems, but
most software applications receive as input and produce their own data formats, making
difficult to integrate and combine distinct tools. The Systems Biology Markup Language
(SBML) [58] was created to address the lack of interoperability between different software
tools in the systems biology field.
The SBML is a XML syntax that allows to represent several elements in the systems
biology universe. The first version of the SBML (SBML Level 1) was mainly oriented
towards dynamic models. Up to date, there are three versions of SBML: Level 1, 2 and 3.
The SBML allows to represent biological entities (species) and their interactions (reac-
tions) that take place in a container space (compartment).
Each species represents an entity (e.g., molecule) in a specific state, while reactions
transform species with a defined mathematical rate.
The scope of entities and attributes discussed in this work is oriented towards the
representation of genome-scale constraint based models. The main component of a GSM
is the stoichiometric network that is defined by the reactions in the model (Definition 12).
The SBML was subject to several updates since the first version (SBML version 1).
The main problem of the earlier versions was the limited capability to add annotations to
the GSM entities, that are relevant to characterize the molecules and reactions, such as,
information regard to genes, mathematical constraints and other important information to
aid the users to interpret the logic of the model.
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All elements of the SBML inherit the abstract base element SBase, that allows other
elements in the SBML to inherit a notes and an annotation sub-element and two at-
tributes metaid and sboTerm. These attributes were introduced after the SBML version 2
to improve annotation options. The sboTerm refers to the Systems Biology Ontology [22]
(SBO) being oriented to modeling terms that characterize components of several families
of objects found in models (e.g., SBO:0000243: gene). It allows categorizing elements in
the SBML that play a distinct role in the model. As an example, the biomass reaction
is described as a regular reaction in the SBML, while with the SBO annotation these re-
actions can be flagged with the proper ontology (i.e., SBO:0000629 biomass production),
which makes these reactions distinguishable from the remaining of the model.
A metabolite in the SBML is defined as an instance of a species (Example 6) identified
by the id attribute of type SId. The SId is a string used to identify objects in the SBML,
only alphanumeric characters are allowed and it must start with a letter or the underscore
character 1. All other attributes are optional (i.e., name, compartment, charge, initialCon-
centration, etc), but for the later versions of SBML the compartment is mandatory since
all species should be defined in a physical location.
Example 6. SBML species
<species metaid="EC0027_meta" id="EC0027" name="D-Glucose[e]"
compartment="Extra_organism" boundaryCondition="false" charge="0">
A reaction is defined by the reaction element, like the species the id is the only re-
quired attribute. The reaction element contains four sub elements, the listOfReactants
and listOfProducts that define the stoichiometry of the reaction by referencing the
species. The kineticLaw (Example 7) was the initial method to define the reaction
constraints and the objective function. The listOfModifiers is less common in a GSM,
and when present most of the models use it for a structural definition of the GPR instead of
a string annotation. In rare occasions, it also defines an enzymatic catalyst (SBO:0000460).
1SId pattern: ( |[a-z]|[A-Z])( |[a-z]|[A-Z]|[0-9])*
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In these cases, the application of ontological terms is crucial for the understanding of the
logic of the entities.
Example 7. SBML Kinetic Law
<kineticLaw>
<math xmlns="http://www.w3.org/1998/Math/MathML">
<ci> FLUX_VALUE </ci>
</math>
<listOfParameters>
<parameter id="LOWER_BOUND" value="0" units="mmol_per_gDW_per_hr"/>
<parameter id="UPPER_BOUND" value="1000" units="mmol_per_gDW_per_hr"/>
<parameter id="FLUX_VALUE" value="0" units="mmol_per_gDW_per_hr"/>
<parameter id="OBJECTIVE_COEFFICIENT" value="0" units="mmol_per_gDW_per_hr"/>
</listOfParameters>
</kineticLaw>
The species and reaction elements are sufficient for the structural representation of
the GSM since together they are capable of describing the stoichiometric matrix. This is
usually the only requirement to run flux analysis methods. However, interpretation of the
model context usually requires additional information. For gene prediction, the reactions
have to be assigned with their respective genes (GPRs), while for better interpretation
of the metabolic content, the structural information regarding the metabolites should be
present because of the ambiguity in compound nomenclature.
The standard SBML supports two methods for extra annotation. The notes (Example
8) element allows to declare an HTML body to annotate every element of the SBML,
since it is defined in the parent SBase abstract class. This would be an easy solution for
the annotation problem, and in fact for human interpretation this is sufficient to describe
entities in the SBML. However, it is not suited for software tools to parse and interpret
the annotation since it is text based, while it is also subject to the proliferation of errors
and ambiguous definitions.
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Example 8. SBML Notes
Annotation of a reaction with notes to specify GPR and Subsystem
<notes>
<body xmlns="http://www.w3.org/1999/xhtml">
<p>GENE_ASSOCIATION: (b1377 or b0929 or b2215 or b0241)</p>
<p>SUBSYSTEM: Transport, Outer Membrane Porin</p>
<p>EC Number: </p>
</body>
</notes>
An alternative approach is to use the annotation (Example 8) element. It provides a
structural approach to annotate any SBML element. Usually, the annotation mixes the
RDF specifications with model qualifiers to provide ontological information. The usage of
BioModels.net Qualifiers[78] provides an ontology to specify the meaning of the relationship
(e.g., is: identity, encodes: encodement, hasPart: part, etc), which is extremely important
since, in most cases, the tools make general assumptions that everything assigned to each
other shares a relationship of identity. However, as described in the previous chapter,
molecules and reactions may share an hierarchical relationship (since some molecules are
sub-instances of others).
The annotation element solves the problem of having a structural method to spec-
ify the relationship between the object and the annotated instances, but it does not
solve the issue of how to provide a standard method to characterize the annotated in-
stance. As an example, in the previous chapter it was described that mapping synonyms
of databases is a major bottleneck of the ETL (e.g., KEGG, KEGG Compound, Ligand
Compound are all possible synonyms to describe an instance from KEGG). The Mini-
mal Information Requested In the Annotation of biochemical Models (MIRIAM) [75] and
later the Identifiers.org [62] provide standard methods to reference external resources. The
MIRIAM registry catalogs biological resources providing standard Uniform Resource Iden-
tifiers that points to the actual web address of these resources, while Identifiers.org is built
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on top of MIRIAM to provides an URL for these resources (e.g., http://identifiers.org/ec-
code/1.1.1.1 is the URL of the MIRIAM urn:miriam:ec-code:1.1.1.1).
Example 9. SBML Annotation
Annotation of a compartment with a GO accession using Identifiers.org with a identity
relationship.
<annotation>
<rdf:RDF xmlns:rdf="..." xmlns:bqbiol="...">
<rdf:Description rdf:about="#Extra_organism_meta">
<bqbiol:is>
<rdf:Bag>
<rdf:li rdf:resource="http://identifiers.org/obo.go/GO%3A0005576"/>
</rdf:Bag>
</bqbiol:is>
</rdf:Description>
</rdf:RDF>
</annotation>
The Flux Balance Constraints (FBC) is an extension that was introduced in the latest
version of SBML (the SBML Level 3) providing structural representation for elements
related to constraint based models. The FBC extension includes structural definition for
genes and GPRs (Example 10). The genes are defined in a list of entities similar to
the species and reaction, allowing proper annotation of genes in a GSM. The GPR
expression was also redefined as an XML elements instead of a string annotation.
Example 10. SBML FBC3 GPR definition
Each gene must be defined as an element, this would allow to add additional properties
to genes (annotation).
<fbc:geneProduct fbc:label="ECSF_3582" metaid="G_ECSF_3582" fbc:id="G_ECSF_3582">
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<annotation>
<rdf:RDF xmlns:rdf="..." xmlns:bqbiol="...">
<rdf:Description rdf:about="#G_ECSF_3582">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="http://identifiers.org/ncbigi/GI:281180792" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF>
</annotation>
</fbc:geneProduct>
The GPR are represented by XML elements instead of a string and all genes must be
declared in the model.
<fbc:geneProductAssociation>
<fbc:or sboTerm="SBO:0000174">
<fbc:and sboTerm="SBO:0000173">
<fbc:geneProductRef fbc:geneProduct="G_ECSF_3582" />
...
</fbc:and>
<fbc:and sboTerm="SBO:0000173">
<fbc:geneProductRef fbc:geneProduct="G_ECSF_3586" />
...
</fbc:and>
</fbc:or>
</fbc:geneProductAssociation>
Since the previous kineticLaw was not fit for constraint-based models, the FBC also
defines specialized elements to describe one or more objective functions, while the reaction
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constraints must also be declared as variables. The lower and upper constraints are defined
as the lowerFluxBound and upperFluxBound attributes in the reaction element and they
are references to elements in the parameters of the model. A listOfObjectives allows to
define one or more objective functions, which was a limitation of the previous version.
The FBC is an official SBML extension, but in the mean time, researchers developed
external extensions to fit their needs. Most of these extensions were developed to solve
problems related to annotation methods that existed prior to the SBML Level 3 and the
FBC.
However, there are a few unstructured annotations that were introduced or assumed in
the SBML GSM due to the lack of SBML structural support. An important aspect is the
explicit definition of the drains (i.e., exchanges, sinks, and demands), since they are highly
relevant for the manipulation and interpretation of the model.
3.4 Model Standardization
To accommodate GSM objects in the CDS defined in the previous chapter (Section 2.3.2),
the domain is extended with a GSM context. Genome-scale metabolic models belongs to
the modeling domain. Like the previous domain of biochemical entities (metabolites and
reactions), genome scale models are viewed as a materialization of these abstract objects
to actual biological organisms.
Each GSM is represented as an individual database in the system, where a unique
namespace is assigned to each individual model. The subset of the GSM namespace is
defined in Ngsm ⊆ N that groups all objects in the universal graph database.
Each metabolite species s is an individual object, and like the previous objects it must
belong to a unique namespace. In this case all modeling objects must belong to a n ∈ Ngsm,
which are the GSM namespaces.
Definition 13. Model Metabolite Specie / Metabolite / Compartment / Gene
The metabolite species, metabolites and compartments in GSM are objects o = 〈id, n, a〉
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(Definition 1), such that n ∈ Ngsm.
The set of species S represents metabolite species of the GSMs, and Mgsm is the set
that defines metabolites in models. In GSMs, a metabolite may be defined as several
species because of compartmentalization.
The compartments and genes are also materialized as objects and they are defined in
the K and Y domains.
Definition 14. Model Reaction
The reactions in GSM are defined as objects (Definition 1, 13), such that the stoichiom-
etry is defined with a set of edges E that connects the reaction with the metabolite species
(Definition 3).
Of all the previous objects the metabolite species and reactions are the only needed to
defined the stoichiometric matrix of the model, G ′gsm = 〈S ∪ Rgsm, Egsm〉, while the full
GSM context is defined in the following subgraph Ggsm = 〈K ∪ S ∪ Mgsm ∪ Rgsm Y ∪
M∪R, Egsm〉, that contains the domain of metabolite species S, model metabolites, model
compartments K, genes Y , model reactions Rgsm, metabolites M, reactions R and model
edges.
3.4.1 Metabolites
The standardization of the metabolites requires the identification of the metabolite species
in the GSM and the translation of these species to a common nomenclature. The method
to standardize the species follows the following steps:
1. Identification of the species context;
2. Expansion of the species annotation;
3. Resolution of internal annotation conflicts;
4. Resolution of overall annotation conflicts;
5. Translation of the species.
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The first two are annotation steps, which are related to annotating the species with
an identity. The metabolite identity is actually a molecular structure, therefore a proper
external database identifier is a common method to describe compounds in GSMs.
The following two steps are related to error correction. Metabolite species that are
annotated with multiple identifiers of the same database become ambiguous (assuming
these identifiers represent different molecules). This occurs for many reasons, such as
problems with the database itself, inaccurate compound structure, integration problems,
etc. Cleaning these conflicts is necessary to translate the nomenclatures to a common
standard.
Lastly, the standardization of the species involves their renaming to a common naming
system, such as the adoption of a single database identification system, or by generating a
new unified space.
Each step is detailed next.
Identification of the species context and expanding the species annotation: The
first two steps of the standardization process are actually the most important steps of the
process. A correct annotation of the species in the model would avoid the need for conflict
resolution. The integration of the metabolites in GSM combines two types of functions, ψ
and ϕ.
Definition 15. Metabolite Species Identification
The molecular identity of the species is inferred by the ψ : S 7→ M. This function is
referred as the species annotation function that annotates metabolite species in the GSM
with database identifiers, thus adding chemical detail to the compounds.
Definition 16. Metabolite Integration
The integration function ϕ : M 7→ M, extends the annotation with additional identi-
fiers to cover more database references (i.e., metabolic database integration).
In a GSM not all species may have a concrete representation, depending on the context
some species are mathematical objects for modeling purposes (e.g., the biomass, a protein,
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a lipid, etc).
The ψ function attempts to guess the species context from the attributes found within
the model. In SBML, the species only requires an unique identifier and a declared com-
partment, the uncertainty level is much higher compared to the integration of database
molecules.
Guessing the species context is done by applying several ψ functions, each of these
trying to guess based on different approaches (e.g., identifier parsing, name matching,
annotation parsing, etc). The Ψ set is a ordered tuple that contains all of the ψ,
Ψ = 〈ψ0, . . . , ψi〉. (3.4)
The metabolic integration functions ϕ expand the initial annotation of ψ by using
metabolite context, since at this stage information of the annotated references may be
inherited by the species. This method is identical to the previous metabolic database
integration methods that allows to infer other instances of the same metabolite in different
databases.
Unlike ψ, the annotation functions can apply subsequent ϕ functions, and so the Φ set
is a n-ary tuple that contains several ordered sets of ϕ functions,
Φ = 〈〈ϕ00, . . . , ϕ0j〉, . . . , 〈ϕk0, . . . , ϕkj 〉〉 (3.5)
where each Φk set represents the k -th set of Φ.
The ζ× defines the Cartesian product of Ψ with Φ, this generates the paring between
all the functions of ψ and ϕ (Example 11).
Example 11. Function Pairing
Ψ = 〈ψ0, ψ1〉 Φ0 = 〈ϕ00, ϕ01〉 Φ1 = 〈ϕ10, ϕ11〉
ζ× = (〈ψ0, ϕ00, ϕ10〉, 〈ψ0, ϕ00, ϕ11〉, 〈ψ0, ϕ01, ϕ10〉, 〈ψ0, ϕ01, ϕ11〉,
〈ψ1, ϕ00, ϕ10〉, 〈ψ1, ϕ00, ϕ11〉, 〈ψ1, ϕ01, ϕ10〉, 〈ψ1, ϕ01, ϕ11〉)
Each element of ζ× is actually the composition of the functions ψ and ϕ that together
map species s into subsets of M ∈ M. The annotation of s is an array of binary values
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that assigns 1 (or true) for each m ∈ M if it is a positive match. The annotation matrix
is the concatenation of all annotations arrays given by the combinations in ζ×.
Definition 17. Genome-scale Metabolite Integration
The integration function ζ : S 7→ Za×b, is the cartesian product of the Ψ and Φk sets,
such that, ζ = Ψ× Φ0,× · · · × Φk
For every function in Ψ and Φk a confidence value (λ) between 0 and 1 (inclusive) is
assigned, and the Ψλ and Φλ sets map those values to their respective functions (Equation
3.6).
Ψλ = 〈λ0, . . . , λi〉, Φλ = 〈〈λ00, . . . , λ0j〉, . . . , 〈λk0, . . . , λkj 〉〉 ∈ R, 0 ≤ λ ≤ 1 (3.6)
The integration array is the scoring array for every m ∈ M, where mi > 0 is assumed
as positive match.
ζλ = Ψλ × Φλ0 ,× · · · × Φλn (3.7)
Like ζ×, the ζλ combines the λ constants, but since 0 ≤ λ ≤ 1, then the product ∏λ
must be between 0 and 1. The ζλ represents the combined score of the functions in ζ×
(since ζλ = Ri.k.j, where i is the total number of ψ functions and k.j the total number of
ϕ functions).
The matrix ζ×(s).ζλ

〈ψ0,ϕ00...ϕkj 〉 ... 〈ψ0,ϕ0j ...ϕkj 〉 〈ψ1,ϕ00...ϕkj 〉 ... 〈ψi,ϕ0j ...ϕkj 〉
m1 a1,1 . . . a1,k.j a1,k.j+1 . . . a1,i.k.j
m2 a2,1 . . . a2,k.j a2,k.j+1 . . . a2,i.k.j
m3 a3,1 . . . a3,k.j a3,k.j+1 . . . a3,i.k.j
...
...
...
...
. . .
...
mm am,1 . . . am,k.j am,k.j+1 . . . am,i.k.j

.

λ0 ∗ λ00 ∗ · · · ∗ λk0
...
λ0 ∗ λ0j ∗ · · · ∗ λkj
λ1 ∗ λ00 ∗ · · · ∗ λk0
...
λi ∗ λ0j ∗ · · · ∗ λkj

=

s1
s2
s3
...
sm

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defines the annotation scoring for every m ∈M given by the total of i ∗ k ∗ j combinations
of the Ψ and Φ functions.
The implemented methods for ψ and ϕ are described in the implementation section.
Conflict resolution: The integration array of ζ×(s).ζλ may map multiple references of
the same database to a single model species, but such occurrences create ambiguity with
the identity given to the compounds.
The internal annotation conflicts are all species that are annotated with more than one
reference of the same database. As a general rule, for every s ∈ S only one metabolite
per database can be assigned. These conflicts are solved by selecting the metabolite with
higher score.
The external annotation conflicts are metabolites that are mapped to multiple species
in the same compartment. It is expected that models have only one replicate per compart-
ment.
Translation: The translation step standardizes the identifiers to a common nomencla-
ture system. A popular practice is to adopt a naming system from one of the metabolic
databases since it also allows a closer connection with the database records with the model.
For translation into a database identification system, metabolite species are renamed
by the assigned annotation and the compartment identifier is attached as prefix since all
identifiers must be unique model wise.
3.4.2 Reactions
The stoichiometry of the reactions in Rgsm is defined by a map function s : Rgsm×S 7→ R.
This is a simpler representation compared to the LHS/RHS tuple for the reactions in
R (that are the reactions in metabolic databases) because the stoichiometry of model
reactions must have unique metabolite species in both sides of the equation. This is due
to the fact that transporter reactions actually operate on two distinct metabolites objects
instead of repeating the metabolite.
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Reaction annotation The integration of reactions is similar to the method implemented
in the previous chapter (Section 2.4.3). However, GSMs contain several transport reactions.
In this work, these reactions are excluded from the integration. Transporter reactions are
difficult to annotate and catalog since every compound may have a transporter associated,
making the catalog of the reactions irrelevant. For the same reason, most of the databases
do not contain any transporter reactions with the exception of a few to describe some
essential mechanisms of certain pathways.
Merging identical reactions Some models have two different reactions to represent
reversible reactions. While the use of this method has some drawbacks it is in some
cases inevitable. The disadvantage of having twice the amount of the reactions to define
reversibility is the requirement of algorithms to decipher the number of actual reactions
in the model, but also makes the model bulky and most softwares to not interpret these
reactions as a single reaction but as independent biochemistry.
Cases where it is inevitable to have multiple reactions for the same biochemistry occur
when an organism contains several enzymes that are capable to perform the same reaction
but some are limited to a certain direction.
Reactions are merged based on their GPR associations and reversibility, the conditions
for merging are the following:
1. All reactions have the same biochemistry;
2. All reactions have the same GPR assigned;
or
1. All reactions have the exact equation.
As an example, if r1 = A+B → C+D and r2 = C+D → A+B have the same GPR (or
in some scenarios no GPR assigned at all), it is safe to merge into r1/2 = A+B ↔ C +D.
If reactions of opposite direction have distinct GPR associations, then this would break
the logic of the model, since in the unmerged version it would be possible to knock out the
direction of the reaction, while in the merged version this would be impossible.
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Combining reactions Many models use pseudoreactions to model the biosynthesis of
macromolecules or groups of compounds. In this case, the biomass reaction demands a
virtual compound such as a lipid, protein, or in some cases an abstract set of metabolites
(e.g., cofactors). These compounds are aggregations of the molecules that are responsible
for satisfying their demand.
In a design perspective, this allows better control of the sets, but perhaps also easier
manipulation of the model. However, it makes harder for software tools to decipher which
are the actual components of these virtual compounds. If these compounds are identified,
an equivalent single step reaction can be generated.
For this purpose a set of reaction arithmetics is defined as the following:
• The scalar multiplication of the reaction coefficients scale(λ, r) or λ.r, where λ ∈ R
and r ∈ R, multiplies the value of each component in the r stoichiometry by λ.
• The arithmetic operation sum(r1, r2, λ) sums the coefficients of r1 with the result
of scale(λ, r2), this would allow basic subtraction and addition (i.e., +(r1, r2, 1) =
sum(r1, r2, λ) and −(r1, r2,−1) = sum(r1, r2, λ)).
• The null(r1, r2,m) generates an equivalent reaction by merging r1 and r2 and removing
m from the stoichiometry.
Definition 18. Reaction combination
null(r1, r2,m) = sum(r1, r2, λ), where λ =
−1.r1[m]
r2[m]
3.4.3 Drains: Media/Sink/Demand
One of the most common scenarios (typically for GSMs of single cell organisms) is the
growth of the cell in a certain environment commonly represented as the growth medium.
The medium defines which of the external metabolites are available in the environment
for uptake, in a modeling perspective these are drain reactions as described in the previous
section.
A common problem is to identify these reactions in the metabolic network. The drains
in the SBML format are represented as any other standard reaction, and in many cases
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they are difficult to differentiate.
There are several possible methods to define drains, but some representations require
manipulation of the stoichiometric matrix before running flux analysis methods. The
boundary compounds are usually dead end metabolites defined in a special compartment
(the boundary) that encloses the entire network (Equation 3.8). However, for flux analysis
methods these compounds must be either removed or drained (adding a further drain to
unbalance each boundary compound).
Ae
R EX A−−−−−→
[-10, 1000]
Ab (3.8)
The best drain representation would be a single reaction that contains no products
with only the metabolite to be drained (Equation 3.9). The constraints would define if the
drain is either for demand, sink or both.
A
R EX A−−−−−→
[-10, 1000]
∅ (3.9)
However, in some models the stoichiometry of the drain is reversed, making harder to
detect if the metabolite is being accumulated ou consumed (since negative flux in this case
is accumulation), but the net flux of the compound would be equivalent.
∅ R EX A−−−−−→
[-1000, 10]
A (3.10)
In reversible scenarios, the drain reactions can also be split into two reactions one for
each orientation (Equation 3.11). In these cases the previous merging strategy is applied.
A
R EX A IN−−−−−−→
[-10, 0]
∅+ A R EX A OUT−−−−−−−−→
[0, 1000]
∅ (3.11)
Finally, some models may couple compounds together for flux forcing (Equation 3.12).
In these cases splitting would not generate an equivalent model, therefore these reactions
are kept and an individual drain is generated for each of the compounds.
A+H
R EX A−−−−−→
[-10, 1000]
∅ (3.12)
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The drains are standardized to the single compound representation (Equation 3.9), and
renamed to the compound identifier with a drain prefix. The R EX prefix is assigned for
every compound drained in the extracellular space. For other drains, these are renamed to
R DM if lower bound is negative, otherwise it is R SK . Each of these three drains are also
assigned with their respective SBO terms SBO:0000627, SBO:0000628 and SBO:0000632
to represent exchange, demand and sink, respectively.
3.4.4 Gene-Protein-Reactions
In most models, the only connection between the model and the genome is assured by the
gene-protein-reaction associations (GPR). The genes in the genome that are responsible
for the occurrence of the reaction are assigned by a Boolean expression commonly referred
as GPR. This method allows a very simple but efficient way to describe all possible com-
binations of genes that enable the presence of the reaction (e.g., gene1 ∨ (gene2 ∧ gene3)).
Before the FBC3 extension, the representation of the GPR was mainly assigned as a
string annotation in the notes section. This creates two problems, the difficult interpreta-
tion of the notes attribute which was discussed above, and the need of additional software
validation for the GPR string.
Equivalent Boolean expressions can be written by switching the order of the terms.
To define a standard comparable order for any expression, a normal form is advised be it
either the conjunctive or disjunctive. For modeling purposes the disjunctive normal form
would be more suitable since it defines all possible gene combinations for the reaction to
occur.
To have a standard comparable expression, the GPRs are rewritten in the disjunctive
normal form and the variables sorted in lexicographic order.
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MetabolicModel ModelSpecie
ModelMetabolite
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Figure 3.1: Neo4j Labels defined for the CDS namespace domain extended with GSM
objects. Metabolite, Reaction and SubcellularCompartment were pre-exiting classes.
3.5 Implementation
The integration of a GSM is similar to the integration pipeline proposed in the previous
chapter. The neo4j constraints are extended with the GSM objects (Figure 3.1).
Each GSM is also subject to an ETL pipeline (Figure 3.2), but no cleansing is made
to the data, the attributes and annotation (i.e., notes and annotation elements) found
within the model are kept as it is. The responsibility to interpret the data is given to the
integration method.
For the extraction phase, a SBML reader is implemented from scratch using the existing
XML parsing methods. No reaction context is applied to integrate the GSM reactions. The
reactions in the GSM may contain unbalanced and custom reactions, which are likely to
feed incorrect information, but the reactions in the model are assigned with database
reactions and not the reverse. However, models are able to integrated against each other,
allowing to infer reactions that are not present in databases but shared between multiple
GSM.
The standardization made to the model (includes all automatized fixes and manual
changes to the original SBML data) is kept in a separated attribute. This is important to
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Figure 3.2: GSM integration pipeline. An ETL pipeline loads the SBML into the graph
database. The model integration module annotates the loaded objects with the existing
metabolic database instances.
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Figure 3.3: The abstract XmlObject class allows to specify any element of an XML file (the
namespace is excluded). The XmlSbmlModel represents the sbml element in the SBML
file. The reader is implemented for the purpose of parsing all elements that are relevant to
a GSM.
preserve the original data for validation purposes, but also to track all changes made to
the original model.
3.5.1 SBML Reader, Validation, Profiling
Instead of using the JSBML library [109], a new reader is implemented that parses the
SBML as a standard XML. The parser is implemented in Java using the XMLEventReader
to parse all XML elements. This will allow to read any SBML file even if it violates any
of the SBML schema definitions as long as the XML is properly structured.
Since the SBML provides support for a wide range of systems biology models, the
reader was implemented to only read components related to constrain-based modeling
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(i.e., stoichiometric models for flux analysis).
The base object is an abstract XmlObject (Figure 3.3) that stores the line and column
of the XML element, its attributes and the body. In SBML, the elements usually do not
contain data.
For every element, a specific interpreter is implemented, while elements without an
interpreter are skipped and a report is provided to notify all unprocessed XML objects.
The data structure for the read components from the SBML follows a hybrid generic
XML format with some SBML syntax. Every object in the XmlSbmlModel inherits the
XmlObject that contains information about the line and column, the attributes and the
data of the element.
Compartments, Species, Reactions The basis of a GSM is the metabolic network
of reactions. The definition of the three core components is specified in three lists in the
SBML (listOfCompartments, listOfSpecies, listOfReactions). An element parser is
dedicated to each of the list objects (compartment, species, reaction).
External references detection: The notes and annotation are the elements that are
searched for external references. To parse references from the notes, a dedicated parser is
implemented to transform the HTML information into a map notes : k 7→ v, that for every
representation of key k in the HTML body, maps to its corresponding string value v. As
default, the ”:” symbol is used as split separator for the key and value, and it is assumed
that every record is written in a single HTML paragraph (i.e., between the paragraph
elements <p></p>). An additional mapping function is needed to decipher the meaning of
each key, to map these into the database namespaces (declared in the universal database
G previously).
Unmapped elements are given a warning to notify unusual keywords.
The annotation element is easier to parse since the XML element iterator is enough to
pass through all elements. The reader extracts only elements enclosed by the is BioModels
Qualifier since it is looking for the identity of the compounds and reactions. Other qualifiers
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may be implemented in the future, but there is little use for additional ontology at the
current state of the methods.
GPR detection: The GPRs are extracted from three distinct places: notes, modifiers,
and geneProductAssociation. The method to extract from the notes is identical to the
one used for references defined above. The HTML block is converted into a simple map and
a mapping function is required to decipher the key that corresponds to the GPR expression
(the default keyword is GENE ASSOCIATION ). If the value is present it is subject to an
expression parser to validate but also extract the genes. The parser is taken from the
OptFlux metabolic engineering software [107].
The second approach is to detect the GPR expression from the modifiers. Many tools
adopted the listOfModifiers element which is a child of reaction to provide a structured
method to represent a GPR. In these scenarios, each modifierSpeciesReference element
references a species element that represents a gene while together they assemble the or
expression. To define the and expression a species is declared to represent the enzyme
complex and a reaction must be declared to consume the required genes in order to
produce the enzyme complex. The reader reverse engineer these occurrences by generating
the equivalent GPR expression and flags these reactions and compounds as genes since
they influence the total numbers with a naive reader.
The last approach is to extract the FBC geneProductAssociation. The assembly of
the GPR expression from the FBC is trivially achieved by iterating the XML elements.
The only validation required is to verify if all genes are declared in the SBML.
3.5.2 Metabolite Integration Methods
In this section several implementations of ψ and ϕ methods are described. The following
methods define implementations of ψ:
Metabolite identifier: The compound identifier is a mandatory attribute for all com-
pounds in the model. In many cases, it is common that the identifier is inherited from
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a metabolite identifier of a metabolic database (commonly the one used for model recon-
struction).
Since the identifier must be unique for each species, to represent the metabolite in
different subcelullar locations, usually a suffix is added. By a general rule, this suffix is
usually the identifier of the compartment. Also, the prefix M is commonly given to every
compound since the SBML specification disallows species elements to start with a symbol
or a number.
Let As be a set of all identifiers of metabolic compounds in a model, then if ss ∈ As
represents an external database identifier i ∈ {id(m)|m ∈ M}, then i is a substring of s.
However, there may exist several database identifiers that are substrings of s since it is
possible that database identifiers be substrings of each other (e.g., o2 is substring of h2o2
in the BiGG identifiers). In this case, the largest i that is a substring of s is accepted, in
scenarios where two distinct identifiers of same size are the highest match they are both
discarded.
The Aho–Corasick algorithm[2] is used for fast substring matching. The algorithm as-
sembles a finite state machine that is a prefix tree from a finite set of strings (or dictionary).
The integration method builds a prefix tree from a set of identifiers (usually from a single
database to avoid conflicts).
For each s ∈ As that matches i in the identifiers set, the prefix and suffix of the
unmatched portion are extracted (e.g., given s = M o2 c and i = o2, the match generates
a prefix M and suffix c). After matching every element in As, the prefixes and suffixes
frequencies are calculated and, for every match that generated a prefix or suffix with
frequency lower than a reject threshold, it is assumed as a false positives.
Name Dictionary: In many cases, the model inherits the names of the database metabo-
lites. Name matching receives a dictionary with compound names assigned to database
identifiers, and only exact string match is accepted.
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Model References: The reference function annotates species by extracting the existing
annotation found within the SBML. The fields scanned for references are the notes and
annotation elements as described above. The method requires a translation map t : k 7→
N that maps the keywords k to database namespaces of metabolites in M.
Manual Annotation: The manual annotation function receives an external file and
assigns their respective metabolite species. The purpose of this function is to provide
manual curation but also allows to receive feedback from external data such as annotation
from the supplementary files of publications. It applies a direct mapping function t : s 7→
M that maps species identifiers s to metabolites in the database.
In this work, only a single ϕ function was implemented:
Reference Expansion: The references are expanded using the integrated metabolite
space provided by I an argument. The I (Definition 8) is a set of metabolite sets, which
represent the clustering of identical metabolites from multiple sources (i.e., databases).
This integrated metabolite space can be either generated using the database integration
methods in the previous chapter, using external sources (e.g., other integrated databases
such as MNXRef), or by using a manually curated set.
The reference expansion function is highly flexible since it can receive any cluster set
of integrated metabolites I, and it is does not have to be a fully integrated set since it will
only expand references with the information given by I.
This allows to combine the confidence scores λ with the layers of Ψ to tune the inte-
gration, by using different sources of I to generate a consensus integration.
3.5.3 KBase Application
The work in this chapter is implemented in the DOE Systems Biology Knowledgebase
(KBase) platform2. KBase is an open source data platform that provides computing in-
frastructure to perform large-scale genome functional analysis.
2http://kbase.us
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The workflow in KBase is done by manipulating a narrative interface that is imple-
mented over the jupyter notebook framework. Users can assemble their pipeline by com-
bining existing applications that are available in the application catalog.
The SBMLTools3 module was implemented, providing two applications to improve the
compatibility of the existing ones with external SBML models. The first application is
dedicated to import SBML models, while the second provides a more customized inter-
face to integrate and modify model components, which were not possible to automatize
(e.g., compartments, malformed GPR, etc). This allows users to configure and adapt the
imported models even if they do not fit the needs of the KBase system. At the time of
writing, the module is available in the beta catalog.
KBase Development Environment The KBase SDK (kb-sdk) provides basic tools
to configure and scaffold the initial configurations of a KBase module. The modules are
KBase application projects that may implement several functions, that are run in a Docker
container. A module development life cycle consists of three stages: development, beta,
release. The initial state (development) is only exposed in the appdev environment4 of the
platform. This is an isolated environment for the purpose of testing, and it provides access
to application publishing options.
Once the module is functionally ready, it can be migrated to the beta stage, that
becomes available in the general platform. Finally, to release the module, a request must
be sent to the KBase system for release approval.
The SDK tool provides helper functions to configure the application, the kb-sdk init
function allows to scaffold the initial module layout and its base configuration (Figure
3.4). The platform supports several technologies (python, Java, R or Perl) to build the
modules, although each module can work only with one of these. The SBMLTools module
is implemented with the Java configurations.
The spec file in the root directory allows to specify the data types, the functions with
3https://narrative.kbase.us/#catalog/modules/SBMLTools
4http://appdev.kbase.us
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Figure 3.4: The layout of a KBase module. The default configurations are automatically
generated with the SDK program.
the input and output data structures available in the module, as for Java projects the
specified data types are generated with the jsonschema2pojo to generate the object class
files. The spec file uses a domain specific language implemented for KBase that is similar
to the type definitions in the C language and the JSON schema. The module contains a
single Server and Client file that provides an interface between the platform engine and the
program logic. Every function defined in the spec file generates a function in the Server
and Client file. The function defined in the Server file holds the logic of the program,
while the Client functions provide the remote procedure call functions for the client (the
platform itself or other modules).
A narrative application interface is declared in the narrative methods sub-folder for
each function to be exposed. Not every function defined in the module must be a graphical
application in the application catalog, but to turn these functions into applications a
narrative specification must be declared. Each narrative application is specified by two
files, the display.yaml declares the HTML text of the interface while the spec.json maps
the input and output parameters of the server with the interface widgets.
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The interface configuration is limited to the widgets implemented in the KBase narrative
system. Currently, it supports text fields, text blocks, check boxes, combo boxes and
combined groups.
The input and output arguments of the widgets can be integrated with the narrative
workspace. As an example, a text field can be filtered to select only objects of a certain
type (e.g., FBAModels) in the workspace for easier usability.
Model Import The ”Import model SBML from web” application allows users to import
SBML models into the workspace (Figure 3.5). This application transforms SBML files
into KBase genome-scale model objects (KBaseFBA.FBAModel) and saves them in the users
workspace. The application also provides automatic annotation of the SBML compounds
and reactions.
Because of the limitations of the narrative interface specification, to import a model
the application must fetch the model from a HTTP web link (e.g., Github, personal web
storage, etc) since no file upload widget is allowed.
The only required field for the importer application is the SBML URL, all other options
are optional. The BOFs can also be assigned in this application, but this is optional since
it can be done in the follow up application.
By default, the importer application performs automatic annotation of the compounds
and reactions.
KBase Nomenclature Integration The ”Integrate Imported Model into KBase Names-
pace” application is the follow up step to integrate external GSMs into the KBase system.
This application allows to perform many tasks to reshape external models to fit the KBase
platform.
In the KBase system, some compartments have logical meaning, and the most relevant
compartments are the extracellular space and the cytosol. The extracellular space is re-
quired to attach the media for flux analysis methods. The application does not provide
any automated guessing of the compartments in the model. It its up to the user to specify
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Figure 3.5: Interface to import SBML files from the web in the KBase application. 1 -
Web URL to download the model (XML or ZIP for multiple import). 2 - Specification
of the biomass reaction. 3 - Perform annotation when importing (both compounds and
reactions). 4 - Delete compounds with boundary condition assign as true. 5 - Output
KBase object name.
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the GSM compartments using the interface options (Figure 3.6) to assign the imported
compartments to the KBase standards.
In the KBase system, the media and the GSM are separated into two different objects.
This allows users to configure and share the media independently from the models.
The application allows the user to specify the medium object in the output field. This
is not a mandatory field, however if specified, it will strip all the drains in the model
and generate a KBase medium object to the workspace. If the extracellular compartment
is integrated, only these drains are stripped to the medium, and the others are assigned
as demand and sink reactions. The object also inherits the default exchange constraints
specified in the model.
The imported GSM is assigned by default to an empty genome. All GSM models in
KBase are attached to a genome object, this integrates the genes of the model with data
from the genome features.
The application allows to assign a genome object from the workspace to be integrated
with the model. It will attempt to match the features in the genome with the genes in the
GPRs of the model. All genes in the model that were not possible to integrate with the
assigned genome are removed and reported in the output.
The KBase platform indexes the entire set of prokaryotic genomes of the NCBI Refer-
ence Sequence (RefSeq) database[104]. The Apache Solr search server is used to create a
search index for many genomic features, that includes annotation, sequences, aliases and
taxonomy. The search kbase solr function of the KBSolrUtil module is used for automated
detection of the GSM genome, this option is enabled if no genome is manually specified.
The application requests a Solr query to retrieve all gene features with identifiers or aliases
that match each gene in the GPR expressions from the model. The genome that covers
most of the genes is automatically assigned to the model, and a copy is given as output to
the users narrative. Similar to manual genome assignment, the genes that do not match
any feature in the assigned genome are removed from the model and reported. In this case,
other genomes (if any) that also had matches, are reported with a matching percentage.
Manual configuration of the model features is also possible in the advanced options. It
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Figure 3.6: Interface to integrate external models into the KBase namespace. 1 - KBase
FBAModel to integrate (from workspace). 2 - KBase Genome to integrate with the model
(empty for automated detection). 3 - Manual assignment of the compartment logic. 4 -
Compound and reaction renaming (ModelSEED / KEGG / BiGG). 5 - Delete boundary
compounds. 6 - Rewrite compound names / formula / structure according to the Mod-
elSEED annotation. 7 - Biomass reaction selection (from the selected FBAModel in option
1). 8 - Manual GPR rewrite. 9 - Manual ModelSEED annotation. 10 - KBase model recon-
struction template (gram negative, gram positive, core and plant). 11 - Generate KBase
Media object from drains (empty to keep drains). 13 - Output integrated FBAModel name.
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includes manual assignment of the GPR with the reactions and the manual annotation of
the compounds.
The translation option allows to rename the compounds and reactions with either Mod-
elSEED, KEGG or BiGG identifiers from the annotation.
Like the importer application the BOF can also be reassigned, but in this stage model
context is available, that allows users to select and search a reaction from a list of reactions
that are found in the model.
3.6 Case Study: Prokaryotes GSM integration
Over the last years, hundreds of bacterial GSMs were manually curated and some had
several rounds of reannotation and reconstruction. In this case study, over 100 prokaryote
GSMs were selected for a semi-automated integration, where the main purpose is to assess
the BOF of these models for the presence or absence of essential components. The models
were collected by Xavier et al. [127] for a follow up research in the biomass formulation of
prokaryote GSMs.
In a prokaryote GSM, the biomass reaction is usually the primary and only objec-
tive function which allows to determine if the cell viability in different conditions after
environmental and genetic modifications.
There is a high discrepancy between GSM BOF, and many models have several BOF
for debugging, different conditions, etc. In a genome-scale scope most of the BOF con-
tains nucleotides, amino acids, and fatty acids for the DNA, RNA, protein and lipids but
regarding to ions, organic cofactors and prosthetic groups these are usually missing.
The enzymes that are related to biosynthesis or transport of these compounds usually
have less literature content, which also implies that the annotation and the knowledge
regarding the origins of these compounds are less to be known, making many GSM miss
reactions regarding these compounds, and in some cases the entire pathway is not present.
To assess the models, first a SBML profiling is conducted to detect possible incon-
sistencies in the SBML structure, followed by the standardization pipeline to unify the
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Figure 3.7: XML Schema’s included in the 108 imported models. Annotation methods
using notes and annotation element corresponds to the usage of the xhtml and RDF
XSD, respectively. The KeyValueData and Metabolic Flux XSD are unofficial SBML
extensions.
metabolite and reactions nomenclature.
3.6.1 Model Characterization
The models are interpreted with the implemented reader and the COBRApy reader for
comparison purposes. From the 108 models, 13 SBML files were not accepted by the
COBRApy library for several reasons: missing identifier attributes, non-unique identifiers,
problems building the stoichiometric model. The implemented reader was able to read all
the models since the only requirement is a syntactically valid XML file, but depending on
the severity of the detected issues some models must be subject to user curation in order
to be viable. The reader is able to fix some issues presented with the COBRApy reader
such as duplicate or missing reaction identifiers, since for reactions these can be generated
automatically. User intervention was required to fix reactions that lacked the species
attribute in the stoichiometry.
An initial SBML profiling shows a variety of XML XSD included in the models (Figure
3.7). The most popular SBML version is the SBML Level 2, which is perhaps related
with the time frame when these models were developed, but also with the use of model
reconstruction tools.
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The versions before SBML3 did not have any semantics to represent genes and flux
constraints. Most of these models relied on ad hoc representation of these parameters using
the generic field to write HTML notes, and the kinetic parameters fields. The problem with
such methodologies is the need to define custom keywords to describe the properties, and
nothing forbids different tools from using different notations to describe these properties,
hence losing the whole purpose of interoperability between software platforms/tools.
A few unofficial community developed SBML extensions were also found (Figure 3.7).
The Metabolic flux model annotations [115] enable reactions to annotate flux analysis re-
sults (such as FBA solutions or other methods), but also include the constraints used,
which improves the reproducibility of the analysis. The KeyValueData is another commu-
nity extension to add a dictionary data structure for the annotation element, avoiding
the usage of the notes element to add arbitrary attributes. It is supported in the PySCeS
[96] framework for cellular modeling.
For a correct interpretation of these models, the parsing of these extensions was imple-
mented in the reader even though their frequencies are low.
On average, 70% of the metabolites were able to be integrated (Figure 3.8), however
some models showed very low integration ratio, in many cases these are models without
any compound annotation while having numerical generated identifiers.
Models that include genes as compounds compromise the total number of metabolites
but also the annotation. The iSB1139 GSM shows a 65% of integration, having more than
50% of species annotated with BiGG. In fact, the total numbers are much higher since
30% of the metabolites are representing genes. This was observed for only three models:
iJC568, iMLTC806cdf and iSB1139, each of these models would have annotation above
90% if genes compounds were removed from the model.
Models that use custom identifiers without providing proper names and annotation
often include additional information in the supplementary materials. However, to properly
annotate these models, such information must be transferred to the SBML and in many
cases the supplied data cannot be directly transferred since they are not organized in regular
tables (the addition of intermediate headers and comments implies dedicated parsers). The
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Figure 3.9: Contribution of each database to identify ids and names of the model species.
iSS352, iKK446 are examples of these models, since they are not provided in SBML but
assembled from spreadsheets.
In general, when the identifier annotation is low, it implies that these models do not
follow database identifiers, but instead they use their own abbreviations. The few matches
are all occurrences of commonly shared identifiers that usually match with the BiGG
naming system (e.g., adenosine triphosphate is commonly abbreviated as ATP).
The iYS432 identifiers did, however, found to be originated from the MetaCyc database,
but minor modifications were made to the identifiers because of the dash ”-” character,
that was replaced by the underscore. This provides room for improving the identifiers
method to include MetaCyc identifier search without dashes. Nevertheless, the MetaCyc
identifiers shown to be the least popular for model reconstruction.
The identifiers method was able to detect in average 30% of the metabolite species
across all models (Figure 3.9), while the BiGG database was the most adopted nomencla-
ture followed by ModelSEED, and together they cover 40% of all identifiers in 108 models.
For readability sake, the identifiers from BiGG are usually preferred since they are abbre-
viations of compound names. Regarding to names, the ModelSEED is the most popular
followed by ChEBI, KEGG (compound) and MetaCyc.
3.6.2 Flux Analysis
Correct interpretation of the mathematical attributes of the model is essential to obtain
the correct results from the flux analysis methods. In some models, default assumptions
may break the model. In most scenarios a zero growth is easier to fix than having an
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Table 3.1: Manual corrections applied to GSM.
Model Action Scope Action
iHK760 Remove b species delete
iJW145 Remove b species delete
iCA1273 Remove b species delete
iRsp1095 Free Exchange exchanges Bound → ]−∞,∞[
iRsp1140 Free Exchange exchanges Bound → ]−∞,∞[
iGT196 Keep Boundary species keep
iLca12A 640 Free Sink exchanges Lower Bound → −∞
iLca334 548 Free Sink exchanges Lower Bound → −∞
iLca12A 640 Manual Uptake exchanges Upper Bound
iLca334 548 Manual Uptake exchanges Upper Bound
incorrect numerical value since this would require additional knowledge about the model
to understand the proper flux ranges.
Only a few models had SBO terms annotated, while for most models that did contain
ontology terms these were annotated in the parameter element5. In the species element
(compounds), three models had the enzyme, protein complex and metabolite terms6 to
distinguish the elements between compounds and genes. As for reactions, no terms were
found to help identify the biomass or drains.
The biomass reaction was manually selected by Joana Xavier. Given these reactions
it is essential that their components are standardized into a single nomenclature system
for comparison purposes. The integration pipeline was ran to translate all the metabolites
into the BiGG universal compound nomenclature for ease of interpretation. It was also
necessary to standardize the compartment naming system, since these prokaryote GSMs
often include only 3 or 2 compartments; with the exception of the cyanobacteria, all the
compartments were manually curated.
Manual modifications were made (Table 3.1) in a few models, including manual as-
5SBO:0000625: flux bound and SBO:0000626: default flux bound.
6SBO:0000014:enzyme, SBO:0000297:protein complex and SBO:0000299: metabolite.
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Figure 3.10: Default read and optimize test using the original and standardized versions.
signment of the exchange fluxes, removal of metabolite species ending with a prefix, and
allowing boundary species.
To test the reader interpretation and standardization, a flux balance analysis was ran
for each model using the default media and the selected biomass reaction. The COBRApy
library is used with both versions of the model (the original and standardized version), the
only modification made was the selection of the biomass. The cobra.io.read sbml model
function call is used without any parameters to read the model. It is understandable that,
for some models the specification for removal of certain compounds is necessary (usually
ending with the b suffix), but the purpose of this test is to assess the default interpretation
of the models. To run flux analysis the optimize() function is used and the objective value
attribute is used to compare the results.
For most of the models that were able to optimize using both versions, the solution
remain equal for both with only a few exceptions. The standardized models were able to
enable default optimization for 15 models that gave zero growth flux using the original
version. Additionally, 13 became parseable after fixes (some required manual intervention)
and were able to obtain default growth rate for the selected biomass. Only 3 models
remained with zero growth for both of the versions.
3.6.3 Genome Integration
The integration of the GSM with its genome is often complicated due to several facts:
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• In some models, the GPR associations are not transfered to the SBML (in these cases
they are usually described in publication supplementary data). A possible reason is
the limitation of the tools used that are not capable of writing the GPR expressions
in the SBML.
• The genome may suffer updates from the time of the publication. These changes can
be the entire merge of an organism with another (e.g., duplicated species), changes in
the gene nomenclature or removal of genes.
• The ”standard” identifier of the genes may be subject to change.
With the integration application implemented it was possible to automatically detect
the genome for 61 models (Figure 3.11), that is a total of 51 distinct genomes (since some
have several models). The total amount of metabolic genes vary between organism and
the total number of open reading frames in the genome.
In a previous study[71], the authors show that for prokaryotic species the number of
metabolic genes may range on average between 15% to 20% of the total amount of genes.
The numbers found in the 61 GSM correlate well with these results. Some models shown
significant improvements from earlier versions, the Clostridium acetobutylicum ATCC 824
(iJL432, iCAC490 and iCac802) display an increase from 10.9% to 18.6% of metabolic
genes and Streptomyces coelicolor A3(2) (IB700 and iMK1208) with an increase from 8.5%
to 15.5%.
Most models had a few genes that were not found in the genome, in many cases ficti-
tious genes. The s0001 was present in many models to represent spontaneous reactions,
another example is a fictitious gene to represent gap filled reactions, but these scenarios
are dependent on the application used to build the model. Some models may include genes
from another close organism, where it is likely that the model was built using comparative
genomics. Nonetheless, the number of genes not found are residual compared to the total
genes in the model.
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Figure 3.11: Automatic genome detection using the KBase SOLR search (highest match
of all genes in the GSM). Match - genes in the GSM found in the matching genome; Miss
- genes in the GSM not found in the matching genome; Other Genes - fraction of the
remaining genes in the genome.
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3.7 Case Study: Yeast GSM
The design of metabolic networks requires several rounds of iterations to build, refine, and
test the models. Of all metabolic reconstructions, only the Escherichia coli and Saccha-
romyces cerevisiae had an extensive refinement from several research groups, along with a
highly annotated genome due the extensive research that is conducted with these species.
There are several genome scale models available for the Saccharomyces cerevisiae, some
inherited from previous reconstructions, others developed independently. Due to the dis-
crepancy in the number of annotated open reading frames, and the variety of metabolites
and reactions in these models, comparative analysis shows moderate divergence of the sim-
ulation results between these models. In a previous study, Heavner et al.[51] described
that the OptKnock algorithm [14] would suggest different targets when different models
are used, but all representing the same organism. A common problem of validating these
models, is the lack of (genome-scale) experimental evidence of the internal fluxes, while
most of these models are validated in a black-box fashion. The most common benchmarks
to validate GSMs is to test if they are capable in predicting a certain phenotype (e.g.,
growth, compound utilization and production, essential genes).
The goal of this study is to create an integrated GSM space of several Saccharomyces
cerevisiae models and extend this domain with additional information to enrich the data
(e.g., additional information regarding genes, compounds, etc) for yeast research and mod-
eling projects.
Ten of the published yeast GSM were selected for integration, most of them developed
before SBML Level 3. Therefore a diverse variety of annotation and nomenclature methods
were found (Table 3.2).
The iMM904, iAZ900, iND750 use the BiGG naming system, that adopts the metabolite
names from the BiGG database to identify their species. Practices such as these allow to
easily match the information of the metabolites with the database, without need of using
annotation strategies in the SBML.
However, the BiGG database does not provide metabolite structural information, and
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must be obtained from other referenced databases such as KEGG or MetaCyc. The BiGG
database contains only a few of the published GSMs, therefore not all metabolites may be
present. In this case the iAZ900 is an external model that contains a few custom BiGG
identifiers.
The consensus models of the yeast (Yeast 1, 6, 7) uses the annotation element to
reference external resources.
Integration becomes complicated when there is no information available in the SBML
models. This leaves the only option to analyze the annotation strategy in the SBML file
to scavenge any property that may be relevant to decipher the species.
An example is the iLL672 GSM. To infer the annotation of the iLL672 GSM, the edit
distance of the name strings was analyzed. The name of the species were compared with
the names found in the BiGG database. Many names were similar to the names given to
the BiGG compounds. This allows to rank the metabolites with minimum edit distance.
But, as shown in the metabolite naming system, the name of biochemical compounds are
usually ambiguous.
Most models had species identification higher than 70% (Figure 3.12). A particular
case is the big difference between the annotation of the species between the Yeast 6.06
and Yeast 7.6. While the first model had a near full annotation, the Yeast 7.6 dropped
to the lowest of all models. The Yeast 7.6 improved the fatty acid elongation process by
unfolding the generic metabolites to the concrete representation of the fatty acids. This
implies replicating the generic fatty acids pathway with each of the defined versions of the
fatty acids, which increases the amount of species and reactions by many folds.
Reaction integration detected several internal duplicates across all models. The pres-
ence of enzymes that perform identical reactions but with limited reversibility must gen-
erate two reactions, as described in the previous section. In the iMM904 model, gene
YMR303C encodes the reaction that converts ethanol to acetaldehyde, while the genes
YOL086C, YGL256W and YBR145W perform the reverse operation. It is impossible to
combine the four of these genes because they dictate different reaction constraints, however,
the last three can be combined together into a disjunctive expression.
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Table 3.2: Yeast metabolic models. iFF708 provides GPR in PDF supplementary files.
Yeast 6/7 did not annotate subsystems for reactions. Genes - (Found in reference
genome)/(Total in model)/(Total protein combinations). GPR annotation method: PDF -
PDF document; XLS - Spreadsheet document; Notes - SBML notes element, Mod - SBML
reaction modifiers element.
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iFF708 None 63 810 4 1382 ? (PDF) ?
iLL672 None No 672 1(3) 1194 871 (XLS) 659/660/660
iND750 BiGG 56 1177 8 1266 810 (Notes) 748/750/677
iMM904 BiGG 59 1392 8 1577 1043 (Notes) 902/905/843
iAZ900 BiGG 60 1404 8 1597 1049 (Notes) 899/901/845
iIN800 None 62 985 3 1706 1199 (Notes) 705/707/707
iTO977 XLS 105 1213 4 1562 1046 (Notes) 947/961/874
Yeast 1 RDF 60 1457 15 1857 1407 (Mod) 832/832/770
Yeast 6 RDF ? 1623 16 1888 1180 (Notes) 900/900/818
Yeast 7 RDF ? 2386 16 3493 2302 (Notes) 909/909/829
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Figure 3.12: Percentage of metabolite species mapped to at least one metabolite from a
database.
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Figure 3.13: Number of duplicate reactions within each model. Blue - strict direction.
Orange - ignores direction.
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In some models, where the number of duplicates were much higher, it is clear that the
number of reactions do not represent the actual count of distinct biochemical activities in
the model. This includes the iFF708, iLL672, iTO977 and Yeast 1, that duplicates the
reaction for any reversible enzyme (one for each direction).
Examples of internal duplicates were found in several GSM, such as the following oc-
currence in the Yeast 7.6 model:
ID Stoichiometry Genes Association Bounds
r 1148: s 0665→ s 0666 YIL013C OR YOR011W ]−∞,∞[
r 1760: s 0666→ s 0665 ]−∞,∞[
This is an example of possible duplicates since the flux bounds are set to be unbounded
(i.e., reversible), and thus, the orientation of the components of the stoichiometry is irrel-
evant. By using the same comparison methods from the reaction integration, it is possible
to find orientation distinct (the example above) or exact duplicates (Figure 3.13).
There are two levels of integration in the GSM. The first is to find equivalent re-
actions within the resources, this allows to further annotate the reactions of the GSM.
Second, models are also integrated against each other. Unlike the previous case study, the
yeast models are integrated against each other. Reactions not found within the metabolic
databases may be shared among models, allowing to identify reactions that are unique to
these models.
It is possible to observe that iAZ900 and iMM900 share a large common set of reactions,
since one is inherited by the other. The Yeast 6.06 is very similar to Yeast 7.6 but the
opposite is not true, since most reactions found in Yeast 6.06 are present in the Yeast 7.6.
The Yeast 7.6 contains twice as many reactions of any other GSM in this study, therefore
its maximum similarity is limited to a fraction compared to the remaining models.
The mapping of species plays a great deed in the integration of the stoichiometry.
Models with lower coverage will eventually display poor results in the integration of the
reactions. As an example, the iLL672 and iTO977 model shown low similarity. But, this is
not the only reason for the lack of integration. By inspecting a few reactions, it is possible
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Figure 3.14: The percentage of reactions that are equal compared agains each model.
MODELID 222668 - iND750; ymn6 06 cobra - Yeast 6; ymn7 7 cobra - Yeast 7
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Table 3.3: Identification of the reactions in GSM with databases. Model - reactions found
in another yeast models. Database - reaction found in a database. Both - reaction found
in at least one model and one database.
Model Database Model Any Both KEGG MetaCyc BiGG
iFF708 0.38 0.87 0.87 0.37 0.32 0.31 0.32
iLL672 0.22 0.48 0.49 0.22 0.18 0.19 0.20
iND750 0.70 0.98 0.99 0.69 0.51 0.47 0.68
iMM904 0.60 0.91 0.91 0.60 0.43 0.41 0.58
iAZ900 0.59 0.90 0.90 0.59 0.43 0.40 0.57
iIN800 0.29 0.80 0.65 0.27 0.23 0.22 0.23
iTO977 0.28 0.80 0.67 0.27 0.25 0.24 0.25
Yeast 1 0.58 0.84 0.84 0.57 0.49 0.47 0.50
Yeast 6 0.41 0.90 0.90 0.41 0.35 0.34 0.36
Yeast 7 0.21 0.50 0.50 0.21 0.18 0.18 0.18
to detect dubious stoichiometry within these models. In the iTO977 several examples of
reactions with missing co-factors (e.g., R FUM1 1, R IPP1) were identified. The missing
species from the stoichiometry of the reactions miss the integration with the remaining
models.
A total of 504 genes were present in all the 9 GSMs (excludes iFF708), while a few
genes were exclusive to 5 models, the iLL672, iAZ900 and Yeast 6 had 2, 2 and 3 exclusive
genes. The latest model of Yeast 7 had 11 unique genes and the iTO977 included 44 genes
being the model having most exclusive genes. The number of genes in the most recent
models are similar, but there are small changes to the genes included (Figure 3.15), and
these changes are much higher when compared to the GPRs in the models. As an example,
iMM904 and iAZ900 share a similar amount of genes compared to the consensus models
Yeast 1, 6, 7 (similarity index >0.85), but when it comes to proteins these numbers drop
to 0.79 compared with the Yeast 7.
The biomass composition is one of the differentiation aspects of these models, from the
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Figure 3.15: Comparison of genes and GPRs with Jaccard similarity index. a) - Individual
genes. b) - Proteins (all and combinations in GPRs)
earliest model to the latest the biomass defined to yeast displayed several modifications on
both coefficients and components.
The composition of biomass decides how complex the network reconstruction is. As
an example, a simple biomass requires less pathways, thus a smaller (incomplete) network
satisfies the growth condition.
From the yeast models a total of 11 biomass formulations were collected and tested
against each other (Figure 3.16). For the components that are not compatible with the
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Figure 3.16: Growth rate of the yeast models by applying cross-model biomass equation.
Left axis: consumption and production of compounds, Right axis (bar plots): growth rate.
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model (i.e., the metabolite is not present in the model), these are discarded from the
biomass.
For DNA, RNA, and protein most of the BOFs were identical except for the iLL672
and iTO977 models, that only differ in the weights.
The riboflavin was the only cofactor in the yeast biomass (except iFF708, iND750,
iIN800, iTO977), only the iLL672 included other cofactors (NAD, FAD, thiamin triphos-
phate, coenzyme-a, tetrahydrofolate, protoheme).
3.7.1 The Metabolic Integrated Yeast Knowledgebase
The Metabolic Integrated Yeast Knowledgebase (MIYeasTK) was created to catalog the
metabolites, reactions and genes of the 10 integrated yeast models, but also integrating the
genes with the Saccharomyces Genome Database (SGD) database. This work was done
in collaboration with several colleagues in the research group (Christopher Costa- web
interface and SGD integration, Sophia Santos - data curation) The database provides and
integrated view of all the metabolites, reactions and genes of the models standardized to
BiGG identifiers as aliases. Each individual component can be displayed in the integrated
view that shows the occurrence of the entity in other models.
The SGD is integrated with the GPR associations of each model, transferring phenotype
information from the SGD to model genes.
The compartments were standardized to the BiGG system, additional compartment
aliases were created for the ones that did not exist in BiGG. Several efforts were also made
to unify the pathway annotation to assign universal pathway identifiers between each of
the models.
The application is implemented in Node.js, using the Neo4j as database, the REDIS in
memory database is used to cache the table information to speed up filter operations. The
Neo4j database is assembled from the universal graph database G into a dedicated version
for the yeast models. The translation methods were applied to generate the BiGG aliases
to the compounds for better user readability.
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Figure 3.17: Metabolite display interface. 1 - Metabolite information. 2 - External links
to metabolic databases. 3 - Reactions with the metabolite present. 4 - Other versions of
the metabolite (in other compartments and models).
The metabolite display (Figure 3.17) provides external links to the model compounds,
also linking reactions where the compound participates and other versions of the same
compound. This offers to users a better browsing experiment to navigate between the
GSM entities.
Like the compounds, the reactions (Figure 3.18) also displays links to external databases,
other identical versions of the reaction across the models, and the GPR is also integrated
allowing the user to browse the genes individually to explore other reactions that are as-
sociated with the gene.
3.8 Conclusions
In this chapter, many of the existing representation methods dedicated to genome-scale
modeling were covered. The implemented standardization pipeline allows both reshaping
the model representation, but also annotation of the model content with external database
references, since they are equally relevant to enable comparative analysis of different mod-
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Figure 3.18: Reaction and gene display interface. 1 - Reaction information. 2 - GPR
association integrated with gene display. 3 - External links to metabolic databases. 4 -
Other versions of the reaction. 5 - Gene information. 6 - SGD phenotypes associated with
the gene. 7 - External references to the gene. 8 - Reactions associated with the gene (across
all models).
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Figure 3.19: Output report for the fully automated integration of the 108 models using
the implemented KBase application.
els.
The implemented application was proven to be capable to automatically annotate a
SBML model with a high success rate (Figure 3.19) compared to the customized usage of
the pipeline. Although there are examples where the implemented methods were unable
to guess the compounds, these were quite a few (and it was only possible in the case
study with the addition of data from supplementary materials). In these situations, the
models usually contain user made string patterns (e.g., name concatenation with formula),
being unpractical to cover each of these individual scenarios. Still, the proposed solution
is flexible to the addition of new integration logic with few implications in the existing
methods.
The extension of the domain logic of the CDS proven that the system is flexible to in-
clude additional domains without the need to reformulate previous implementations. This
was demonstrated with the addition of SGD genes and phenotype data in the MIYeasTK
database.
The integration of GSM content is data intensive, the implemented solution in the
KBase platform provides the infrastructure necessary without requiring users the necessity
to setup several databases. For most of the GSM that included GPR within the model,
the application was able to detect the correct genome from the RefSeq repository.
The standardization tools make comparative analysis of existing GSM more practical,
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while it also provides a recycling method taking advantage of the curation efforts in the
GSM models to improve future reconstruction and annotation.
Chapter 4
Pathway Optimization
Abstract
Metabolic Engineering targets the microorganism’s cellular metabolism to design new
strains with an industrial purpose. Applications of these metabolic manipulations in
Biotechnology derive from the need of enhanced production of valuable compounds.
The development of in silico metabolic models proposes a quantifiable approach for
the manipulation of these microorganisms.
These systems are also prone to be represented as networks, taking advantage of
different graph-based paradigms, including bipartite graphs, hypergraphs and pro-
cess graphs. This chapter explores these representations and underlying algorithms
for metabolic network topological analysis. The main aim will be to identify poten-
tial pathways towards the optimized biochemical production of selected compounds.
Related to this task, algorithms will be designed aiming to complement networks of
specific organisms, taking as input larger metabolic databases, inserting new reactions
making them able to produce a new compound of interest.
To address these problems, and also related tasks of data pre-processing and evalu-
ation of the solutions, a complete computational framework was developed. It inte-
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grates a number of previously proposed algorithms from distinct authors, together
with a number of improvements that were necessary to cope with large-scale metabolic
networks. These are the result of problems identified in the previous algorithms re-
garding their scalability.
A case study in synthetic metabolic engineering was selected from the literature to
validate the algorithms and test the capabilities of the implemented framework. It
allowed to compare the performance of the implemented algorithms and validate the
proposed improvements.
4.1 Pathway Optimization
4.1.1 Synthetic Pathways
An important branch of ME deals with the exploration of nonstandard routes of cellular
metabolism. These routes involve metabolic activities possibly occuring in several organ-
isms. Application of these hybrid pathways is mostly related to the synthesis of nonnative
substrates in a specific microorganism, although other applications such as the study of
metagenomic communities will also involve the analysis of these heterologous pathways.
The design of these pathways involves several steps. The first step is to select a proper
chassis (host organism) to be used as a basis for synthesis. This chassis can be computation-
ally represented by a metabolic network or model, if this is available for the microorganism,
allowing simulation using constraint-based methods (detailed in one of the next sections).
In the following step, a suitable set of reactions must be identified that are capable to
perform the synthesis of the compound of interest, from a set of source metabolites assumed
to be available (produced by the host internal metabolism). For the reactions that exist
in the host’s metabolic portfolio, those are mapped to a set of encoding genes. For the
ones that do not exist in the host, a suitable donor organism needs to be identified and the
gene needs to be inserted into the genetic material of the host, using genetic engineering
techniques.
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From a computational point of view, the problem of finding a suitable set of reactions
will be a combinatorial search to identify suitable (sub)sets of reactions from a metabolic
domain, matching a specific set of constraints and, optionally, maximizing one or several
criteria. This task will be referred in this work as pathway optimization, when an objective
function is used to rank each set of reactions and the purpose is to maximize/ minimize
it, and as pathway enumeration when the target is to enumerate all possible subsets that
obey a given set of constraints.
An identical task seeks to find the pathway that enables the biodegradation of a target
compound. In this scenario, the set of reactions added, instead of producing will consume
the compound of interest leading to the production of compounds of interest.
While the host selection was defined as the first step, in many cases it is a problem
deeply entangled with pathway optimization. Indeed, in some cases, the order of the tasks
can be reversed, dealing first with the selection of interesting pathways and, afterwards
selecting the best host to support these pathways. The criteria to evaluate the pathways
and their interconnection with the host will be summarized in a later section of this chapter,
although the complexity of this matter is out of the scope of this text.
There are several studies conducted on synthesis problems both with experimental
results or just considering a computational analysis. Valuable compounds such as butanol
[5], artemisinin [121], vanillin [46] or curcumin [67] were successfully engineered over several
host microorganisms.
Regarding computational methods, there is a vast portfolio of algorithms available in
the literature that are capable to discover and enumerate heterologous pathways. These
are explained in more detail over the next sections.
4.1.2 Metabolic networks and graphs
In computational biology, Metabolic Networks (MN) play an important role being their
more common and simplest representation attained by the use of regular graphs. The words
network and graph are even commonly used interchangeably. In biological networks, nodes
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are typically biological entities such as genes, proteins or metabolites, while graph edges
represent relationships between those entities (e.g. reactions in metabolism, regulatory
interactions, signaling cascades). In the metabolic context, nodes are typically metabolites
and edges are chemical reactions which transform metabolites, acting as substrates and
products. A diversity of chemical compounds connect to each other performing chain
transformations of compounds, termed as metabolic pathways.
Metabolic networks have been studied in detail and they usually exhibit typical char-
acteristics of scale free (the majority of the nodes have very low degree, while a few nodes
have a very high degree) and small world networks (average path length is smaller than
what would be expected of a random network of the same size) [60]. In graph analysis
methods, these properties will bring some challenges.
In ME applications, these networks are often studied for their robustness, while other
analyses can be performed to understand the average diameter for each organism network
and the difference between related and unrelated organisms [82].
Taking graph representations as metabolic domains, path searching algorithms can be
used to extract minimal length sequences of transformations between compounds with the
purpose of identifying viable pathways [26]. These make the most straightforward ap-
proaches to pathway optimization. Enumeration of possible paths is also possible, but the
problem significantly grows in complexity, even considering these simple representations.
There are several studies conducted using graph paths to infer pathways from MNs.
Most of these are able to enumerate pathways computing k-shortest paths between com-
pounds. Other stochastic methods such as k-walks have also been applied to deal with the
complexity of these networks. Also, the DESHARKY algorithm [108] uses Monte Carlo
Markov Chains to generate solutions for both biosynthesis and biodegradation problems.
4.1.3 Limitations of regular graphs
For more complex tasks, graph representations are too simplistic since they do not fully
represent the biological meaning of metabolic transformations, once many functionalities
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are much more complex than the information regular graphs can contain. One important
example is the fact that chemical reactions are interactions involving typically more than
one input and more than one output, thus not being well defined by a regular graph edge.
Related to this issue, in most scenarios, the shortest path between two compounds in
a graph does not represent a biological meaningful path, since chemical reactions usually
contain cofactors and pool metabolites (e.g, ATP , NAD, H2O, H
+). The high connectivity
of these compounds reroutes the shortest path (that is directly translated from a MN) to
favor pool metabolites, which in most cases leads to biological meaningless solutions [36].
One solution to overcome this problem is to strip cofactors and pool metabolites (also
known as currency metabolites) from the network, leaving most reactions with a single
substrate and a single product. This, however, involves user expertise and manual curation
of the network. Also, by removing the entire set of currency metabolites, it is impossible
to obtain solutions that are able to synthesize these compounds (e.g. ATP).
An alternative is to apply weights to each compound node based on their degree [36].
Compounds with high degree are penalized, allowing shortest path methods to find the
proper route avoiding currency metabolites. Nonetheless, false positives remain a problem,
but compared to the previous solution, the usage of compound weights does not require
chemical knowledge about the content of the network.
Additionally, graph-based systems analyzed are usually limited to linear paths over the
graph. This is an important limitation since many relevant biochemical reactions have
two or more substrates and/ or compounds. One solution to overcome this limitation is
the implementation of further techniques to infer branched pathways over regular graphs.
One of the earliest solutions is provided by the ReTrace method [103]. This algorithm
involves the computation of minimal pathways, which in turn was proven to be NP-hard
by reduction to the minimal set cover problem.
Apart from the mentioned solutions, these limitations have been addressed both enrich-
ing the representation, for instance with set systems, and considering additional biological
information. Both approaches will be addressed in the following sections.
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4.1.4 Atom Mapping
As mentioned previously, a major limitation in graph paths is the identification of the
correct transitions between substrate/ products (i.e., edges) due to the presence of pool
metabolites that induce short length paths that are biologically meaningless. The solutions
presented previously involve the arbitrary specification of these metabolites or of arbitrary
weights which may help to soften the problem, but in general do not provide a final
solution. A common characteristic of graph representations of metabolic networks is that
the compound itself is irrelevant for the context. In a metabolic graph, the compounds are
usually presented as vertices with some unique identifier to distinguish different compounds,
and the actual characteristics of the compound are all discarded (e.g. the chemical formula
or structure). In this scenario, shortest path algorithms have a hard time to predict
biological meaningful paths.
The atom mapping approach attacks the substrate/ product routing problem using the
chemical structure of the compounds involved in the reaction. A solution to overcome this
problem is to descend to a lower level where compounds are bound by atoms instead [10].
The key principle behind this approach is to track atom conservation between reactions,
making it possible to infer meaningful paths between two compounds.
The application of the maximum common subgraph algorithm [3, 10] allows to track
the conservation of carbon atoms between substrates and products, and therefore the
conservation of carbon atoms in an entire pathway. This methodology requires no explicit
assignment of currency metabolites or any heuristics to avoid these.
The KEGG Reaction pair database [72, 73] stores mapped solutions for each reaction (if
available) of the KEGG reactions based on graph theoretical methods of common subgraphs
of chemical structures.
This allows to bypass the requirement to atom map the reactions since they are already
pre-computed. This information allows to easily access linear paths between compounds
by filtering the correct transitions [35, 50].
A disadvantage of these methods is the necessity of knowing the chemical structure
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of the compounds. Additionally, some compounds feature generic structure (e.g., the R
placeholder), and such structures can be dealt if this does not interfere with the atom
conservation [50].
4.1.5 Set Systems
To address the limitations of regular graphs, several other models have been used to study
these systems. There are several representations of graph structures depending on what
level of information is captured (Figure 4.1). A common transformation is to unfold reac-
tions into a bipartite system, such that vertices can be of two types representing compounds
and reactions, while edges represent the interactions between compounds and reactions (i.e.
a certain compound is a substrate or product of a reaction defining the direction of the
edge) [23].
One alternative is the application of the so called set systems to represent chemical
reactions, which allows to capture more complex network topologies. In these systems,
entities representing reactions connect to a set of vertices instead of the binary relationships
between two nodes in regular graphs. Moreover, this allows to overcome many problems
related to directed graph search, for instance branching pathways and pool metabolites.
Structures such as hypergraphs [69] or process graphs [39] (which are similar to directed
bipartite graphs) are set systems representations, which are capable to model chemical
reactions with higher detail. This allows to address the problem of multiple products and
reactants, since edges connect to vertex sets instead of a single vertex.
Process graphs were used by Friedler et al [39, 40, 41] in an exhaustive approach for
decision mapping in synthesis processes, being later adapted for pathway identification
[79]. More recently, the work of Carbonell et al [15] introduced an enumeration strategy
to extract pathways using hypergraphs. Both algorithms are enumeration approaches that
attempt to list all possible pathways towards the desired target.
Although using these more robust structures some problems are solved, other limi-
tations still arise. The complexity of enumerating minimal pathways was proven to be
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Figure 4.1: Example of several network representations.
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NP-hard by reduction to SAT-3 [15]. Also, the scalability of these methods is another
problem to address. Finally, there are several network patterns that are not trivial to
traverse, such as feedback loops.
Because of the potential of these methods, they are analyzed in further detail in the
next chapter, together with pathway enumeration algorithms working over these structures.
There, some of their main limitations will also be further discussed.
4.1.6 Constrain-Based Approaches
As their main advantage in pathway optimization, CBM based approaches avoid the com-
binatorial explosion of possible pathways in graph-based methods, through optimization
based on a selected objective function. Furthermore, the constraints imposed in the sys-
tem are able to guarantee that the obtained solutions are stoichiometrically valid and obey
steady-state. However, a limitation is the capability to determine only a single solution
and, therefore, in this regard have similar limitations to the shortest path approaches based
in regular graphs. Indeed, these methods do not enumerate exhaustively other alternative
solutions, which may offer valuable information on alternative routes.
A lot of effort has been put in the past years to reassemble MNs of organisms. These
networks can be distinguished in two distinct categories, which are related. The term
Genome Scale Network Reconstruction (GENRE) refers to a structured knowledge base
for a specific network model (either a single organism or a community) [37]. These GENREs
contain information that can support the creation of a mathematical model, denoted as
a Genome-scale Metabolic Model (GSM). A GSM contains specific information related to
the biochemistry of the model which varies in the context of the model. In CBM, these
would be the constraints of the system, such as uptake boundaries for each reaction.
An an example, the KEGG database referenced earlier contains information about
multiple organisms, including a network of chemical reactions most of them annotated
with their corresponding enzymes and genes. These knowledge bases can be the basic
building blocks to build a GSM for a specific organism [52].
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4.1.6.1 Flux Balance Analysis
FBA is mainly used to conduct phenotype simulations, calculating flux distributions for
different environmental and genetic conditions. By maximizing specific flux values, it can
also be used to calculate the potential maximum/ minimum values for specific fluxes under
the defined constraints. This is useful, for instance, to calculate maximum production
values for specific compounds.
The analysis potential of the FBA is limited. The relevant information attainable from
this method is the value of the objective function, while the flux distribution obtained
may in some scenarios be just one of the many possible alternatives with the same optimal
objective value.
FBA can be used for pathway optimization, returning a possible path (if it exists) that
maximizes the used objective function. However, a MN may contain several alternative cir-
cuits to perform a certain task that could be alternative optima for FBA, or even solutions
that return lower values for the defined objective function.
Nevertheless, FBA may be used as a valuable tool to be incorporated in other methods,
since the computation of the optimal flux distribution is usually cheap. Among many other
applications, within pathway optimization, FBA was used to determine producible non-
native compounds [18] by merging a GSM with large databases such as KEGG, allowing
to infer putative heterologous reactions for defined purposes.
4.1.6.2 OptStrain
In the context of synthetic pathway design, the OptStrain algorithm [101] is a CBM based
approach to search for heterologous pathways, i.e. to discover a set of reactions to add
to a host GSM to allow the optimal production of a non-native compound. Compared to
FBA, while keeping steady-state conditions, it uses a different set of constraints to search
within a domain of reactions and metabolites (assembled by the authors from the KEGG
database) for the pathway with the smallest number of heterologous reactions, but with
highest yield in the production of the target compound. This method is composed by four
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steps to design such pathways. A first step is dedicated to preprocessing and building the
search domain, while the following steps are related to the optimization tasks.
Step two solves a LP to find the maximum theoretical yield. This step is important to
identify if the problem is feasible and also to acquire the maximal flux value a solution may
attain and is obtained with a formulation very similar to the one shown above for FBA,
changing the objective function to maximize the production of the target compound.
The third step (Definition 19) involves solving a Mixed-Integer Linear Programming
(MILP) problem that allows to obtain the solution that minimizes the number of non-
native reactions, while keeping the production at maximal levels. The minimization of
non-native reactions is obtained through reaction switches from the last three constraints
(4.5, 4.6, 4.7), while the constraint (4.4) ensures the yield value Y ieldtarget is the maximal
theoretical computed from the second task.
Definition 19. (OptStrain) The third step of the OptStrain pipeline is defined by the
following MILP:
min
∑
j∈Mnon−native
yj (4.1)
s.t.
M∑
j=1
Sij.vj ≥ 0 , ∀i ∈ N, i /∈ < (4.2)
∑
i∈<
(MWi.
M∑
j=1
Sij.vj) = −1 , (4.3)
MWi.
M∑
j=1
Sij.vj ≥ Y ieldtarget, i = P (4.4)
vj ≤ vmaxj .yj , ∀j ∈Mnon−native (4.5)
vj ≤ vminj .yj , ∀j ∈Mnon−native (4.6)
yj ∈ {0, 1} , ∀j ∈Mnon−native (4.7)
where Sij is the stoichiometric matrix with i metabolites and j reactions; vj is flux vector;
yj are binary variable assigned to each reaction (on/ off switch); Y ield
target is the maximal
theoretical flux constant; MWi is the molecular weight of the metabolites ; P the product;
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N a set of metabolites; < a set of substrates; M a set of reactions; Mnon−native a set of
reactions flagged as “non native”.
After the identification of a feasible pathway it is necessary to couple to production
of the product with cellular growth. This is achieved in the last step in which involves
the application of the OptKnock algorithm [14] to find a set of knockouts to apply to the
extended host GSM.
4.1.6.3 Elementary Flux Modes
Still within the CBM framework, Elementary Flux Modes (EFM) are defined as the min-
imal subsets of reactions to maintain steady state. Both previously mentioned methods
are objective-based, specifying the cellular or optimization purpose. EFMs allow the enu-
meration of the steady state solution space given a MN. This space confines all possible
routes that a steady state solution may take, which provides valuable insights of cellular
capabilities and network robustness.
This space can be analyzed by considering the entire flux cone which are the extreme
rays of a bounded polyhedron, which is identical to the extreme ray enumeration problem
from computational geometry. The algorithms to enumerate the extreme rays are based on
the Double Description method which is able to compute minimal generating sets. These
minimal flux sets are sets of reactions that require the entire set to maintain the steady
state constraint.
For the computation of EFMs, variants of the Double Description method are used.
The canonical basis approach and the null space approach are two common variants for
the computation of the EFMs, where this last algorithm is an improvement of the previous
for better efficiency.
Although the EFMs offer an extreme valuable analysis tool, their complexity remains a
question. Indeed, the enumeration of all EFMs in a MN is a NP-hard problem [120]. Due to
this fact, the computation of EFMs is restricted to small networks [83]. Figueiredo et al.[25]
propose an enumeration strategy to compute the k -shortest EFMs expanding the size of
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computable problems, but still the enumeration is computationally expensive and restricted
to small values of k. Indeed, database size networks (e.g. KEGG or MetaCyc) still offer
an impossible challenge for exhaustive EFM computation. For large-scale networks (e.g.
GSM), the only option is to apply heuristics to reduce the search space or to use stochastic
approaches [42].
4.1.7 Rule Based Systems
The other facet of MN analysis is the discovery of novel reactions or compounds based on
chemical knowledge. These methods are commonly characterized as rule based approaches
which share a common trait with the atom tracking approach, as they both use chemical
structures to infer pathways, but with the additional capability to infer novel reactions and
compounds.
A rule system applies base rules to classify reactions based on the related enzymes. A
common practice is to use the Enzyme Commission (EC) classification system that involves
four tiers i.j.k.l classification hierarchies [48]. The i class identifies the primary function
of the enzyme, while the j involves in the functional group where the enzyme acts and the
remaining k.l refer to the cofactors and substrates. The application of the first three tiers
generates generalized enzyme rules which are not substrate specific, allowing to apply to a
comprehensive range of biochemical compounds.
This approach is used in Biochemical Network Integrated Computational Explorer
(BNICE) [48] framework to generate novel pathways. A reaction rule is a template re-
action that transforms a certain type of compound into another. Using this approach,
given a set of substrates and matching the reaction rules, it is possible to predict the prod-
ucts. This allows to generate a sequence of possible transformations. A rule based system
allows to predict novel pathways. Such pathways can contain novel reactions that are not
found in chemical databases.
The method developed by Cho et al.[20] predicts pathways by applying several iterations
of reaction rules. The first generation loop applies all rules that match the structure of
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the target compound, which in turn will generate the next set of structures containing
precursors of the target. After several iterations until the predefined limit, a sequence of
chemical transformations are predicted that synthetize the target compound from a variety
of substrates.
A major limitation of the previous methods is the high dependency on the available
information of the chemical reactions. Furthermore, because of the template matching,
these methods generate novel reactions which in turn, increase the number of possible
combinations reaching intractable levels. Also, a higher degree of validation will be required
to validate unrecorded reactions.
4.1.8 Pathway Ranking
Some of the mentioned algorithms, for pathway optimization, rely on a pre-defined objec-
tive function that internally ranks the solutions. However, the set of possible biologically
meaningful criteria to rank solutions is quite vast and different application scenarios will
require a distinct validation. Also, since these methods merely return computational pre-
dictions it is, in most cases, more interesting to provide an enlarged set of solutions.
Thus, we will focus here on criteria to evaluate (and rank) solutions to pathway enu-
meration algorithms. Indeed, graph enumeration strategies do not follow any optimization
criteria, while some use the most basic topological measure: the path length. This implies
that, after the computation, solutions should be scored based on biological criteria.
The ranking methods vary with the problem context. For chassis independent analysis,
the size of pathway, thermodynamic feasibility and maximum achievable yield are common
ranking criteria [86]. The pathway size is usually denoted by the number of reactions in the
pathway. Thermodynamic feasibility is attained by computing the Gibbs free energy change
of each reaction in the pathway. Lastly, the achievable yield is computed by the maximum
flux value of the product divided by the flux value of the supplied carbon source (e.g., if
the flux value of the product is 3 mmol/gDW/h with consumption of 2 mmol/gDW/h of
glucose, then, we would obtain a yield value of 1.5).
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The coupling of synthetic pathways to other information about cellular mechanisms may
involve more analysis methods, in which are related to the chassis. In the DESHARKY
[108] algorithm, the genetic load is also taken into consideration by calculating the energy
loss in transcription and translation.
Furthermore, an important evaluation is to assess the computed pathway by integrat-
ing these in the GSM of the host microorganism. This will allow to conduct phenotype
simulation to compute the in silico predicted performance of pathway.
The computation of ranking criteria may involve more information than the given from
the optimization process (e.g., genes, enzymes and organisms that associated with the
reaction). Such information may not be attainable in some scenarios due to lack of high
quality curated data.
4.2 Set Systems Algorithms
In this chapter, a detailed description of the set systems algorithms (i.e., SSG and FP) is
addressed. In both cases, the original algorithm will be described first, together with the
limitations found. Afterwards, the proposed improvements towards better computational
efficiency will be described.
Beforehand, a set of definitions is presented for a more formal definition of the synthetic
metabolic problem.
4.2.1 Problem Definition
In the following, metabolic networks will be composed only by metabolites and reactions.
In this system, metabolites are the vertex entities, while reactions are represented by an
ordered pair 〈M1,M2〉, that connects two disjoint sets of metabolites.
Definition 20. (Reaction Simplified) A reaction is simplified to an ordered pair 〈M1,M2〉
of two disjoint sets of metabolites (i.e., M1∩M2 = ∅). The first set represents the reactants,
while the second represents the products.
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Definition 21. (Metabolic Network) A metabolic network Σ is a pair composed by a set
of metabolites Π and a set of reactions Υ .
In the set systems context, the reaction is only defined with compounds. A reversible
reaction r is represented by including another entity r′, such that the metabolite sets are
swapped. Additionally, a network Σ ′ = 〈Π ′, Υ ′〉 is defined as a subnetwork of Σ〈Π,Υ 〉 if
every element of Σ ′ is contained in Σ (i.e., Π ′ ⊆ Π and Υ ′ ⊆ Υ ), then Σ ′ ⊆ Σ.
Definition 22. (Retrosyntehtic Metabolic Problem) A retrosynthetic metabolic problem Γ
is defined by a triplet 〈Σ,S, T 〉, where Σ is a metabolic network that represents the search
space, while S and T are two disjoint sets of metabolites (i.e, S ∩ T = ∅) which are
the constraints of the heterologous pathways. The set S keeps the initial substrates (e.g.,
supplies or raw materials), while the set T defines the target compounds of interest.
A heterologous pathway is a set of reactions, in most cases a subnetwork of a larger
network (defined as the search space), that satisfies the following conditions.
Definition 23. (Heterologous Pathway) A heterologous pathway σ of a synthetic problem
Γ is any network (or subnetwork) Σ = 〈M,R〉, such that: a) the product set T is included
in M , i.e., T ⊂M and b) for every metabolite m in the subnetwork that is not included in
the substrate sets of Γ (i.e., M − S) there is a reaction r in R such that m is a product of
r.
The heterologous pathway definition is not sufficient to guarantee that the solution is
feasible, because it omits the stoichiometry of the reactions. Both algorithms addressed
in this work do not take into account this property for the computation of heterologous
solutions. This eventually will lead to the computation of unfeasible solutions that later
can be verified by applying FBA.
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4.2.2 Solution Structure Generation
4.2.2.1 Original algorithm
The Solution Structure Generation (SSG) algorithm (shown as Algorithm 4) enumerates
heterologous pathways of Γ by recursively branching all possible combinations. This tech-
nique, denoted as decision mapping, can be described as follows: let Σ ′ be a subnetwork
such that condition a) in Definition 23 verifies. Then, in order to fulfill condition b), the
sub-problem Γ ′ is solved producing the unsatisfied metabolites in Σ ′. Given for example
Σ = 〈T, ∅〉, a network containing T and no reactions, then a) trivially verifies. Then,
℘(producers of t), t ∈ T where ℘(X) denotes the power set of X, are candidates for partial
solutions of Γ , since if solutions of Γ exist, at least one element of ℘ eventually must be
present in one or more solutions of Γ . Recursively, we solve the sub-problem Γ ′, with the
new target set T ′ = R − S −M , where R is the set of reactants of the newly introduced
reactions (minus the initial set S and producible metabolites in the partial solution), until
eventually either there are no possible reactions to add (this implies that we have reached a
dead end that happens when we pick a producer of T that does not belong to any solution)
or T = ∅ which implies that we achieved a solution.
Algorithm 4 Solution Structure Generation
1: procedure SSG(T,M, δ[M ])
2: if T = ∅ then
3: return δ[M ] . δ[M ] is a solution structure
4: let x ∈ P
5: C ← ℘(∆(x))\{∅} . Generate all combinations of ∆(x)
6: for c ∈ C do . For each combination test if is valid
7: if ∀y ∈ m, c ∩ δ(y) = ∅ ∧ (∆(x)\c) ∩ δ(y) = ∅ then
8: δ[m ∪ {x}]← δ[m] ∪ {(x, c)}
9: SSG((p ∪ ϕ−(c))\(R ∪m ∪ {x}),m ∪ {x}, δ[m ∪ {x}])
10: return
There are several limitations of the SSG method. The first is the high amount of
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memory that is required to compute power sets which grow exponentially with the number
of elements (2n). Additionally, this generates an extensive amount of possible combinations.
If the network is not pruned, meaning that the network contains reactions that do not
belong to any solution, then the algorithm may contain branches that return no solutions
and, depending on the depth of these branches, this increases severely the computation
time to obtain solutions. Friedler et al.[40] proposed a polynomial algorithm to prune
process graphs to remove all reactions that might exhibit such behavior. Because of these
limitations, in the next section, we propose some modifications to the original algorithm
in order to be able to compute larger networks.
4.2.2.2 Improving SSG by computing minimal solutions
The major bottleneck of the SSG algorithm, is the computation of the power set (line 6
in Algorithm 4). Furthermore, because of the union closure property of the solutions, it
implies that every combination of two distinct solutions σα and σβ is also a solution (i.e.,
σα ∪ σβ is a valid solution). This severely increases the amount of candidate solutions and
the computation complexity of the problem.
We propose modifications to this algorithm in such way that: a) we compute only
minimal solutions; and, b) we generate partitions of the power set instead of generating
the entire set. A minimal solution is a solution that satisfies the steady state condition
and no reaction can be removed from it. From a graph extraction viewpoint, a minimal
solution implies that it cannot be disassembled into sub solutions. The condition b) allows
to reach a) as it will be explained below.
Let us consider ℘n(X), which filters the power set in such way that it contains only the
subsets with n elements. Then, instead of performing C ← ℘(∆(x))\{∅}, we loop through
n = 1 to |∆(x)|, by assigning C ← ℘n(∆(x)). This is equivalent to the line 6 of the SSG
algorithm, with the advantage that we do not hold in memory the entire power set during
the search.
We conjecture that, assuming a solution exists for a combination c ∈ ℘i(X), then every
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combination of higher degree ℘i+1(X), that contains c, can be excluded, as these do not
generate the minimal solution.
Example 12. If X = {a, b, c} is a set with 3 elements, where ℘(X) = {∅, {a}, {b}, {c},
{a, b}, {a, c}, {b, c}, {a, b, c}}, then ℘0(X) = {∅} is a subset of ℘(X) with sets of 0 elements.
Subsequently, ℘1(X) = {{a}, {b}, {c}} is the subset with all sets of 1 element and so on.
Note that, for ℘(X), every ℘n(X), where n > 3, is the empty set (i.e., ℘4(X) = ∅).
Given Example 12, assuming a, b, c are reactions, if we are able to find a solution for
the singleton set {a}, then we exclude combinatorial sets with a (e.g., {a, b}, {a, b, c}).
This allows to remove many, if not all, non minimal solutions thus severely increasing the
capability of the SSG algorithm to perform well over larger domains.
4.2.3 Find Path
4.2.3.1 Original algorithm
The Find Path (FP) algorithm proposed by Carbonell et al.[15] enumerates pathways
by using hypergraphs. In a metabolic context, both hypergraphs and process graphs are
similar (Definition 24). A solution of the FP algorithm is defined as a hyperpath (Definition
25). P , which is an hypergraph (i.e., a subgraph) where the hyperarcs (reactions) can be
ordered as r1, r2, . . . , rm, such that ri is dependent only on the substrates in S and the
products of the previous reactions.
Definition 24. (Hypergraph) A hypergraph H = 〈V,E〉 with vertices V and hyperarcs E,
can be defined in this context to be isomorphic to a metabolic network Σ (Definition 21),
where V represents the set of metabolites Π and E the set of reactions Υ . Additionally, a
hyperarc has a structure to a reaction (Definition 20), both encompassing two disjoint sets
of vertices 〈V1, V2〉 (each vertex corresponds to a metabolite).
Definition 25. (Hyperpath [15]) A hyperpath P going from a source subset SH of V to
a target subset TP of P in a hypergraph H = 〈V,E〉 is a hypergraph HP = 〈VP , EP 〉 with
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Figure 4.2: An example of a cyclic network. Vertex s0 is the input substrate and t0 the
target metabolite. Circles represent metabolites and vertical bars represent reactions. (a)
a network that does not contain pathways to produce neither p0 nor p1, leading to an
infeasible problem to the FindPath algorithm, since no ordering is possible for reactions
r0, r1. (b) the same network but now containing a pathway H0 producing p0.
VP ⊆ V , EP ⊆ E, such that there is an ordering F of the hyperarcs EP with the following
properties:
• ∀k ∈ {0, . . . , |F |}, substrates(Fk) ⊆ SH ∪ (∪j<kproducts(Fj))
• TP ⊆ SH ∪ (∪eq∈Epproducts(e))
While addressing many of the problems of using shortest paths over regular graphs
to represent metabolic pathways, this representation still has limitations. Indeed, not
all pathways can be expressed by the definition of an hyperpath (Definition 25). Let us
consider for instance co-factor metabolites ma and mb.
Usually, these metabolites are both present in a single reaction r0 = 〈M1,M2〉 where
p0 ∈ M1 and p1 ∈ M2 or vice versa (Figure 4.2). These reactions can be satisfied by each
other in a way where there is an r1 = 〈M ′1,M ′2〉 such that p1 ∈M ′1 and p0 ∈M ′2. Therefore,
it is impossible to sort a hyperpath if neither p0 or p1 are included in S. Given the example
in Figure 4.2a, assuming s0−m0 and m2−t0 is feasible, then, s0−t0 should be also feasible.
But a hyperpath (Definition 25) dictates that reactions (or hyperarcs) in the hyperpath
must be sortable in a particular order, where given any reaction Fk it must be satisfiable
by the previous instances of Fj, j < k or the initial set of substrates SH . Now considering
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the two reactions r1, r2, this condition could never be achieved since they are dependent
of each other. Examples of these metabolites are the pairs ATP-ADP and NADH-NAD.
Fortunately, if assuming S to be an organism chassis (host), these metabolites are usually
included in S since they are part of the metabolism. However, this does not guarantee
that other more complex cycles do not exist.
This issue enables the generation of redundant solutions. Let Γ = 〈Σ, {s0}, {t0}〉 be a
retrosynthetic problem. Assume that: a) a heterologous pathway Σ ′ ⊂ Σ exists from s0 to
t0, such that b) r0, r1 ∈ Σ ′, where r0 = 〈{m0, p0}, {m1, p1}}〉 and r1 = 〈{m1, p1}, {m2, p0}〉.
The FP algorithm can only identify such pathway if Γ ′ = 〈Σ, {s0}, {p0,m0}〉 is feasible. In-
stead of reaching from s0−m0 as it should, the algorithm will eventually find a workaround
route from s0 − {m0, p0} (Figure 4.2b). Since r0, r1 satisfy the metabolites p0, p1 of each
other (i.e., r+ r′ = 〈{m0}, {m2}〉) this implies that any effort to produce p0 in Γ ′ is unnec-
essary and every solution that b) verifies may contain multiple redundant solutions (the
reactions included in the solutions are unique but in steady state they are redundant).
The Find Path algorithm (Algorithm 7) makes use of the Find All (Algorithm 5) and
Minimize (Algorithm 6) subroutines. Find All (FA) implements a pruning algorithm that
reduces an hypergraph H to H′, with a special property: the reactions Υ ∈ H′ are sorted
by the definition of a hyperpath. This ordering is only essential to the Find All algorithm
to branch correctly, while it can be discarded (i.e., any order is acceptable) in the Minimize
routine.
The Minimize routine reduces a network to the minimal set of reactions by testing each
reaction in the network H (Algorithm 6, line 7), so that if the reaction is removed from the
network, the set of products is still reachable. This testing mechanism can be achieved by
invoking FA with the new network (i.e., without the reaction to be removed). If FA returns
a solution without the product, then the reaction is assumed to be critical. This implies
that, for each reaction in H, an invocation of FA is performed. Therefore, the Minimize
routine shows quadratic complexity to the number of reactions in the network.
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Algorithm 5 Find All
1: procedure FindAll(H, S) . H hypergraph, S source metabolites
2: for each r ∈ H do
3: m[r]← Ψ−(r)
4: V ← S
5: D ← S
6: F ← ∅
7: while V 6= ∅ do
8: let x be an element of V
9: V ← V \x
10: D ← S ∪ x
11: for each r ∈ H ∧ x ∈ m[r] do
12: m[r]← m[r]\x
13: if m[r] = ∅ then
14: F ← {F, r}
15: for each j ∈ Ψ+(r) ∧ x /∈ D do
16: V ← V ∪ j
17: return F
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Algorithm 6 Minimize
1: procedure Minimize(H, Rf , S, T ). H hypergraph, Rf reactions to not test, S source set, T
target set
2: F ← FindAll(H, S) . 2-4 Test if µ 6= ∅
3: H′ ← H
4: if T ∩Ψ+(F ) = ∅ then
5: H′ ← ∅ . µ = ∅ return ∅
6: else . µ 6= ∅ proceed to minimization
7: for each r ∈ H do . For each reaction not in Rf test if µ 6= ∅ for H\r
8: if r /∈ Rf then
9: F ← FindAll(H\r, S)
10: if T ∩Ψ+(F ) 6= ∅ then
11: H′ ← H′\r . Remove reaction from hypergraph
12: return H′ . Return either ∅ or a minimal solution structure of H
4.2.3.2 Improved Minimize Heuristic
In this work, we propose an alternative to the Minimize heuristic that aims to overcome
the problem of its quadratic computational complexity. We address this issue by proposing
a different heuristic to test the reactions in the Minimize routine.
Assume that Γ = 〈Σ,S, T 〉 contains valid solutions that are searchable using the Find
Path algorithm. Assume that we increase the size of the search space to Σ ′ = 〈Π ′, Υ ′〉,
where |Υ ′| is much larger than |Υ |. This also implies that the previous searchable solutions
of Γ are preserved, since it is impossible to invalidate a solution by adding more reactions
to the search space. The computational cost of the previous solutions in Γ will eventually
increase because of: a) there are more reactions in the new network to test, therefore
the computational cost of Find All increases; and, b) the Minimize now contains more
reactions to remove in order to achieve the previous minimal solutions of Γ . Furthermore,
it is natural that new solutions may be possible because of the newly added reactions in
Υ ′.
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Algorithm 7 Find Path
1: procedure FindPath(H, Rf , S, T ) . H hypergraph, S source metabolites, T target
metabolites, Rf for branching solutions (initially as ∅)
2: F ← FindAll(H, S)
3: H′ ← ∅
4: H′ ← H′ ∪ F ∪Rf
5: Hσ ←Minimize(H′, Rf , S, T ) . Hσ the first minimal solution
6: En← ∅
7: if Hσ 6= ∅ then
8: En← Hσ
9: F ← FindAll(Hσ, S)
10: for k ∈ {|F |..1} do . for each element in F (i.e., hyperarcs of Hσ) branch
alternative solutions
11: r = Fk
12: if r /∈ Rf then
13: En← {En, FindPath(H\r,Rf , S, T )}
14: Rf ← Rf ∪ r
15: return En
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Our goal is to reduce the penalty to compute solutions when adding more reactions to
the set. Instead of testing each reaction r (Algorithm 6, line 7), we test the removal of
an entire set R of reactions. This speeds up the computation cost, specially in the search
of the smallest solutions in huge networks generated from large databases, such as KEGG
and MetaCyc. The size of R is an important factor, since it impacts the speed up obtained
by the bulk removal of reactions.
We follow the strategy of the bisection optimization method to find the reactions that
cannot be removed, thus generating a minimal set of reactions. Let X be the entire set
of reactions in a network, we split X into two halves XL and XR, we attempt to remove
from left to right each half. If XL cannot be removed, i.e., if by removing XL the Find
All routine returns a sequence without the set T , this implies that XL contains a reaction
that must be present in the minimal solution; otherwise, there is no solution possible.
Then, we split XL into further halves X ′L, X ′R and perform again the Find All test. This
routine is recursively performed until either the entire subset can be removed or we have
a singleton set that cannot be removed, which implies that the reaction belongs to the
minimal solution. This will generate a tree pattern where the leafs are either a singleton
set with only one element (i.e., the reaction that belongs to the minimal solution) or sets
of reactions that were discarded.
No modifications were made to the main Find Path algorithm.
4.3 Case Study
4.3.1 Setup
The algorithms were tested through their application to three case studies of synthetic
metabolic engineering. The first example is the production of 1-butanol using E. coli [5],
the second concerns vanillin synthesis using S. cerevisiae [46] and last the biosynthesis of
curcumin in E. coli. Both modified SSG and FP algorithms are applied using the set of
compounds in the KEGG Ligand and MetaCyc databases as the chemical search space.
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Additionally, to integrate and test the obtained solutions in silico, a GSM is required:
the iJO1366 [97] GSM for E. coli and iMM904 [88] GSM for S. cerevisiae were used. In
both cases aerobic conditions were used with an uptake flux of glucose of 10 mmol/gDW/h.
Therefore, a total of 12 result sets were generated for the two algorithms, three case studies
and two search spaces (databases).
Before running the algorithms, several pre-processing tasks were required. The first
was to select and define the constraints of the problem, selecting the search space Σ, the
initial set S and the target compounds T . For all case studies, the target set is a singleton
containing only the compound of interest (i.e., 1-butanol, vanillin and curcumin). For the
substrate set, all metabolites included in the GSMMs were selected. This later will allow
to integrate the obtained solutions with these models and evaluate their performance. The
BiGG database [110] aided in the transformation of the species identifiers of the model
to those in the databases. The species that did not match any cross-referencing were
discarded.
Part of the reference pathway of the 1-butanol synthesis was mostly present in the
iJO1366 GSMM as part of the Membrane Lipid Metabolism pathways. So, to obtain
alternative pathways, we removed the following species: M btcoa c (Butanoyl-CoA), M
btal c (Butanal), M b2coa c (Crotonyl-CoA), M 3hbcoa c (3-hydroxybutyryl-CoA), M
aacoa c (Acetoacetyl-Coa). Additionally, every reaction connected to these compounds
was also removed. The impact in the biomass value calculated using the FBA was minimal
(less than 1%). Removing these species will allow to find alternative paths from other
internal metabolites of iJO1366 to 1-butanol. This is done because we wanted to reach
alternative solutions to the identified in [5], which may not be optimal, depending on the
desired criteria. Furthermore, the algorithms do not generate solutions with reactions
producing substrates in the initial set, since these are defined as supplied compounds. The
curcumin case study required a new substrate in the medium, which involved the addition
of a new metabolite to the iJO1366 GSMM, the ferulic acid.
A minor modification was made to the MetaCyc database, since it contains reactions
with the metabolite pairs NAD-P-OR-NOP/NADH-P-OR-NOP which are an instance of either
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NAD/NADH or NADP/NADHP. These reactions were unfolded to their correct instances. This is
essential for instance to infer the 1-butanol reference pathway, as several reactions of this
pathway were expressed in this format. The KEGG Ligand database did not require any
pre-processing.
Both algorithms and the described modifications were implemented in Java according to
the algorithms previously defined. All experiments were run on a machine running CentOS
6.4 (Linux 2.6.32) with two Intelr Xeon X5650 (2.66 GHz) and 64GBytes of memory. The
java programs were compiled and run with JDKTM7 (version 1.7.0 45). The implementation
of FBA and other CBM related methods over GSMMs was taken from the core packages
of the OptFlux ME platform [107] (version 3.1). The CPLEX solver (version 2.14) was
used to perform the linear optimization tasks related to FBA. The KEGG information was
obtained from the release 68.0 (October 1, 2013) and the MetaCyc database was taken at
the same time period (release 17.5, October 11, 2013).
Because of the combinatorial explosion of possible pathways, it is impossible to obtain
every solution existing in a database size network using any of the algorithms. To compare
the algorithms’ performance, the search space was split into subsets by radius. The radius
is an integer that defines the minimum number of links (i.e., reactions) required to reach
that reaction from an initial set of metabolites. This implies that a reaction belonging to
radius i also belongs to i + 1, and therefore a subnetwork Σi of radius i always complies
to Σi ⊆ Σi+1.
With these reduced search spaces, solutions were computed using each of the algorithms.
An attempt was made to obtain the entire set of candidate solutions for each radius, until
either the process crashed due to lack of memory or exceeded computational time allotted
(> 24 hours). To validate the solutions, FBA was used to maximize the product flux of
the target compound and validate its feasibility integrating the solution into the respective
GSMM
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Figure 4.3: Pathways computed for each of the problems by radius.
4.3.2 Results
Figure 4.3 shows the number of solutions computed and their feasibility. SSG is more
limited than FP by the size of the search space. A major problem of the SSG algorithm
is the high memory demand because of the power set computation. With the reduction of
the power set size (only partial sets are computed), it still presents high memory demand
to branch all the possible combinations. Moreover, the SSG computes every solution that
satisfies Definition 23 which eventually leads to the computation of infeasible pathways.
Still, in general, the SSG shows better performance in the computation of solutions
(Figure 4.4) mainly because of the branching technique which gives a major advantage to
the computation time per solution because of the backtracking. As the algorithm moves
to a candidate solution, the next solution reuses the previous partial solution. This results
in a neglectable impact on the computation time per solution as the search space increases
(i.e., increasing size of the radius). However, since the number of solutions exponentially
grows with the increasing size of the search space, the total computation time increases.
The FP is capable to compute larger search spaces, being the major bottleneck the
computation time per solution, since the internal Minimize routine has quadratic complex-
ity to the number of reactions [15]. A scenario was also found where FP computes multiple
distinct redundant solutions, due to the problems explained above in detail.
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Figure 4.4: Time cost (milliseconds) per each solution. On the x-axis is the search radius
(a higher radius implies a larger search space).
Table 4.1: Number of solutions obtained for the curcumin case study (on the left the
number of solutions feasible with the iJO1366 GSM). For the KEGG dataset, solutions
are up to radius 5 and 3 for FP and SSG, respectively. The MetaCyc dataset was fully
computed.
FindPath SSG
Total Feasible Total Feasible
KEGG
285 217 5 5
MetaCyc
10 7 10 7
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The curcumin case study revealed a much smaller solution diversity (Table 4.1) since
the amount of solutions is highly dependent on the diversity of reactions in the search
space. Curcumin is a compound found originally in a few plants and thus the diversity of
pathways for its production is still low. Both SSG and FP were able to fully compute the
entire dataset of reactions in MetaCyc obtaining just a few solutions. The FP method was
able to compute a much higher amount of solutions using the KEGG reaction set; however
the SSG was unable to pass the 4th radius having only five solutions in the 3rd radius of
the KEGG search space. The KEGG dataset showed increased complexity compared to
the MetaCyc reactions which led the SSG algorithm to block due to memory limitations.
Again the FP algorithm prove to be more capable of obtaining complex pathways mostly
due to the assumption that pathways are acyclic.
For every solution that satisfies the feasibility test, the fitness was evaluated by inte-
grating it into the corresponding GSM. The farthest radius that either algorithm was able
to compute was selected for this process. For the 1-butanol case, from the 42482 and 60356
solutions obtained from the FP algorithm, a total of 32692 and 22968 were compatible with
the iJO1366 GSM for search spaces of MetaCyc and KEGG, respectively. In the vanillin
case, 944 out of 974 computed solutions are valid (MetaCyc), being the numbers for KEGG
of 1600 out of 1852. Finally, for the curcumin pathways 217 out of 285 KEGG pathways
and 7 out of 10 MetaCyc pathways were feasible with the iJO1366 GSM. The 1-butanol
case shown a massive amount of solutions mostly because of the NAD/NADH alternatives
for many reactions.
The KEGG dataset provided the solution with highest yield for vanillin and curcumin.
Moreover, 152 pathways were found in KEGG with the maximum yield for 1-butanol (0.99,
given by 9.99 mmol/gDW/h for the butanol production flux divided by 10 mmol/gDW/h
for glucose uptake) compared to 114 pathways from MetaCyc, while for the curcumin
case study the amount of solutions obtained from MetaCyc is quite limited. There is
a noticeable difference in the configuration of the yield distribution between KEGG and
MetaCyc (Figure 4.5), which demonstrates that there are key reactions that are unique to
each database, therefore leading to different pathway configurations.
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Figure 4.5: Histogram of theoretical flux values of each case study (1-butanol/curcumin -
iJO1366; vanillin - iMM904). Last value is the optimal solution (for better product flux).
In summary, it can be concluded that overall the algorithms were able to find widely
known efficient pathways but also less utilized ones. For example, in the case of butanol,
the best performing pathways in terms of yield include the commonly used pathway from
Clostridium acetobutylicum, which has also been validated [5] as a heterologous pathway
in E. coli, but also less common pathways that have been recently patented and that use
2-ketoisovalerate as an intermediate [126]. Moreover, pathways that use amino-acids as
precursors have also been identified, such as the one recently described which starts from
glycine [11]. In the case of curcumin, most of the solutions take tyrosine as a precursor, as
has been described elsewhere [67]. Nevertheless, in both cases there are many alternatives
that are stoichiometrically feasible but for which no reports have been found in the litera-
ture. Those cases need to be further inspected for biological and biochemical consistency
before implementation. Nevertheless, they constitute promising alternatives to produce
valuable products.
4.4 Conclusions
The algorithms analyzed (SSG and FP) both present shortcomings in the computation of
heterologous pathways. Although topologically they are correct, they may be stoichiomet-
rically inconsistent within a microorganism’s context, as they have the common goal of
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inferring heterologous pathways (subnetworks) that satisfy the rules of initial substrates
and target product. However, by using post-processing methods such as FBA, stoichio-
metrically valid solutions can be identified, which allows to correctly enumerate multiple
steady-state pathways. The case study of 1-butanol shows that there are many viable
and optimally efficient (regarding yields) routes for the production of this compound using
as basis the iJO1366 model. Moreover, even if a problem contains only a single optimal
solution (e.g., vanillin in iMM904), examples of sub-optimal pathways also show a broad
range of yield value near the optimal. Due to their nature, deterministic methods hardly
can achieve such a range of feasible steady state heterologous pathways.
Overall, the FP has proven to be more flexible regarding the complexity and the size of
the graph, and, although being more penalized with the number of reactions in the search
space, it is more capable to compute larger sets.
Thus, it is shown that although neither of the algorithms is readily suitable to compute
steady state heterologous pathways for large databases, they are still able extract potential
pathways, after targeted improvements in scalability. Additionally, they offer a generic
method to infer pathways for multiple purposes, since they do not follow any strict objective
function (e.g., yield or size).
As future work, both these algorithms can still be improved towards their scalability.
One line of work will certainly be the efficient parallelization of these algorithms resorting
to adequate software development tools [102]. A complementary research topic will address
the comparison of these approaches with recent proposals within EFM research.
Chapter 5
Conclusions
Genome-scale metabolic modeling is highly data oriented, and the completeness of these
models is many times dependent on the existing information to describe either directly or
indirectly the biological mechanism.
Databases are often specialized into a certain topic, and their integration allows to
gather all the individual strengths into a single location for better decision making.
Integration errors are inevitable because of many reasons (poorly described data, am-
biguous definitions, etc). In existing integrated databases, it is difficult to evaluate which
portion of the information is most reliable. The proposed methods allow to control the
certainty of the integration, allowing users to choose which configuration suits best their
needs.
Demanding a high degree confidence level to the integration may generate less clusters.
but it scaffolds a high confidence initial set. The implemented pipeline allows to combine
integrations (because of the curation function), which permits to generate consensus sets
by combining the solution of previous or external integration.
Even though SBML provides a structure to represent GSM entities, the flexibility of
the annotation methods (i.e., both notes and annotation elements) allowed developers to
adopt their own strategies to fit additional data into the models. The 108 models used as
benchmark showed that it is possible to automatically annotate models with a high success
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rate. Still in a few cases, it is also shown that without user intervention, it is unlikely that
there is any chance for automated annotation.
The centralized database provided a rich dataset of metabolite references and names
increasing the chance for annotation. Compound names proven to be essential to integrate
metabolites since genome-scale models usually inherit attributes from the databases.
Integrating compounds, reactions and genes is data intensive. However, the KBase
platform provides these resources saving tremendous effort that otherwise would require
the user to setup. With the entire prokaryote genome catalog of RefSeq, the integration
application was able to automatically integrate the genome features with the genes found
in the GPRs in most of the models, thus allowing to automatically detect the correct
species/strain genome for a given model. In average, most of the examples when methods
failed to identify the correct instances, it implied custom string patterns that were intro-
duced in the models (e.g., concatenation of formula with the name attribute, modified gene
names).
The integration of GSM makes models compatible with each other making compara-
tive analysis studies more viable but also more scalable. Each of these published models
contains many curation efforts to assign metabolic functions to the organism’s genome.
The unification of these models enables large scale knowledge extraction to reuse their
information for future reconstructions.
The complete enumeration of minimal pathways of the entire metabolic space of databases
is unlikely to be possible because of the combinatorial explosion. However, fully enumera-
tion is possible by limiting the size of the pathways this would at least exhaust all possible
solutions within its range. The improvements made to the enumeration methods allow to
scale the methods to much larger problem sizes shifting the bottleneck to memory instead
of computational power.
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5.1 Main Contributions
Metabolic Database Integration Pipeline: The integration pipeline follows a flexible
and configurable approach to unify metabolic databases. The main concern of the pipeline
is to provide a maintainable strategy to have a flexible system that facilitates the synchro-
nization of the reference spaces of the metabolic databases. The high parameterization of
the integration methods allows for a better control of the confidence scores of the given
solutions.
SBML Standardization Application: The module developed for the KBase platform
allows to integrate external SBML models with the KBase system. Since a SBML model
is the only required input data, the application offers a practical approach for any user to
annotate existing models but also to export the matching genome and default simulation
constraints (media).
Minimal Pathway Enumeration Methods: Fully enumeration can be achieved using
graph methods up to a certain size limit of the pathways. The improved searching kernels
allows to increase this limit to a much larger size.
5.2 Future Perspectives
Hierarchy and Ontology: The relationship between compounds is hierarchical, in
many databases this hierarchy is not detailed. Extending the integration to include hierar-
chy would greatly benefit the integrated solution since it would allow to create additional
relationship between databases.
Model Reconstruction: The standardization of models allows to extract curated knowl-
edge about the metabolic features of the organisms. Using existing models to propagate
previous models is a common reconstruction strategy. With the increasing number of cu-
rated models, it provides a rich dataset of annotated metabolic networks of organisms to
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aid future reconstructions.
Integrated Pathway Optimization: Current methods are oriented to find optimal
routes targeted to a single organism. With standardized models it is possible to extend
the methods to optimization against a set of organisms.
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